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Executive summary 
 
 
The role of pharmacists in immunisation and vaccination varies across the world; in some countries 
pharmacists are primarily involved in ensuring the safe supply and dispensing of vaccines, as well as 
advocating for immunisation, while in other countries they are empowered to play a more active role, as they 
are legally authorised organise 
vaccinations activities and campaigns. 
 
It is estimated that ten million lives per year could be saved by increasing access to medicines and vaccinations. 
Community pharmacists are therefore in a strong position to provide a major contribution to public health due 
to their accessibility, distribution and available medicines expertise.  Pharmacists are also highly trusted 
healthcare professionals and can therefore significantly improve communication channels and provide public 
reassurance on product quality. 
 
We conducted a survey, disseminated to 137 FIP member organisations, to gather a better understanding of the 
current role of pharmacists in immunisation across the world and the impact of these activities. 
 
We also provide here a closer look at the immunisation activities undertaken in eleven different countries and 
territories presented as case studies. 
 
Vaccination policies vary across the world; the legal authority to perform immunisation activities currently 
varies significantly across countries and the integration of community pharmacies and pharmacists in national 
vaccination policies tends to develop as a gradual process over time. Strategic and integrated partnerships 
between healthcare professionals are increasingly common and the role of pharmacists as educators, 
facilitators and immunisers is becoming more readily recognised. 
 
Several countries authorise vaccination in pharmacies and/or by pharmacists (for example in Argentina, 
Australia, Philippines, South Africa, UK and USA); this practice has been initiated, in the majority of the cases, 
with pharmacy-based vaccinations against influenza and then expanded to include other vaccines from the 
immunisation schedule. In most cases, it is associated with specific requirements such as pharmacist training, 
management of vaccination records and specifications on premises, equipment and waste management. 
 
Based on the sample of countries presented in this report, 940 million people live in countries where over 
193,000 community-pharmacies can potentially offer access to vaccination services.  In this sample alone, we 
further estimate that currently, pharmacist-administered vaccination services have the potential to reach a 
total global population of 655 million.  These estimates are based on our sample of 45 countries and territories; 
the potential in health gain to have pharmacy-led outreach to global populations is clear and this report 
suggests that community-based pharmacies are safe and high quality vaccination centres. Providing direct 
administration of vaccines, using pharmacists and pharmacies, is a highly effective public health strategy for 
health systems and healthcare planners, complementing the existing service offerings for immunisation. 
 
Pharmacists are trusted healthcare professionals and as such can offer strong advocacy for building societal 
trust in vaccines as essential medicines.  Added to this is the pharmacy-based opportunity for promoting 
immunisation in communities linked with the easy access to vaccination that community pharmacies bring 
and the outreach opportunities for healthcare planners. 
 
On the technical side, and highly significant, is the medicines expertise embedded in the vaccination supply 
chain and storage of cold-chain products; the safety and quality assurance that society demands of vaccines 
also has significant input from pharmacists.  Pharmacists offer convenience, product safety, advocacy support 
and an overall highly impactful contribution to the public health challenges of immunisation and vaccination 
policies. 
 
The continuing trend to authorise pharmacists to provide direct access to immunisation allows policy makers 
to ensure additional resilience for national public health systems.  Unexpected outbreaks of preventable 
communicable disease (from influenza to events such as H1N1) will happen again, somewhere, at some time, 
and pharmacists should be considered as invaluable contributors, together with our healthcare professional 
colleagues, in the delivery, access and administration of vaccines also during emergencies. 
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1 A Focus on Immunisation 
 
Authors: 
Helena Rosado and Ian Bates, FIP Collaborating Centre at UCL and FIPEd Education Development Team. 
 
 
1.1 Introduction 
In 1796, Edward Jenner undertook an experiment on eight-year old James Phipps that was to change the world 
of infectious disease.  The resulting story about this first instance of immunisation against smallpox is well 
known.  The outcomes of this innovation would be published two years later and coined by Jenner as 
1,2,3  The vaccine era had begun. 
 
In 1980 the World Health Organization (WHO) declared smallpox an eradicated disease. This was the result of 
coordinated public health efforts by many people, but vaccination was an essential component.4  Today it is 
estimated that eradication of smallpox currently saves approximately 5 million lives each year.5  Although 
smallpox has been the only successfully and fully eradicated infectious disease to date, other diseases may also 
be potentially eradicated provided that effective vaccination programmes, treatments and diagnostics are 
available. 
 
Between 1990 and 2015, the WHO Millennium Development Goal (MDG4)6 aimed to reduce child mortality by 
implementation of robust strategies such as national and global Expanded Programmes for Immunization 
(EPI).7 Later in 2012, the Global Vaccine Action Plan (GVAP) 2011-2020 was endorsed by 194 WHO Member States 
to stimulate universal access to immunisation.8,9  Poliomyelitis, in particular, is one the infectious diseases 
targeted for eradication, although there are still significant global challenges to be addressed in this area.8,9,10  
Pharmacists have an essential public health role by acting as educators and advisers, facilitating and 
participating in national and global routine immunisation strategies and practices and/or delivering pharmacy-
based vaccinations - these have already been successfully implemented in various countries around the world. 
 
This report presents and summarises the current global trends on the role of pharmacists in immunisation. 
 
 
1.2 Key concepts 
1.2.1 Immunisation and vaccination 
Immunisation is the process whereby an individual becomes immune against an infectious disease either by 
natural contact with an infectious agent or by vaccination (administration of a vaccine to stimulate 
immunisation).  Although immunity against an infectious disease may not be complete, people who are 
immunised or vaccinated are more likely to resist to an infection. 
 
Vaccines are biological preparations containing one or more active and relatively harmless antigens.  These are 
obtained by attenuating or inactivating microorganisms which cause infectious diseases, their products or 
derivatives. When inoculated, the antigens induce active specific immunity protection against the disease 
caused by the infectious agent where the antigen derived from. If an immunised person comes into contact 
with the microorganism, the body will recognise the antigen and produce defences against the vaccine-
preventable disease. 
 
The WHO estimates that vaccination saves between 2 to 3 million lives each year across all age groups;8,11 it is 
one of the safest, more efficient and cost-effective measures for preventing, controlling and eradicating life-
threatening infectious diseases. 
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1.2.2 Vaccine-preventable diseases 
According to the WHO, there are currently over 26 infectious diseases that can be effectively prevented by a 
vaccine:11 
 
Human papillomavirus (HPV) Lyme disease Rubella 
Cholera Malaria Shingles 
Dengue Measles Smallpox 
Diphtheria Meningococcal meningitis Tetanus 
Haemophilus influenzae type b (Hib) Mumps Tick-born encephalitis 
Hepatitis A Pertussis (whooping cough) Typhoid fever 
Hepatitis B Pneumococcal disease Tuberculosis (TB) 
Hepatitis E Poliomyelitis Varicella (Chickenpox) 
Influenza (Flu) Rabies Yellow Fever 
Japanese encephalitis (JE) Rotavirus gastroenteritis  
 
 
1.2.3 Incidence, prevalence, coverage and surveillance 
There are various factors that can have a significant impact on the incidence and prevalence of vaccine-
preventable diseases. Microbes can spread very easily and rapidly, particularly in children, and their generally 
more vulnerable immune status also makes them less likely to efficiently fight against an infectious disease.  
Infection was the major cause of child death before the global implementation of routine vaccination 
programmes which currently effectively protect children from these diseases.6-10  Moreover, the increase in 
travelling (approximately 1 million/day) and the significant number of people at-risk (elderly, chronic disease 
and immunocompromised patients, etc.) also has a considerable impact on the incidence and prevalence of 
vaccine-preventable diseases.12 
 
There is significant evidence that national immunisation programmes have an impact on infection 
prevalence;13  rates of vaccine-preventable diseases are very low where vaccinations programmes are very well 
established, particularly in developed countries where there is easier access to vaccines and vaccination 
services.  Vaccination has contributed, for example, to the eradication of smallpox, the decrease in the global 
incidence of polio by more than 99%, and neonatal tetanus by 94%.9 
 
Changes in infection incidence and prevalence are strongly associated with immunisation rate and coverage; 
these parameters are also primary indicators of success in implementation of national and global vaccination 
programmes.  Nevertheless, low immunisation rates and coverage are still major public health concerns and 
there is a need to stimulate global efforts to increase vaccination and to evaluate the impact of these initiatives.  
Adequate surveillance is crucial to identify people and populations at risk of contracting an infectious disease 
and to oversee any significant changes in levels of vaccine-preventable diseases. 
 
 
1.2.4 Why is vaccination and immunisation important? 
The basic principle for the elimination and/or eradication of any communicable disease by vaccination is to 
have an effective vaccine and to act on the maximum number of individuals who are susceptible to the disease.  
From an epidemiological perspective, individual actions are not sufficient and therefore effective promotion 
through vaccination campaigns is also essential to encourage/stimulate an effective response. 
 
In addition to personal protection, vaccination also brings benefits to the whole community; when the majority 
of a population is immunised, transmission of disease is interrupted.  This is particularly important to protect 
those individuals who are unable to be vaccinated due to health reasons (e.g. people with allergies or 
immunocompromised patients) or who did not respond to immunisation. 
A number of infectious diseases have become extremely rare because of vaccination (e.g. poliomyelitis);8,9  there 
are currently great efforts to efficiently diagnose and treat several infectious diseases which, together with 
successful vaccination programmes and strategies, may lead to eradication of other diseases.  However, there 
remain challenges in some societies and immunisation cover has not always been fully embraced by some.  
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1.2.5 Immunisation barriers and challenges 
Barriers to immunisation may have a significant impact on vaccination rates and, consequently, to the 
incidence and prevalence of vaccine-preventable diseases.  They are also likely to affect the implementation of 
effective strategies for vaccination and surveillance as well as the accomplishment of national and global 
immunisation goals.  It is therefore essential to better understand these barriers and challenges to enable the 
development of more tailored and efficient interventions to improve immunisation.  A number of studies have 
focused on investigating the main factors that affect vaccination rates and the best strategies to overcome 
them (Table 1). 
 
Table 1: Perceived barriers and challenges to immunisation. 
Perceived barriers and challenges 
Individual factors 
Misinformation/lack of accurate information about vaccination 14,15,16 
Lack of understanding of the importance/benefits of vaccination 14,17 
Concerns about the risks and adverse effects of vaccination 14,16,18 
Belief that vaccinations cause infectious disease and/or other health conditions (e.g. autism) 14,19 
Belief that vaccines are not effective and/or do not provide sufficient protection against infection 19 
Cultural and religious beliefs 14 
Fear of injections 14,19 
Language and communication barriers 16 
Poor communication with/by vaccination providers 17 
Vaccination process 
Lack of a strategic and integrated response from all healthcare professionals 19 
Complex vaccination schedules 14 
Missed vaccination appointments 14 
Forgetting that additional or booster vaccines are required 14 
Reduced/limited accessibility to vaccination providers 19 
Difficulty to schedule vaccinations appointments 17 
Lack of accurate and complete immunisation records 14 
Vaccination system 
Limitations in vaccination storage or capacity 14 
Cost and lack of/inconsistent vaccine reimbursement schemes 14,16,20,21 
Factors affecting the supply and distribution of vaccines (e.g. lack of manufacturing capacity, 
misdistribution) 14 
Financial constrains (particularly in situations of financial crisis and severe austerity measures leading to 
significant cuts to the healthcare system) 20 
Legal constraints 20 
Lack of political commitment 22 
Legislation, regulation or administrative constraints 20,23 
Humanitarian emergencies - refugees, asylum-seekers and migrants situations 24,25,26 
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Proposed strategies to overcome barriers/ challenges 
Individual factors 
Improve communication methods, inform and motivate communities 15 
Increase access to vaccine information and adequate communication by creating robust distribution 
systems that effectively reach their audiences 16,18 
Organise effective advocacy and promotional initiatives across the healthcare sector 15,16,22 
Provide education and training opportunities for healthcare professionals and to the public 15,16 
Deliver and facilitate risk communication and evidence-based communication 18 
Effectively communicate the risks and benefits of vaccination 14 
Characterise existing beliefs by questioning, address concerns and encourage questioning 18 
Build public trust by keeping information simple, clear, credible and consistent across healthcare sectors 
16,18,22 
Vaccination process 
Improve access to vaccination services - offer vaccinations at multiple locations and times 16,19,23 
Improve collaboration and partnership between all healthcare professionals 19 
Implement robust reminder/recall systems shared by all healthcare professionals 14,16 
Improve vaccination record systems 14 
Vaccination system 
Improve vaccination infrastructure 14 
Improve legislation and regulation interventions involving changes in vaccination policies 23 
Establish well defined vaccination policies 19 
Obtain political commitment to emphasise the importance of vaccination 22 
Implement fair reimbursement systems 14,16 
Strengthen and improve surveillance and monitoring of vaccination coverage rates 23-26 
Establish role models, vaccination advocates and champions; involve leaders and senior staff to encourage 
vaccination 23 
Measure and feedback/report vaccination coverage rates 23 
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2  contribution to immunisation 
 
Authors: 
Helena Rosado and Ian Bates, FIP Collaborating Centre at UCL and FIPEd Education Development Team. 
 
 
2.1 Introduction 
Pharmacists can provide a major contribution to public health by playing active roles in immunisation. The 
accessibility and distribution of community pharmacies make them a first point of contact with patients, 
providing an excellent opportunity to expand and increase access to immunisation services.  Another major 
advantage is the convenient opening hours of community pharmacies; this can be very attractive to both 
working and non-working individuals and particularly important in rural, isolated and medically underserved 
areas, where access to vaccination points can be very challenging. 
 
In some jurisdictions in Canada, flu vaccination rates have risen dramatically as a consequence of the increased 
service accessibility and convenience offered by community pharmacies.1  In Portugal, since the first year of 
implementation of the service, around 40% of all sold flu vaccines are administered in community pharmacies.2  
In USA, ten years after the implementation of pharmacy-based vaccination, vaccination rates more than 
doubled in young adults also reinforcing the advantages of the service provided. 3 
 
It is estimated that ten million lives per year could be saved by increasing access to medicines and 
vaccinations.4 For many years, pharmacists supported immunisation efforts through advocating and 
promoting vaccination to participating in the supply chain management of vaccines but, given regulation, were 
not engaged in the provision of vaccination services - these being exclusive to hospitals, do
health centres.  Today, pharmacists in many countries and territories are involved in immunisation activities 
through administering vaccines. 
 
The role of pharmacists as educators, facilitators and immunisers is particularly important during pandemics 
(e.g. influenza) and/or other challenging situations that may significantly affect the morbidity and mortality of 
the general population.5  Vaccination policies tend to vary across the world; the legal authority to perform 
immunisation activities can vary significantly across countries and territories and the integration of 
community pharmacies and pharmacists in the vaccination policy tends to develop as a gradual process over 
time.  Nevertheless, a significant number of countries and territories have been actively involved in this type of 
activities and helping to tackle a significant number of vaccination barriers and challenges. 
 
Community pharmacies are in a strong position to lead on vaccination advocacy and promotion campaigns, 
effectively communicating the risks and benefits of vaccination and educating patients and the community 
about immunisation.  Their high visibility and accessibility positions community pharmacists at the heart of 
the healthcare system and in a strong position to deliver, communicate and disseminate positive messages 
about vaccination.  It is estimated that, only in the European Union, 46 million people visit a community 
pharmacy every day; this translates into around 400,000 community pharmacists contributing to the health of 
over 500 million people.6 
 
Pharmacists can also more easily identify patients at higher risk and specific target groups for vaccination, 
providing the necessary advice and actively participating in reminder and recall systems to ensure that 
vaccination schedules are met and regional/global goals achieved. 
 
CPhA) strongly encourages pharmacists to take an active role on 
advocacy and immunisation promotion activities.  The profession gained the acceptance from the public, with 
88% of Canadians trusting pharmacists to provide advice on vaccinations.  From a public health perspective, a 
national immunisation strategy is one of the three top advocacy priorities for CPhA.7,8 
Pharmacists can also be very much involved in vaccine supply policies, from manufacturing to procurement, 
storage and distribution. Inappropriate procedures may compromise the supply chain and put vaccines at risk 
of degradation.  For this reason, explicit legal requirements, comprehensive guidelines or recommendations as 
well as robust procedures should be in place during the process.  Pharmacists can be pivotal to ensure that high 
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quality cold chain storage systems are established and efficiently maintained throughout the whole supply 
chain. 
 
In the UK, pharmacists are actively involved in the supply chain.  In primary care in particular, pharmacists can 
be responsible for the re‐ distribution of vaccines in areas where there are fewer vaccines than required.  In 
Scotland, community pharmacies successfully control the complete supply process of all the seasonal flu 
vaccines  surgeries, from procurement and purchasing to distribution 
and delivery, ensuring the maintenance of the cold chain.9 
 
Throughout the years, a number of countries and jurisdictions have allowed pharmacists to play a key role in 
administering vaccines. A resolution from November 1958 authorised pharmacists in Argentina to administer 
intramuscular or subcutaneous injections under medical indication.  Later, this regulation was extended and 
ratified to incorporate specific details on vaccination in pharmacies and by pharmacists as well as 
-study Part 3). 
 
In 1973, pharmacists in Tunisia were authorised to administer injections, including vaccines, under the 
presentation of a medical prescription.  In addition, pharmacy technicians were also authorised to administer 
injections under the pharmacist's responsibility, provided they held a professional aptitude certificate (both 
theoretical and practical components) issued by the Ministry of Public Health.  The administration of vaccines 
could only be undertaken in pharmacies with the use of appropriately sterilised material and equipment.  A 
vaccination record was also required, including details on the prescribing physician, the patient's name, the 
type of product injected and the mode of administration.10 
 
In USA, in 1994, a group of 50 pharmacists undertook the first organised immunisation training for pharmacists, 
held in Seattle, Washington.  Later in 1996, the American Pharmacists Association (APhA) House of Delegates 
passed a resolution calling for pharmacists to assume a key role as vaccination advocates, facilitators and/or 
immunisers.  During the latter half of 2009, amid fears of a H1N1 pandemic, several states enabled pharmacists 
to administer vaccinations together with other health professionals.  This event highlighted the important role 
of pharmacists as immunisation providers and was the stepping stone to generalise pharmacy-based 
vaccination across all 50 states.  Today, pharmacy-based vaccination in USA is extremely successful, increasing 
significantly vaccine uptake throughout the country (see case study Part 3). Other country/territory specific 
examples are described in Part 3 of this report. 
 
The role of the pharmacists can be particularly important for the prevention, control and management of high-
incidence vaccine-preventable infections as well as during disease outbreaks and pandemics.  Several studies 
provide significant evidence of the benefits of the various potential immunisation roles that can be assigned 
to pharmacists, including collaborative and multi-disciplinary roles: from education, coordination and 
communication, to prevention and containment, procurement, distribution and vaccination as well as 
recording, monitoring and assessing vaccination strategies.11,12 
 
For seasonal influenza, for example, a resolution of the Executive Board of the WHO recommended the 
establishment and implementation of vaccination strategies, particularly aimed at all people at-risk, to 
increase seasonal influenza vaccination coverage to 75% or higher by 2010.13,14  Throughout the years, it has 
been challenging to translate these recommendations into action.  Increasingly, pharmacists have an essential 
role in immunisation activities to ensure that these goals are met. 
 
Since the beginning of the 21st century, pharmacy-based vaccination services have developed at a rapid pace 
and are now well established in countries such as the USA (1994-2009), Portugal (2007) and Australia (2014-2016).  
Nationally or regionally, the role has been supported and encouraged by several groups and associations and 
is gaining notable acceptance and endorsement from the public, governments and other healthcare 
professionals across the world.7,9,15,16 
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2.2 Global outlook  a survey 
The role of pharmacists in immunisation and vaccination varies across the world; in some countries 
and/or 
organise vaccinations activities and campaigns; in other countries, however, pharmacists are not able or 
authorised to play an active role in immunisation.  This section of the report presents the outcome of a global 
survey which was disseminated to 137 FIP membership organisations and (at the time) applicant organisations. 
 
The aim of the Report survey was to gather a better understanding of the role of pharmacists in immunisation 
across the world and the impact of these activities.  The set and format of the questions was developed by the 
University College London FIP Collaborating Centre and was validated by a selected group of expert 
representatives from FIP member organisations; the survey included six main questions on the various roles of 
pharmacists in immunisation (see Appendix).  The questions focused on 6 main subjects: advocating for 
immunisation (Q1), administering vaccines (Q2), training the pharmacy workforce for 
immunisation/vaccination services (Q3), access to vaccination records (Q4), additional services related to 
immunisation (Q6).  
Responses were collected during February and March 2016.  The data collected was coded and entered into a 
database for subsequent analysis.  Any incomplete data fields for specific variables are accounted for in all the 
reported per cent numbers in this section. 
 
 
2.2.1 Demographics 
We surveyed 137 FIP member organisations and received responses from 45 countries and territories (33% 
response rate; 33% of FIP Member Organisations; 23% of WHO Member States).  Figure 1 shows the distribution 
of the countries and territories that responded to our survey as well as additional FIP member organisations. 
Based on the sample of 45 countries and territories surveyed, a higher percentage of countries from Europe and 
The Americas returned completed surveys compared to other WHO regions. In contrast, a lower percentage of 
South East Asia countries responded to the survey (see Appendix). 
 
 
Figure 1: FIP member organisations and countries/territories responding to survey. 
Legend: 
 Countries/Territories and FIP Member Organisations responding to survey 
     FIP Member Organisations not responding to survey 
 Non-FIP Member Organisations 
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In our country-level sample, there were a total of approximately 1.7 million pharmacies represented (from 44 
countries with verifiable data), with an average of over 5,000 local population per pharmacy (this excludes two 
country outliers, Democratic Rep. of Congo and Ethiopia, which respectively had 101,000 and 142,000 population 
counts per pharmacy; these countries, as with many African countries, have acute shortages of healthcare 
personnel and facilities).  This illustrates the outreach and access demographics that community pharmacies, 
as health care environments, can offer public health planners in relation to immunisation programmes (Figure 
2). 
 
 
 
Figure 2: Distribution of population capita per pharmacy in the country-level sample from this report. 
Source: FIP-RPS Global Workforce Observatory 2015. 
 
 
Table 1 lists the 45 countries and territories that responded to our survey and provides a general overview of 
the activities undertaken in each (responses to Q1 to Q4). Country/Territory specific information is summarised 
in the Appendix section. 
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Table 1: General overview of the immunisation activities undertaken in each of countries/territories that 
responded to our survey (responses to Q1 to Q4). 
Countries 
Advocacy for 
vaccination 
Vaccination 
administration 
Training 
required 
Access to 
Records  
Argentina Y P Y N 
Australia Y PH Y Y 
Belgium Y N N Y 
Bolivia Y H N N 
Brazil Y N N Y 
Canada Y PH Y Y 
 Y N N N 
Congo (Democratic Republic) Y H Y N 
Costa Rica Y P Y Y 
Denmark Y PH Y Y 
Ecuador (Quito ) N N N N 
Ethiopia Y N N N 
Finland Y H N N 
France Y N N Y 
Germany N N N Y 
Hong Kong  N N N N 
Hungary N N N N 
Iceland N H N N 
India N N N - 
Iraq Y N N N 
Ireland Y P Y Y 
Israel N N N - 
Italy Y N N N 
Japan Y N N N 
Jordan Y - - - 
Lebanon N H N N 
Netherlands Y H N Y 
New Zealand Y P Y N 
Nigeria Y N Y Y 
Norway N N N N 
Pakistan Y H N Y 
Paraguay (Asunción) N N N N 
Philippines Y PH Y N 
Poland Y N N N 
Portugal Y PH Y Y 
Russian Federation Y N N N 
Senegal Y N Y N 
South Africa Y PH Y Y 
Spain Y N Y N 
Switzerland Y PH Y Y 
United Arab Emirates N N N N 
Ukraine N N N N 
United Kingdom Y PH Y Y 
United States of America Y PH Y Y 
Uruguay N N N N 
Legend 
Y Yes H Other healthcare professional 
N No PH Pharmacist and other healthcare professional 
P Pharmacist - No response 
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2.2.2 Advocacy activities 
From all respondents, 71% (32 countries and territories) reported some level of engagement in support and 
advocacy activities connected with immunisation service provision.  Of those countries that did support 
immunisation activities, distributing leaflets and providing information were the most common activities (with 
around 88% of these respondents engaged in these types of activities).  More active, patient-facing activities 
were less common, with campaigning (63% of respondents) and identifying and advising higher risk patients 
(53% of respondents) being more common.  Using pharmaceutical expertise for advising on health committees 
or policy was least utilised by country respondents (31% of respondents). 
 
Table 2 shows the relative frequencies of promotional activities undertaken by respondent countries and 
territories as per cent of all responses. Figure 3 highlights the world distribution of pharmacies/pharmacists 
undertaking immunisation advocacy activities. 
 
Table 2: Relative frequencies of promotional activities undertaken by respondent countries and territories. 
Support and advocacy activities % responses (n) 
Provide information & advice 21 (26) 
Distribute leaflets 22 (28) 
Engage with campaigns 16 (20) 
Identify and advise high risk patient groups 14 (17) 
Engage in multi-disciplinary campaigns 10 (12) 
Keep vaccination status/reminders for patients 10 (12) 
Serve or advise immunisation committees/groups 8 (10) 
Total responses 100 (125) 
 
 
 
Figure 3: Countries and Territories where pharmacies/pharmacists undertake  
immunisation advocacy activities. 
 
Legend: 
 Yes No  Data not obtained in this survey 
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2.2.3 Administration of vaccines 
The administration of vaccines was less common in our sample, with 29% (13) of respondents stating that 
pharmacist-administration is possible.  However, 44% (20) stated that using pharmacies (as accessible 
healthcare premises), including both pharmacists and other healthcare professionals administering vaccines, 
was possible in their countries. Table 3 summarises this, with the list of countries where administration of 
vaccines is possible shown in Table 4. 
 
Table 3: Administration of vaccines in pharmacies and/or by pharmacists. 
Countries and territories where administration of 
vaccines in pharmacies is allowed (in our sample) % (n) 
Yes (by pharmacists and other HCPs) 29 (13) 
Yes (but only by other HCPs) 16 (7) 
No 55 (25) 
Total 100 (45) 
 
 
Table 4: Countries where administration of vaccines in pharmacies and/or by pharmacists is allowed. 
Country Administration in 
pharmacies 
Administration by 
pharmacists 
Argentina Yes Yes 
Australia Yes Yes 
Bolivia Yes - 
Canada Yes Yes 
Congo (Dem Rep) Yes - 
Costa Rica Yes Yes 
Denmark Yes Yes 
Finland Yes - 
Iceland Yes - 
Ireland Yes Yes 
Lebanon Yes - 
Netherlands Yes - 
New Zealand Yes Yes 
Pakistan Yes - 
Philippines Yes Yes 
Portugal Yes Yes 
South Africa Yes Yes 
Switzerland Yes Yes 
UK Yes Yes 
USA Yes Yes 
Total 20 13 
 
In this sample, around 20% of all country-level pharmacies (approximately 193,000) are being used as 
community-based immunisation centres, with an outreach to a combined population size of 940 million people.  
In addition, around 120,000 pharmacies in this sample (14% of all represented) have the potential for 
pharmacist-provided vaccination administration services (serving a collective population of around 655 million 
people).  
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2.2.3.1 Synergy between vaccine administration and advocacy activities 
It is also clear from this sample that there is an association between advocacy and support for vaccination 
activities and being able to legally provide administration in pharmacy premises (by either pharmacists or 
other healthcare professionals).  Table 5 (and Figure 4) shows a generally higher level of engagement associated 
with vaccination advocacy activities and being able to physically provide the opportunity for administration 
of vaccination. 
 
Table 5: Association between advocacy and support for vaccination activities. 
 
Countries and territories allowing vaccines to be 
administered in pharmacies or by pharmacists 
 Column % (n) 
 No Yes 
Distribute leaflets 64% (9) 94% (16) 
Provide information and advice 78% (11) 94% (16) 
Engage with campaigns 50% (7) 77% (13) 
Multi-disciplinary campaigns 29% (4) 47% (8) 
Keep vaccination status/reminders for patients 29% (4) 47% (8) 
Identify and advise high risk patient groups 28% (4) 77% (13) 
Serve or advise immunisation committees/groups 14% (2) 47% (8) 
Count (country cases responding) 14 17 
 
 
 
Figure 4: Vaccination activities undertaken by pharmacists/pharmacies by vaccination provision status. 
 
The indication is that where pharmacists are engaged with actual administration, there is a deeper engagement 
with a wider scope of activities associated with public health delivery.  This is not wholly surprising, but does 
provide some evidence that allowing pharmacists to vaccinate, or using pharmacies as accessible healthcare 
premises for vaccination, can enhance the public health messaging and provide greater opportunity for public 
health provision in relation to vaccination.  In particular, there is a greater tendency for pharmacies, where 
vaccination services are delivered, to be engaged with multi-disciplinary campaigning activities and - 
significantly - to be identifying and advising high risk patient groups, which is a key strategy for public health 
policy for vaccination access. 
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2.2.3.2 Requirements for administration of vaccines 
The question of specific requirements (for standards and training) was asked to our respondents.  This was sub-
divided into specific requirements for the use of accessible premises as vaccination delivery centres (i.e. 
pharmacies, for example legal and safety issues, guidelines, etc.) and also access for individual training for 
pharmacists in those countries where administration is permissible.  Table 6 shows these two proportions 
(noting a different base count for each).  Of those who responded to having legal basis for administering 
vaccines, training was deemed mandatory in 8 of these countries (representing about 57% of those able to 
provide vaccination). 
 
Table 6: Association between specific requirements for administration of vaccines in pharmacies and access to 
training for vaccine administration. 
 Countries and territories with specific 
requirements for administration of  
vaccines in pharmacies 
(legal, guidelines, training, etc.)  
% (n) 
Countries and territories where 
pharmacists can access training for 
vaccine administration  
% (n) 
No 33% (8) 62%(28) 
Yes 67% (16) 38% (17) 
Total (country cases 
responding) 
100% (24) 100% (45) 
 
 
For the majority of countries in our sample, formal training for vaccination administration and services is a 
post-registration activity (79%) although some indicated that vaccination administration education was part 
of initial education and training (31%, n=6).  There is scope here for a review of how access to training 
(particularly for physical skills) is being organised as part of overall professional education; making better links 
with education and training will strategically have a greater impact on widening the access to vaccination 
through pharmacies and pharmacists as a routine service provision.  
 
Currently, in our sample, mandatory and specified pharmacist training is required in: 
Argentina Portugal 
Australia Senegal 
Canada South Africa 
Congo (Dem. Rep.) Spain 
Denmark UK 
Ireland USA 
Philippines  
 
 
2.2.4 Recording of immunisation 
For those cases where vaccination in pharmacies (or by pharmacists) is available, the recording of vaccination 
record keeping (out of 20 cases where vaccination 
is permissible in pharmacies).  Furthermore, accessing vaccination records and immunisation data for patients 
also seems to be variable with only 10 cases reporting a system for accessing immunisation data (50% of cases 
with national immunisation rights).  Accessing patient medical data is becoming more of an issue for many 
countries, whereby it is argued that community-based clinical pharmacy potential can only be fully realised 
with equitable access to relevant patient medical data; vaccination as a pharmaceutical care service is 
becoming more prevalent and this is an area that could be utilised as a mechanism to advocate for fuller access 
to relevant medical data. 
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2.2.5 Perceptions of limits and challenges. 
Figure 5 (and Table 7) illustrates the perceptions of acceptance and support on pharmacy-led vaccinations 
services from this sample of country cases, displayed by those countries and territories that have established 
vaccination services and those without.  It is of interest that countries with accepted services generally have a 
more positive attitude (showing as fewer limitations in Figure 5) and is perhaps not wholly surprising; at the 
same time, these cases are also characterised by patient (and government) acceptability being stronger and 
with having less anxiety about economics and other healthcare professionals.  The limitations of training needs 
 
 
 
Table 7: Association between perceptions of acceptance and support on pharmacy-led vaccination services. 
 
Countries and  territories allowing vaccines to be 
administered in pharmacies or by pharmacists 
Row % (n) No Yes 
No perceived limitations or barriers 17% (1) 83% (5) 
Limited acceptance by government 64% (18) 36% (10) 
Limited acceptance by other HCPs 60% (12) 40% (8) 
Limited support economically 42% (8) 58% (11) 
Limited acceptance by patients 80% (4) 20% (1) 
Limited due to training needs 50% (8) 50% (8) 
Limited due to lack confidence by pharmacists 46% (6) 54% (7) 
 
 
 
Figure 5: Perceptions of limitations or barriers on acceptance and support for pharmacy-led vaccination 
services. 
 
 
Supplementary data can be found in the Appendix section. 
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2.2.6 Summary and conclusions 
There is variance, globally, in the engagement of pharmacists in direct vaccination and immunisation services, 
with a rising proportion of countries that have legislation in place to allow administration in pharmacies and 
by pharmacists.  This policy increases the accessibility of wider vaccination cover for populations and enhances 
vaccination programmes by allowing patients to have a wider medicines review or ask for other healthcare 
advice.  In this sample alone, we estimate that community pharmacy-based access to vaccination is currently 
available to over 940 million people (assuming all pharmacies take the opportunity to provide these available 
immunisation services).  Furthermore, pharmacist-administered vaccinations are available to 655 million 
people (with similar assumptions). 
 
It is clear from this sample that those pharmacies/pharmacists who are providing direct vaccination services 
are also more engaged with a wider range of public health activities and with higher risk patient groups and 
other healthcare professionals; these respondents also tend to have a more positive attitude about removing 
restrictions and barriers and indicate better patient acceptance.  The country-case studies provided (Part 3) 
provide support for this association, and there is a clear theme of proactivity that runs through those countries 
that have embraced, legally and professionally, the concept of widening access to vaccines and immunisation 
services, often working closely with fellow healthcare professionals. 
 
In most countries that allow provision of vaccination services in pharmacies, there is a strong element of 
mandatory training or at least access to training to support the activity.  Education and training of the 
pharmacy workforce is a key strategic lever towards making direct vaccination services acceptable for 
governments and other healthcare professionals. 
 
 
2.3 References 
1. Canadian Pharmacists Association (CPhA). 2016. A review of pharmacy services in Canada and the health 
and economic evidence. Ottawa, ON, February 2016. Online access: https://www.pharmacists.ca/cpha-
ca/assets/File/cpha-on-the-issues/Pharmacy%20Services%20Report%201.pdf [Accessed 12 Jul 2016]. 
2. Barbosa C.M. 2015. Serviços farmacêuticos nas farmácia comunitárias Portuguesas - Vacinação e. 
administração de medicamentos injectáveis. III Jornada nacional sobre servicios profesionales 
farmacéuticos  Servicio de vacunación 
en farmacia  Online access: 
http://www.sefac.tv/media/ponencias/07_Barbosa.pdf [Accessed 10 Mar 2016]. 
3. Wick Y. 2016. Pharmacy immunizations have improved flu vaccine uptake. Pharmacy Times, 3 May 2016. 
Online access: http://www.pharmacytimes.com/resource-centers/flu/pharmacy-immunizations-have-
improved-flu-vaccine-uptake [Accessed 10 Jul 2016]. 
4. World Health Organization (WHO). 2004. Equitable access to essential medicines: a framework for 
collective action. WHO policy perspectives on medicines, Geneva, Switzerland 2004. Online access: 
http://apps.who.int/medicinedocs/pdf/s4962e/s4962e.pdf [Accessed 10 Mar 2016]. 
5. American Society of Health-System Pharmacists (ASPH).2003. 
immunization. Medication therapy and patient care: Specific practice areas  Guidelines. Am J Health-Syst 
Pharm. 2003; 60:1371 7. Online access: 
http://www.ashp.org/doclibrary/bestpractices/specificgdlimmun.aspx [Accessed 23 Jun 2016]. 
6. Pharmaceutical Group of the European Union (PGEU). Website. Online access: http://www.pgeu.eu/en/ 
[Accessed 03 Jul 2016]. 
7. Canadian Pharmacists Association (CPhA). 2015. Pharmacist's role in flu vaccination. Ottawa. Online 
access: https://www.pharmacists.ca/education-practice-resources/patient-care/influenza-
resources/pharmacists-role-in-flu-vaccination/ [Accessed 12 Jul 2016]. 
8. Canadian Pharmacists Association (CPhA), McCondach M., Morrison J. 2015. Pharmacists play key role in 
achieving higher immunization rates in Canada. Ottawa, 16 March 2016. Online access: 
https://www.pharmacists.ca/news-events/news/pharmacists-play-a-key-role-in-achieving-higher-
immunization-rates-in-canada/ [Accessed 12 Jul 2016]. 
9. Royal Pharmaceutical Society (RPS). 2011. Consultation response: A review of the procurement of seasonal 
flu vaccine. 17 August 2011. Online access: https://www.rpharms.com/consultation-responses-
pdfs/consdoc110817.pdf [Accessed 13 Jul 2016]. 
An overview of current pharmacy impact on immunisation | p23 
 
 
10. Ministre de la Santé Publique. 1974. Pratique des injections - Arrêté du ministre de la Santé Publique du 27 
juillet 1974  fixant les conditions dans lesquelles est autorisée la pratique des injections par les 
pharmaciens ou leurs préparateurs. Le Journal Officiel de la Republique Tunisienne, n. 50, 30 Jul 1974. 
Online access: http://www.legislation.tn/sites/default/files/journal-officiel/1974/1974F/Jo05074.pdf 
[Accessed 08 Jun 2016]. 
11. Europharm Forum Working Group Pandemic Influenza. 2009. The role of the pharmacist in fourteen 
national pandemic influenza preparedness plans in Europe: An analysis. EuroPharm Forum - PCNE 
Documents, March 2009. Online access: 
http://europharm.pbworks.com/w/page/19341627/EuroPharm%20Forum%20-%20PCNE%20Documents 
[Accessed 12 Jul 2016]. 
12. Association of State and Territorial Health Officials. (ASTHO). Pandemic influenza. Programs: Infectious 
Disease. Online access: http://www.astho.org/Programs/Infectious-Disease/Pandemic-Influenza/ 
[Accessed 12 Jul 2016]. 
13. WHO Executive Board. 2003. Prevention and control of influenza pandemics and annual epidemics. 111th 
Session of the World Health Assembly, agenda item 5.8, 23 Jan 2003, EB111.R6. Online access: 
http://apps.who.int/gb/archive/pdf_files/EB111/eeb111r6.pdf [Accessed 08 Jun 2016]. 
14. European Union Council. 2009. Council recommendation of 22 Dec 2009 on seasonal influenza vaccination 
(Text with EEA relevance) (2009/1019/EU). Official Journal of the European Union. Online access: 
http://www.epha.org/IMG/pdf/Council_Reccomendation_on_seasonal_flu_vaccine.pdf [Accessed 08 Jun 
2016]. 
15. -delivered Vaccination. Position 
Paper. Brussels: June 2015. Online access: http://epsa-online.org/index.php/publications/press-release 
[Accessed 10 Mar 2016]. 
16. Pharmaceutical Group of the European Union (PGEU). 2009. Community Pharmacists: An essential 
resource for the control of pandemic influenza. PGEU statement; Brussels, 17 November 2009. Ref: 
09.10.05E 07 PGEU. 
 
p24 | An overview of current pharmacy impact on immunisation 
 
3 Case-studies 
 
Timeline of events for the development of vaccination services in community 
pharmacies in eleven of the countries/territories surveyed in this study 
 
 
The legal authority to perform immunisation activities, including administration of vaccines, can vary 
significantly across countries and territories. The integration of community pharmacies and pharmacists in the 
vaccination policy tends to develop as a gradual process over time. This timeline highlights the gradual changes 
of this expanded area of pharmacy practice, with rapid developments taking place particularly in the last 
decade. 
 
 
 
1983 Argentina Legal requirements specified for vaccine administration in pharmacies and/or by 
pharmacists. 
1991 South Africa Private training institutions start offering vaccination training opportunities to 
pharmacists. 
1994 USA Pharmacists in Seattle, Washington, trained for the first time to administer 
vaccinations. 
1996 USA A total of 14 States authorised pharmacists for influenza vaccination. 
2002 UK Legal authorisation for pharmacy-based vaccine administration. 
2007 Portugal Legal expansion of the scope of services provided by pharmacies and pharmacists, 
including vaccine administration. 
2008 UK Increase in focus on pharmacists delivering commissioned immunisation services. 
2008 Portugal 
Association model. Development of recommendations for pharmacy-based 
vaccination by the Portuguese National Association of Pharmacies. 
2009 USA All 50 States legally authorised vaccine administration by pharmacists. 
2010 Portugal Amendment of legislation to include further details on pharmacy-based 
vaccination. 
2011 Ireland Legal authorisation for pharmacy-based vaccine administration. 
2012 Portugal Mandatory electronic vaccination records were adopted. 
2013 Portugal Publishing of new guidelines by the Portuguese Pharmaceutical Society for the 
training of pharmacists in immunisation with competency certification. 
2013 USA to define the 
close collaboration, coordination, and communication between all immunisation 
stakeholders. 
2014 Australia Pharmacy Board of Australia ann
current practice. Pharmacy-based vaccination initiated in Queensland (Pilot). 
2014 Philippines Vaccine administration rights granted to trained pharmacists. 
2015 Switzerland Pharmacy-based vaccine administration authorised in 2 Cantons followed by 4 
more later in the same year. 
2015 Australia Trained pharmacists in South and West Australia administer flu vaccinations. 
2015 Ireland Amendment to the 2011 legislation enabling pharmacists to also administer 
pneumococcal and herpes zoster (shingles) vaccines. 
2015 Switzerland Pharmacists invited for the first time to serve on immunisation advisory 
committees. 
2016 Australia Victoria was the final state jurisdiction to introduce vaccinations in pharmacies. 
2016 Ireland Plan to deliver training to pharmacists to enable administration of pneumococcal 
and herpes zoster (shingles) vaccines. 
2016 Philippines and 
protocols for vaccination by pharmacists. 
2016 USA All Accreditation Council for Pharmacy Education (ACPE)-accredited schools of 
pharmacy required to include immunisation training in their undergraduate 
curricula. 
2017 Switzerland Plans to integrate comprehensive immunisation training at undergraduate level. 
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Indicators AR AU BE FR IE PH PT SA CH UK USA 
 
           
Population (millions) 42.98 23.5 11.2 66.5 4.6 98.4 10.4 54.0 8.2 64.1 316.5 
Population > 65 years (% total) 11 14.7 18.0 18.7 12.1 3.9 20.1 5 18 17.5 14.0 
Health Expenditure (% GDP) 7.3 9.4 11.2 11.7 8.9 4.4 9.0 8.9 11.7 9.1 17.1 
Number of community pharmacies 20,000 5,456 4,950 22,510 1,807 32,443 2,885 3,136 1,774 14,361 32,500 
Immunisation advocacy activities Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Vaccine administration by pharmacists Yes Yes No No Yes Yes Yes Yes Yes Yes Yes 
Management of vaccination records No Yes Yes Yes Yes No Yes Yes Yes Yes Yes 
Training of pharmacists Yes Yes No No Yes Yes Yes Yes Yes Yes Yes 
AR: Argentina; AU: Australia; BE: Belgium; FR: France; IE: Ireland;  PH: Philippines; PT: Portugal; SA: South Africa; CH: Switzerland; UK: United Kingdom; USA: United States of America 
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3.1 Argentina 
 
Contributors: 
Ester Filinger, Scientific Coordinator at the Pharmaceutical Confederation Argentina (COFA). Gustavo Dodera 
Martinez, Pharmacist at the College of Pharmacists of the Buenos Aires Province (CFPBA). Laura Raccagni, 
Pharmacist at the CFPBA. Susana Migliaro, Pharmacist at the CFPBA. Helena Rosado, FIP Collaborating Centre 
UCL School of Pharmacy. 
Disclaimer: the information represents the state in July 2016 and may be subjected to changes 
 
 
Indicators 
Population (millions) 1,2 42.98 
Population > 65 years (% Total) 1,2 11 
Health expenditure (% GDP) 1,2 7.3 
Number of community pharmacies 3 20,000 
 
 
3.1.1 Advocating for immunisation and promoting immunisation services in 
pharmacies 
Pharmacists in Argentina participate in a range of activities including distributing vaccination leaflets and 
providing information and advice to the public about the importance of vaccination.  There is a great 
encouragement to comply with vaccination in all age groups and pharmacists actively organise and participate 
in multi-disciplinary immunisation campaigns.  One of the objectives of the National Programme for Control of 
Vaccine-Preventable Diseases (ProNaCEI) is to promote, establish, maintain and disseminate standards for the 
treatment of vaccine-preventable diseases to reduce morbidity and mortality in Argentina. In order to improve 
the delivery of immunisation services, the Ministry of Health acquires and distributes vaccines from the 
National Vaccination Schedule; the administration of these vaccines is free and mandatory across the country 
in the attempt to achieve national vaccination coverage equal or greater than 95%.4  
 
Every year, the Argentinian government also guarantees free access to flu vaccines across the country to young 
children up to 2 years old, pregnant women and people over 65 and/or with risk factors.  The National Institute 
of Social Services for Pensioners (PAMI) was created in 1971 with the intent to provide medical, social and 
welfare assistance to a population requiring specific care; it provides a range of public health services for 
people below 25 or over 65 years old, pensioners and people with disabilities.  The PAMI Influenza Vaccination 
Campaign takes place every year during autumn and winter. Pharmacists have the important role in this 
campaign immunisation status and reminding them when their next vaccination is due; 
they also identify and advise high risk patient groups and administer the vaccines. In 2015, more than 5,000 
pharmacies, distributed across the national territory, administered 480,000 vaccines to members of PAMI free 
of charge.  No prescription was required for the pharmacy-based administration of influenza and 
pneumococcal vaccines to people over 65. The jurisdiction with best performance was Mar del Plate where 88% 
of the vaccines supplied by the Ministry of Health were administered in pharmacies; high vaccination rates 
were also achieved in Morón, Capital Federal, San Justo, La Plata, Lanús, Luján and Rosario where pharmacies 
administered over 70% of total distributed vaccines. Regarding the number of administered doses, 209,000 
vaccinations were administered in the province of Buenos Aires, with Mar del Plata achieving the highest 
number of vaccinations, followed by Córdoba with 59,000, Santa Fe 68,000 and the Capital Federal with 34,000 
thousand vaccinations5.  The PAMI campaign has been running successfully for 19 years and in pharmacies 
since 2010 with patients providing a very positive feedback about the services provided. 
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3.1.2 Administration of vaccines in pharmacies 
In Argentina, the title of pharmacist currently enables the administration of vaccines although there are 
differences between the 24 jurisdictions.  The Resolution 1732/58 of La Plata, Buenos Aires, November 1958, 
initially authorised pharmacists to administer intramuscular or subcutaneous injections under medical 
indication.  Later, in May 2011, this regulation was extended (Res. 1460/11) to incorporate intradermal injections 
with the specific interest to enable vaccination by this route.6 
 
In September 1983, the Law 22909 specifically stated that vaccination was authorised in pharmacies, under a 
prescription requirement as well as other specifications such as recording of the vaccination procedure and 
details.7  Throughout the years, pharmacies across jurisdictions in Argentina have implemented vaccination 
services; these must comply with the minimum requirements for vaccination centres when incorporating 
immunisation services for the community.  The requirements are set out in Resolution MSP 67/95 of 10 May 1995 
of the National Law for Pharmacy Practice 17565/67 and in specific standards for each jurisdiction.8  The various 
legal documents include detailed specifications on the premises, equipment, material and waste management. 
The COFA Standard No. 4/04 of 26 February 2004 describes the standards and provides guidelines and 
recommendations for the administration of vaccines and injectable medicines in pharmacies.9 
 
Administration of vaccines in: 
Community pharmacies Public hospitals, health centres 
Healthcare professional(s) administering vaccinations 
Pharmacist 
Doctor 
In some jurisdictions (e.g. Mendoza) a pharmacist, a 
nurse and/or other healthcare professional is also 
required. 
Legal accountability 
Pharmacy owner or Adjunct Pharmacist Professional administering the vaccine 
Vaccination provided 
National Vaccination Schedule (mandatory):  
 HB (Hepatitis B) 
 Hib (Haemophilus influenzae type b) 
 Pneumococcal disease 
 DTP and DTPa (Diphtheria, Tetanus, 
Pertussis) 
 Rotavirus 
 Influenza 
 HA (Hepatitis A) 
 SRP (Measles, Rubella, Mumps) 
 Varicella 
 VPH (Papilloma virus) 
 FA (Yellow fever - only jurisdictions at risk) 
 
The above vaccines can be administered according to 
the recommended age and vaccination schedule. 
 
Other vaccinations are only available in public 
hospitals and health centres. 
National Vaccination Schedule (mandatory):  
 BCG (Tuberculosis) 
 HB (Hepatitis B) 
 Hib (Haemophilus influenzae type b) 
 Pneumococcal disease 
 DTP and DTPa (Diphtheria, Tetanus, 
Pertussis) 
 OPV (Polio) 
 Rotavirus 
 Influenza 
 HA (Hepatitis A) 
 SRP (Measles, Rubella, Mumps) 
 Varicella 
 VPH (Papilloma virus) 
 FA (Yellow fever - only jurisdictions at risk) 
 FHA (Argentinian haemorrhagic fever - only 
jurisdictions at risk) 
 
Other vaccines: 
 Cholera 
 Leptospirosis 
 Meningococcal meningitis 
 Rabies 
 Typhoid fever 
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Administration of vaccines in: 
Community pharmacies Public hospitals, health centres 
Vaccination requirements 
Prescription: Not required for vaccinations included 
in the National Vaccination Schedule (except if the 
recommended 
vaccination age or is under a specific treatment). 
Prescription required for all other vaccinations. 
Certified/accredited pharmacist training: Yes 
Vaccination record: Yes 
Specifications on premises, equipment, material and 
waste management: Yes 
Other: implementation of immunisation protocols, 
good practice, standing orders and guidelines. Some 
requirements depend on jurisdiction. 
Prescription: Not required 
Vaccination rates 
No official pharmacy national vaccination rates data; 
only for pharmacies participating in PAMI 
vaccination campaigns. 
Official data from the Ministry of Health published in 
2013 regarding public vaccinations only:2 
 Vaccination coverage rate for the 3rd dose 
of quintuple vaccine (DPT-Hib-HepB) in 
children < 1 year  93.9%. 
 Vaccination coverage rate for the 3rd dose 
of polio vaccine in children < 1 year  90.0%. 
 Vaccination coverage rate for BCG vaccine 
(unique dose) in children < 1 year  100%. 
 Vaccination coverage rate for the triple viral 
vaccine (Measles- Rubella-Mumps) in 
children < 1 year  93.6%. 
Vaccination supply 
Vaccines included in the National Vaccination 
Schedule are purchased directly from 
pharmaceutical industries or wholesalers by the 
Ministry of Health (usually by tender) and supplied 
free of charge to pharmacies. Other vaccines are 
purchased by pharmacies directly from 
pharmaceutical industry/wholesalers. 
Vaccines included in the National Vaccination 
Schedule are purchased directly from 
pharmaceutical industries or wholesalers by the 
Ministry of Health (usually by tender) and supplied 
free of charge to public hospitals and health 
centres. In addition, cholera, leptospirosis, 
meningococcal meningitis, rabies and typhoid are 
also provided free of charge. 
Vaccination payment and reimbursement 
Patients pay for the pharmacy service which 
includes administration of the vaccine. 
Reimbursement programmes with the social 
insurance may apply. Influenza and Pneumococcal 
vaccines are administered free of charge to children 
between 6 and 24 months, pregnant women, at-risk 
patients and people over 65, PAMI and the Medical 
Work Assistance Institute of the Province of Buenos 
Aires (IOMA) associates. 
Vaccines included in the National Vaccination 
Schedule are administered free of charge. Influenza 
and Pneumococcal vaccines are administered free 
of charge to children between 6 and 24 months, 
pregnant women at-risk patients and people over 65 
or PAMI and IOMA associates. 
 
 
3.1.3 Training of the pharmacy workforce 
Pharmacists who wish to administer vaccines in their pharmacy premises must ensure the certification and the 
approval of refresher courses in the immunisation subject, approved by the competent authorities, including 
the COFA and by the various Colleges which make specific courses available. Colleges in Argentina are regional 
associations (i.e. branches of COFA).  All healthcare professionals providing vaccination services must have the 
required knowledge and apply the current vaccination standards for the administration of vaccines, cold chain 
and biosafety.  There is a range of training courses available across the 24 jurisdictions and therefore contents 
An overview of current pharmacy impact on immunisation | p29 
 
 
may vary significantly.  A standard training course may include, for example, 60 hours of face-to-face and/or 
distance learning on vaccine preservation and confiscation, what to do in case of a power outage, vaccine 
administration techniques, new vaccines and strains, warnings and precautions, surveillance of events 
supposedly attributable to vaccination and immunisation (ESAVI) and anaphylaxis. Although refresher 
requirements are not defined, annual updates on the training contents are provided. 
 
 
Training of the pharmacy workforce 
Contents Contents vary significantly across the different training providers and may 
include general immunisation concepts, National Vaccination Schedule, 
handling and storage of vaccines, administration of vaccines and 
injectable medicines; allergic reactions and anaphylaxis. 
Certification/accreditation Training is accredited by the Pharmaceutical Confederation Argentina 
(COFA) and by the various Colleges which make specific courses available. 
Providers Various Colleges and Associations across Argentina 
Requirement Mandatory 
Level Continuous Professional Development 
Training duration Depends on the training course and provider 
Cost Paid by employers or individual pharmacists. Costs can vary with the 
training provider. The online training for the PAMI campaign is free and 
with certification. 
Refresher requirements None 
 
 
3.1.4 Tools and resources available to pharmacy professionals 
The National Administration of Medicines, Food and Medical Technology (ANMAT) provides a range of up-to-
date information on immunisation including the strains recommended for influenza vaccines for each 
vaccination season, the available vaccine trademarks and batches as well as alerts on withdrawals and/or 
transient shortages.  There is also information on the National Immunisation Standards and Communication of 
Adverse Events Supposedly Attributable to Vaccines and Immunisation (ESAVI).10 
 
The COFA website also provides a range of tools and resources to support pharmacy professionals in 
immunisation activities, including e-learning courses, information on vaccinations, ANMAT alerts and reports 
of adverse reactions.3  Moreover, a number of colleges and associations also offer specific support and 
information for pharmacists and other healthcare professionals providing immunisation services in each 
jurisdiction across Argentina.  The Information Centre of Pharmaceutical Drugs (CIMF) of the College of 
Pharmacists of the Buenos Aires Province is the responsible for assisting pharmacists and other health 
professionals who require information to resolve situations arising from the daily practice. It promotes the 
rational use of medicines through relevant, up-to-date information and databases which are duly processed 
and efficiently evaluated.11 
 
The Ministry of Health, through the Department for Control of Vaccine-Preventable Diseases (DiNaCEI), provides 
information and advice to all healthcare professionals providing immunisation services; the website includes 
education and training resources, guidelines and recommendations, alerts, as well as information and 
resources for vaccination campaigns such as graphic and audio-visual materials.4,12 
 
 
3.1.5 Vaccination records 
Vaccination records are mandatory in the public sector in Argentina although there is currently no systematic 
recording in the private sector, including pharmacies.  Nevertheless, as defined in the COFA Standard No. 4/04 
of 8 October 2012,9 pharmacies must keep a register of vaccines and injectable medicines administered, 
organised by month of administration and individualising the identification number, age and gender of the 
patient, the type and dose of vaccine administered.  Vaccinations must also be recorded in a specific 
vaccination card which should be given to each patient. Individual certificates of immunisation for children, 
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adolescents and adults are available from the Ministry of Health website and there is also an international 
certificate of vaccination or prophylaxis. At present, any recorded vaccination information is not shared across 
pharmacies; there is also no interaction between the private and public sector. Official data published by the 
Ministry of Health relates only to the public sector since data from pharmacy-based vaccinations is not 
officially used nor analysed. 
 
 
Vaccination records 
Details recorded Details recorded in the pharmacy register: 
 Individual details: ID number, age and gender 
 Product details: name/type of vaccine 
 Administration service details: administration dose and date 
 
 Individual details: name, ID number and address 
 Product details: name/type of vaccine 
 Administration service details: administration dose and date, 
signature and stamp of the professional responsible for the 
administration, seal of the pharmacy establishment.  
Record format Paper 
Record requirement Mandatory in the public sector (COFA Standard No. 4/04 of 8 October 2012) 
9 
Record storage In the pharmacy where the administration of the vaccine took place; 
records must be organised by month of administration. 
Record sharing Vaccination records are not shared 
Use of recorded information Safety and malpractice inspection, surveillance of events supposedly 
attributable to vaccination and immunisation (ESAVI) or ministerial 
control inspection. 
Minimum record keeping 10 years 
 
 
3.1.6 Advocating for immunisation services in community pharmacies, limitations and 
challenges 
One of the main limitations for further development of pharmacy-based vaccination in Argentina is the limited 
acceptance and support by the government and by the health system.  Currently, pharmacies do not possess 
suitable vaccine stock for the National Immunisation Programme; moreover pharmacy-based vaccination 
services are paid by the public and reimbursement programmes only apply in certain situations. 
 
It would also be of value to increase advocacy and promotion of vaccination in pharmacies in Argentina.  After 
the polio epidemic in Argentina, vaccination services were available in all pharmacies; however, the country 
has seen a decrease in this type of activities since then.  There is, to some degree, a lack of confidence by 
pharmacists to perform immunisation services and activities and therefore robust and integrated pharmacy 
training would be essential. 
 
At present, in some endemic areas of haemorrhagic fever, pharmacists work very actively and co-ordinately in 
awareness campaigns with remarkable success; the vaccine is supplied in a 10 multi-dose pack and therefore 
pharmacists must ensure that they recruit and provide the service to 10 individuals when one pack is opened.  
Effective immunisation activities such as this should be expanded throughout the country. 
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3.2 Australia 
 
Contributors:  
Paul Sinclair, Pharmacy Guild of Australia New South Wales Branch President; Joe Demarte President of the 
Pharmaceutical Society of Australia. Oksana Pyzik, FIP Collaborating Centre UCL School of Pharmacy. 
Disclaimer: the information represents the state in July 2016 and may be subjected to changes 
 
 
Indicators 
Population (millions) 1 23.5 
Population > 65 years (% Total) 1 14.7 
Health expenditure (% GDP) 1 9.4 
Pharmaceutical spending (% Health expenditure) 1 15.4 
Number of community pharmacies 2 5,456 
 
 
3.2.1 Advocating for immunisation and promoting immunisation services in 
pharmacies 
Pharmacists promote immunisation activities using posters and leaflets as well as on television and radio 
advertising spots. Pharmacists in Australia are actively involved in immunisation advocacy activities, for 
example, identifying and advising vulnerable individuals based on their profile and referring them to their 
physicians to get the vaccine prescriptions.  However, historically pharmacists have been excluded from the 
National Immunisation Program (NIP), which provides funding to jurisdictional governments to procure 
vaccines listed on the NIP schedule mainly in GP clinics.  Thus, the national immunisation campaign has had 
less of a focus on community pharmacy in comparison to clinics run by nurses and general practitioners.  
 
Pharmacists are encouraged to identify patients that may be at-risk of vaccine-preventable disease and counsel 
-
Register, which records vaccinations administered by doctors and nurses, and therefore pharmacists cannot 
remind patients' when their next immunisation schedule is due.3 
 
 
3.2.2 Administration of vaccines in pharmacies 
In Australia, pharmacy based immunisation services is a new service which commenced in 2014, starting with 
the Queensland Pharmacist Pilot (QPIP).  The pilot provided immunisation services for more than 35,000 adults 
over a two year period.3   Western Australia (WA) was the first jurisdiction to pass legislation enabling 
pharmacists to administer the influenza vaccine, followed by South Australia (SA) and New South Wales (NSW) 
in 2015. 
 
Most recently, in 2016, amendments were made to the Poisons Regulations to allow appropriately trained 
pharmacists to provide immunisation against influenza in adults over the age of 18 in Tasmania (TAS), Australian 
Capital Territory (ACT) and Victoria (VIC).  In addition, approved pharmacists in Victoria will have access to the 
National Immunisation Program and the Victorian Government Parent Whooping Cough Immunisation 
program by 2017.4 
 
The legislative requirements governing the administration of vaccines differ between States and Territories. In 
general, pharmacist immunisers must not be responsible for any other professional activity while providing 
vaccinations in a pharmacy, including dispensing.  Also, guidelines stipulate that a pharmacy staff member who 
is appropriately trained in first aid and CPR must visually observe the patients who have been vaccinated for 
15 minutes post-vaccination. The pharmacist or health care professional administering the vaccine is legally 
accountable for the service e.g. pre-vaccination screening; administration of vaccine.5 
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Vaccines must be administered in accordance with standards outlined in the current edition of the Australian 
Immunisation Handbook (www.immunise.health.gov.au).  While the requirements are jurisdictionally based 
there are specifications to deliver the service, legislation to enable pharmacists to administer vaccines, 
guidelines that stipulate pharmacy premise and consultation room requirements, cold chain management, 
record management, staff training and adverse event management.5 
 
Administration of vaccines in primary care in: 
Community pharmacies Healthcare centres 
Healthcare professional(s) administering vaccinations 
Pharmacist or nurse Doctor or nurse 
Legal accountability 
Pharmacy manager and immunising pharmacist N/A 
Vaccination provided 
Determined by jurisdictional legislation 
 Australian Capital Territory, New South 
Wales, South Australia, Western Australia, 
Tasmania  influenza 
 Northern Territory, Queensland  Influenza, 
measles, pertussis 
 Victoria  Influenza, pertussis 
 BCG (Tuberculosis) 
 VHB (Hepatitis B) 
 Hib (Haemophilus influenzae b) 
 DTPa (Diphtheria, Tetanus, Pertussis / 
Whooping Cough) 
 VIP (Polio) 
 Pn13 (Streptococcus pneumoniae) 
 MenC (Neisseria meningitides C) 
 VASPR (Measles, Mumps, Rubella) 
 HPV (Human papillomavirus) 
healthcare units. 
Vaccination requirements 
Prescription: No 
Certified/accredited pharmacist training: Yes 
Vaccination record: Yes 
Specifications on premises, equipment, material and 
waste management: Yes (differs between 
jurisdictions) 
Prescription: No if provided under the National 
Immunisation Program. 
Flu vaccination is also available for high-risk groups 
for free and not subject to a prescription. 
Certified/accredited training for nurses: Yes 
Vaccination record: Yes 
Specifications on premises, equipment, material and 
waste management: Yes 
Vaccination rates 
Currently not required on the Australian 
Immunisation Register so exact data not available. 
National average of over 90% coverage for most 
childhood vaccines. 
Vaccination supply 
Vaccines are purchased directly from 
pharmaceutical wholesalers or negotiated directly 
with the pharmaceutical manufacturer. 
Vaccines are purchased directly from 
pharmaceutical manufacturer by the Federal 
Government through a tender process. 
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Administration of vaccines in primary care in: 
Community pharmacies Healthcare centres 
Vaccination payment and reimbursement 
Patients pay privately for vaccines and for the 
pharmacy service that includes administration of the 
vaccine. 
Flu vaccines are free of charge for patients eligible 
under the National Immunisation Program. General 
practice may charge the patient a co-payment for the 
service. 
Travel vaccines are not available through all medical 
centres.  There are some practices that specialise in 
travel immunisation or alternatively, doctors may 
provide the patient with a prescription where the 
patient will need to purchase the vaccine from a 
pharmacy and return to the practice to have the 
vaccines administered. 
 
 
3.2.3 Training of the pharmacy workforce 
In late 2013, the Pharmacy Board of Australia, which develops standards, codes and guidelines for the pharmacy 
profession in Australia, confirmed that the administration of vaccines was within the scope of practice of a 
pharmacist.6  The recognition by the Board followed the work done by the Advanced Pharmacy Practice 
Framework Steering Committee, a profession wide multi-stakeholder group, in developing a set of 
competencies for immunisation by pharmacists which was derived by comprehensively mapping the 
Australian National guidelines for immunisation education for registered nurses and midwives (2001) with the 
Canadian Immunisation competencies for health professionals (2008) and reverse mapping with the National 
competency standards framework for pharmacists in Australia (2010).7 
 
The Australian Pharmacy Council (APC) subsequently developed Standards for the Accreditation of Programs to 
support Pharmacist Administration of Vaccines (the APC Standards) and Pharmaceutical Defence Limited 
announced that professional indemnity was offered for pharmacists providing vaccination services.  The 
current Standards, including performance criteria and examples of evidence that must be provided are 
available here: https://www.pharmacycouncil.org.au/library/standards/ 
 
The Pharmacy Guild of Australia and The Pharmaceutical Society of Australia developed practice guidelines for 
 
In general the areas of training that should be covered include: 
 Relevant policies, procedures  
 How to access all relevant resources, references and forms  
 Roles and responsibilities of the staff involved in vaccination service  
 Information about vaccines provided under the vaccination service  
 Monitoring requirements for the vaccination service  
 Adverse events that may occur from a vaccination  
 Roles and responsibilities during an emergency situation arising from a vaccination  
 Privacy and confidentiality requirements of vaccination programmes. 
 
Pharmacists must maintain current first aid, CPR and anaphylaxis certificates in order to provide the service.  
In addition, it is recommended that the staff assisting the vaccinator should also complete the anaphylaxis, 
CPR and first aid courses, to help in the case of any adverse events. In some jurisdictions, it is required that in 
addition to the pharmacist administering influenza vaccine, a second pharmacy staff member who is 
appropriately trained must also be present.7 
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Education and Training Requirements for Immunisation Pharmacists 
State APC Standards 
State 
Government 
Approval 
Refresher 
training Other relevant information 
NSW Training must be 
approved by APC 
No  No  - 
ACT Must meet APC Standards No  No  
Must maintain ongoing competence 
to administer vaccines.  
NT 
If course not 
administered by NT 
Government  
Yes Every 3 years 
Pharmacist must complete the NT 
course which meets APC 
accreditation and approved the Chief 
Health Officer 
QLD 
Must meet APC 
Standards No  
Yes  measles 
vaccine only 
(refer under 
relevant 
information) 
Where the time elapsed since initial 
practical training is more than 12 
months and where a pharmacist has 
not administered at least two 
subcutaneous measles vaccines in 
the preceding 12 months, practical 
refreshment of this subcutaneous 
injection technique and review of the 
measles vaccine must be undertaken 
before administration of a measles-
containing vaccine. 
SA Not required to meet 
APC Standards  
Yes Every 3 years Participate in immunisation CPD 
activities 
WA Not required to meet 
APC Standards 
Yes  No  - 
TAS 
Not required to meet 
APC Standards Yes 
Must complete 
6 hours of 
immunisation 
CPD each year 
Pharmacists must submit an annual 
application form to the Tasmanian 
Government  
VIC 
Must meet APC 
Standards Yes - 
Further training requirements have 
not yet been announced by Victorian 
Government As of 8 June 2016. 
 
Currently immunisation training is available post-registration; however intern pharmacists are able to 
undertake training.  In Australia, the pharmacy intern will have completed the pharmacy degree and must 
undertake further exams and training in the workplace before qualifying as a registered pharmacist. ACT, NSW 
and QLD intern pharmacists are able to vaccinate under the supervision of a pharmacist who holds a full 
registration and has completed a recognised immunisation training course.  
 
In the future, the Pharmacy Guild of Australia envisages that immunisation training will be delivered as part of 
the pharmacist university study course.  
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Training of the pharmacy workforce 
Contents  Education and administration of vaccines and injectable medicines 
Basic life support (automated external defibrillation is optional) 
First aid training 
Certification/accreditation Administration of vaccines and injectable medicines training is 
recognised and certified by the Australian Pharmaceutical Society. 
Providers Pharmaceutical Society, The Pharmacy Guild of Australia, State 
Government and other education and training courses that meets 
jurisdictional requirements.  
Requirement Compulsory 
Level Post-registration (however some pharmacy universities are incorporating 
into their syllabus.  
Training duration Duration can vary with the training provider. 
Cost Paid by employers or individual pharmacists. Costs can vary with the 
training provider. PSA and Guild cost for training course: $550.00. 
Refresher requirements Refer to above table 
Basic life support  Every 3 years (SA annually). 
 
 
3.2.4 Tools and resources available to pharmacy professionals 
The Pharmaceutical Society of Australia and The Pharmacy Guild of Australia provide training courses, webinars 
and guidelines alongside recommended reference texts such as: 
  
   
 
 
3.2.5 Vaccination records 
When a vaccine is used in the vaccination service of a pharmacy, the record must be retained between seven 
years from the date of vaccination, apart from the region of Western Australia where the duration is two years.  
The record may be made electronically in dispensing software or in specific recording software such as the 
GuildCare Vaccination Recording program. However, it is important to note that a copy of the patient-signed 
consent form must be retained by the pharmacy and stored in a secure place, regardless of whether other 
vaccination information is stored electronically.8 
 
 
Vaccination records 
Details recorded 
 
Product details: brand, batch, expiry date. 
Administration service details: name of the professional who initiated and 
administered the vaccine, the address and contact number of the 
pharmacist who initiated and administered the vaccine, the accreditation 
certificate number of the pharmacist who initiated and administered the 
vaccine and the unique identifying/reference number allocated to 
administration of the vaccine by the pharmacist and site of administration.  
Record format Electronic and paper format 
Record requirement Mandatory 
Record storage Pharmacy electronic system or paper based if jurisdiction allows 
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Vaccination records 
Record sharing ACT - Vaccination records are reported to the ACT Health Department 
annually. 
All other jurisdictions do not share records at this point in time 
Use of recorded information Data is used to analyse uptake and demographics of patients who utilised 
the service.  
Minimum record keeping Tasmania   Seven years   
WA - Two years   
NSW - Seven years   
ACT - Seven years   
SA - Seven years 
Other information Other information may be recorded in the software, such as the presence 
of chronic diseases or pregnancy. 
 
 
3.2.6 Outcomes 
The data below is based on information from pharmacies utilising Guildcare reporting software. 
 
Outcomes of Flu Vaccination Campaigns 
Campaign year 
2014 2015 2016 
Number of participating pharmacies (% total number of pharmacies) 
<2% 7% 14% 
Number of pharmacies reporting data 
<2% 7% 14% 
Average number of flu shots administered per pharmacy 
115 100 96 
Vaccinations administered by pharmacists (% total pharmacy administered 
vaccines) 
80% 80% 80% 
Patient overall service satisfaction 
>98% >98% >98% 
 
 
As not all pharmacies use this software the total numbers of participating pharmacies and vaccinations 
delivered may be greater than reported. 
 
Since 2014 when trials of pharmacist delivered influenza vaccination began in Queensland, other jurisdictions 
have gradually initiated pharmacy based immunisation services and began to utilise the software.  During and 
prior to 2014 many pharmacies ran Nurse vaccinator clinics, within the pharmacy, delivering influenza vaccines 
to patients. 2016 is the first season where most states and territories in Australia have allowed pharmacist 
delivered influenza vaccination. 
 
 
3.2.7 Advocating for immunisation services in community pharmacies, limitations and 
challenges 
In Australia, currently community pharmacies do not receive any financial support from the government for 
provision of immunisation services and as such the service is fully funded by community pharmacies and 
patients are charged a private price.  Some banner groups have chosen to engage doctors and immunising 
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nurses so that they can claim the administration of the vaccine on the Medicare Benefits Scheme (MBS), rather 
than using a vaccinating pharmacist who cannot claim the service on the MBS.   This has created competition 
between pharmacies on price - those claiming on the MBS can provide an influenza vaccination service for 
approximately $9 - $10 per service and those who provide a privately funded service charge $20 - $30 per service. 
 
Other issues include:  
 Pharmacist and pharmacy assistant staffing, especially in rural and remote areas; 
 Risk of jeopardising the relationship that they have with the doctors, particularly in rural and 
remote areas; 
 Availability of the influenza vaccine; 
 Pharmacy premise meeting legislative requirements to provide a vaccination service. 
 
The foremost issue in launching the pharmacy based immunisation service has been resistance from other 
immunising health professionals, especially doctors and nurse immunisers. Nonetheless, progress has been 
made in developing pharmacy based immunisation with scope to expand to other common vaccines in children 
as well as in adults.  It would be of great benefit if the Health Authorities shared immunisation records with 
pharmacies and allowed access to the Australian Immunisation Register.  
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3.3 Belgium 
 
Contributors: 
Jan Saevels, Scientific Director, Association of Pharmacists Belgium (APB); Dirk Vos, General Secretary, APB. 
Helena Rosado, FIP Collaborating Centre UCL School of Pharmacy. 
Disclaimer: the information represents the state in July 2016 and may be subjected to changes 
 
 
Indicators 
Population (millions) 1,2 11.2 
Population > 65 years (% Total) 1,2 18.0 
Health expenditure (% GDP) 1,2 11.2 
Number of community pharmacies 3 4,950 
 
 
3.3.1 Advocating for immunisation and promoting immunisation services in 
pharmacies 
Belgian community pharmacies have always been very much involved in immunisation advocacy. Since the end 
of the 20th century, all childhood vaccines are administered in pre-school and school health centres, with 
pharmacists playing only a minor role.  Adult boost vaccines are very often administered by physicians ( ) 
who are provided with the products directly from the regional authority. 
 
The only real exception is seasonal influenza where pharmacists keep playing a very important role for non-
institutionalised patients.  For instance, during the autumn of 2007, a pilot campaign led by the APB encouraged 
community pharmacies to actively contribute to raising awareness about the benefits of vaccination against 
influenza, particularly in diabetic patients. 
 
Later in 2009, in a similar initiative, Belgian pharmacists assisted in identifying diabetic patients based on their 
medication history and referred patients to their physicians to obtain an influenza vaccine prescription using 
a specific form.  The results of these initiatives were encouraging; between 2006 and 2009 there was an increase 
in flu vaccination rates for the general population, from 14.8% to 17.3%.  Among diabetic patients, the 
vaccination rate increased from 45.6% to 48.6%; for diabetic patients younger than 50 years old the vaccination 
rate increased from 12.7% to 16.6%.4,5  In each of these campaigns, pharmacists aligned with the national or 
regional vaccination programmes, particularly aimed at chronically ill, pregnant women, or healthcare 
personnel. 
 
 
3.3.2 Administration of vaccines in pharmacies 
The current legislation in Belgium does not authorise pharmacists to administer vaccines to patients. Although 
there may be a public health advantage (since pharmacists see in the pharmacy at-risk patients who do not 
consult medical doctors) the pharmacy workforce is hesitant in developing this role. In addition, there is limited 
support by other healthcare professionals, in particular GPs. 
 
 
3.3.3 Training of the pharmacy workforce 
As administration of vaccines does not take place in the pharmacies, no specific immunisation training has yet 
been organised or planned.  There is, however, a yearly communication to pharmacists about the influenza 
vaccine its composition and high-risk patient groups. 
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3.3.4 Tools and resources available to pharmacy professionals 
Pharmacy professionals have two main sources for tools to help them advocating for influenza vaccination: 
regional authorities often provide posters and brochures; professional associations such as APB often 
disseminate pharmacy-specific tools (video, print and online). 
 
 
3.3.5 Vaccination records 
Currently community pharmacies collect, store and manage electronic records of flu vaccine deliveries.  The 
information is recorded locally, and shared nationally 
across community pharmacies.  Pharmacists can use vaccination records, for example, to verify and remind 
patients of their vaccination status and when their next vaccination is due.  The management of electronic 
records for other vaccinations in addition to flu is currently undertaken by physicians and by schools (children 
vaccinations only); extension to this service to include community pharmacies is under development. 
 
Vaccination records in pharmacies 
Details recorded -medication 
Vaccine details: name, batch, expiry date 
 
Record format Electronic 
Record requirement Mandatory 
Record storage Pharmacy electronic system 
Record Sharing Records are nationally shared between pharmacies, on a voluntary basis, 
 
Use of recorded information immunisation 
Remind patients of their vaccination status and when the next 
vaccination is due 
Minimum record keeping 10 years 
 
 
3.3.6 Advocating for immunisation services in community pharmacies, limitations and 
challenges 
One of the main challenges for the development of pharmacy-based vaccination services is the limited 
acceptance and support by other healthcare professionals.  For example, the Belgian Association of Medical 
Unions (BVAS) presents practical objections identifying pharmacies as busy environments that are not 
equipped to provide vaccination services.6  Moreover, there is lack of confidence by pharmacists to perform 
immunisation services and activities since they are not being fully trained to administer vaccinations. 
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An overview of current pharmacy impact on immunisation | p41 
 
 
6. Belga. 2015. Griepprik door apotheker is niet wettelijk. Online access: 
http://www.standaard.be/cnt/dmf20150929_01892654 [Accessed 05 Oct 2015]. 
 
  
p42 | An overview of current pharmacy impact on immunisation 
 
3.4 France 
 
Contributors: 
Olivier Gross, Director for professional affairs, Ordre National des Pharmaciens (ONP). Helena Rosado, FIP 
Collaborating Centre UCL School of Pharmacy. 
Disclaimer: the information represents the state in July 2016 and may be subjected to changes 
 
 
Indicators 
Population (millions) 1,2 66.5 
Population > 65 years (% Total) 1,2 18.7 
Health expenditure (% GDP) 1,2 11.7 
Number of community pharmacies 3 22,510 
 
 
3.4.1 Advocating for immunisation and promoting immunisation services in 
pharmacies 
Pharmacists are encouraged to participate in national immunisation campaigns and to provide information to 
patients; every year, the Ministry of Health publishes vaccination calendars containing information about 
vaccination schedules and ages.  The ONP, through its organisation Cespharm, disseminates these and 
produces and distributes leaflets explaining facts about immunisation and its benefits.4-7 
 
During September of 2010, a campaign was organised to educate patients about vaccination and to invite them 
to discuss any immunisation issues with healthcare professionals, including pharmacists.  This campaign was 
co-organised by the ONP in collaboration with several pharmaceutical associations, scientific societies and the 
association of pharmaceutical industries (Leem).  Pharmacies were provided with vaccination education 
materials, posters and leaflets; 4-7 one poster was specially designed to disseminate the role of pharmacists in 
immunisation There is no vaccine against misconceptions; for vaccines go to your doctor 
or pharmacist   In July 2016 the ONP published a booklet containing complete information on immunisation. 
This brochure was distributed to all pharmacists and stakeholders.8 
 
 
3.4.2 Administration of vaccines in pharmacies 
The current legislation in France does not authorise pharmacists to administer vaccines to patients and these 
are undertaken by physicians, midwives or nurses in hospitals, public vaccination centres, mother and child 
protection centres (for children under 7 years old), occupational health services, and vaccination centres for 
travellers.  Most vaccinations administered by nurses require prescription, except against influenza for which 
only the first vaccination requires a prescription and except for pregnant women and minor children.  Provision 
of pharmacy-based vaccination would increase accessibility as well as national capacity for response to 
pandemic risks without compromising the service quality. 9 
 
 
3.4.3 Training of the pharmacy workforce 
Training in immunisation is undertaken during undergraduate pharmacy studies.  Voluntary training is 
available post-registration; however, it does not include training for administration of vaccines since 
pharmacists are not legally authorised to vaccinate in France. 
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3.4.4 Tools and resources available to pharmacy professionals 
Cespharm provides support to pharmacists and their activities on immunisation by supplying communication 
tools leaflets and brochures to facilitate information dissemination to patients.4-6  Information and support is 
also available from the Ministry of Health through the Institut national de prévention et d'éducation pour la 
santé (INPES), which is now the Agence nationale de Santé Publique, and the regional public health Agencies 
(ARS). 
 
 
3.4.5 Vaccination records 
Currently community pharmacies collect, store and manage electronic records of all medicines including 
vaccines.  
shared across community pharmacies; the system was recently extended to hospital pharmacists and 
physicians.  Pharmacists can use vaccination records, for example, to remind patients of their vaccination 
status and when their next vaccination is due. The management of electronic records for other vaccinations is 
currently undertaken by physicians and by schools (children vaccinations only). 
 
Vaccination record in pharmacies 
Details recorded  
accines) details: name  
Date of dispensing in the pharmacy 
Record format Electronic 
Record requirement Optional  patients provide details on a voluntary basis 
Record storage Local pharmacy electronic system and on two identical servers  in order 
to allow the sharing 
Record Sharing Records are nationally shared between community pharmacies and 
hospitals 
Use of recorded information immunisation 
Remind patients of their vaccination status and when the next 
vaccination is due 
Minimum record keeping 21 years 
 
 
3.4.6 Advocating for immunisation services in community pharmacies, limitations and 
challenges 
The National Academy of Pharmacy9 published an argument supporting the development of pharmacy 
vaccination services.  Currently, around 10 million of people in France purchase their vaccine at the pharmacy 
and they are then vaccinated by their doctor or nurse without prior consultation.  In 2008/2009, the flu 
vaccination coverage was 65% for patients over 65 years and only 52% in 2013/2014, a percentage significantly 
below the European target of 75 % in all groups. For this reason the Académie Nationale de Pharmacie (ANP) 
states that this underlies the need to implement strong public health measures, including vaccination services 
in pharmacies, in the attempt to improve vaccination coverage in France. In July 2016 the ONP published a 
booklet containing complete information on immunisation.8 
 
One of the main challenges for the development of pharmacy-based vaccination services is the limited 
acceptance and support by other healthcare professionals, in particular physicians and nurses.  Moreover, 
there is lack of confidence by pharmacists to perform immunisation services and activities since they are not 
being fully trained to administer vaccinations. 
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3.5 Ireland 
 
Contributors: 
Pamela Logan, Director of Pharmacy Services, Irish Pharmacy Union (IPU). Irene Patterson, Senior Pharmacist 
Adviser, Pharmaceutical Society of Ireland (PSI). Helena Rosado, FIP Collaborating Centre UCL School of 
Pharmacy. 
Disclaimer: the information represents the state in July 2016 and may be subjected to changes 
 
 
Indicators 
Population (millions) 1, 2 4.6 
Population > 65 years (% Total) 1, 2 12.1 
Health expenditure (% GDP) 1, 2 8.9 
Number of community pharmacies 3 1,807 
Number of registered pharmacists 3 5,626 
 
 
3.5.1 Advocating for immunisation and promoting immunisation services in 
pharmacies 
Community pharmacists in Ireland have been authorised to administer the influenza vaccination, and have 
been actively involved in the national seasonal influenza vaccination campaign, since 2011.  As the 
representative group for community pharmacies in Ireland, the Irish Pharmacy Union (IPU) designs, produces 
and disseminates leaflets and posters to advertise flu vaccinations in pharmacies; it also produces radio ads 
which are aired during the flu season to highlight the pharmacy vaccination service.  The National 
Immunisation Office (NIO) and the Health Service Executive (HSE) also have their own radio ads and leaflets to 
highlight the flu vaccination campaign and their message is to get the flu vaccination from the doctor or 
pharmacist. 
 
 
3.5.2 Administration of vaccines in pharmacies 
Pharmacists in Ireland have been legally authorised to administer the seasonal influenza vaccination in 
registered pharmacies since 2011.  The legislation S.I. No. 525/2011 - Medicinal Products (Prescription and 
Control of Supply) (Amendment) Regulations 2011 enables trained pharmacists to supply and administer the 
seasonal influenza vaccine, at registered pharmacies, without the requirement for a prescription.4  In order to 
provide this service, pharmacists must have completed accredited Influenza Vaccination training; pharmacists 
are currently only trained to administer the influenza vaccine to those persons 18 years and older.  The 
legislation also enables pharmacists to supply and administer adrenaline for the emergency treatment of 
anaphylactic shock arising from the flu vaccine. 
 
In October 2015, an amendment to the legislation was made to enable pharmacists to also administer the 
pneumococcal vaccine and herpes zoster (shingles) vaccine (S.I. No. 449 of 2015 - Medicinal Products 
(Prescription and Control of Supply) (Amendment) (No.2) Regulations 2015).5  From July 2016 a new modular 
system of training will be in place to equip pharmacists with the necessary skills and knowledge to safely 
administer these vaccines.  The training takes account of previous training and experience that many 
pharmacists have from providing an influenza vaccination service. 
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Administration of vaccines in: 
Registered pharmacies  
Healthcare professional(s) administering vaccinations 
Pharmacist Doctor, nurse 
Legal accountability 
The pharmacist administering the vaccine and the 
superintendent pharmacist are legally accountable 
for the vaccination service. The pharmacy owner 
also has specific responsibilities (these are outlined 
in section 2.2 of the PSI  Guidance on the Provision 
of Vaccination Services by Pharmacists in Retail 
Pharmacy Businesses). 
The healthcare professional administering the 
vaccine. 
Vaccination provided 
Seasonal influenza, pneumococcal and shingles (>18 
years old). 
National Immunisation Schedule 
 BCG - Bacille Calmette-Guérin (TB) 
 6 in 1 - Diphtheria, Haemophilus influenzae 
b (Hib), Hepatitis B, Pertussis (Whooping 
cough), Polio, Tetanus 
 PCV - Pneumococcal conjugate 
 MenC - Meningococcal C 
 MMR - Measles, Mumps, Rubella 
 Hib - Haemophilus influenzae b 
 4 in 1 - Diphtheria, Pertussis (whooping 
cough), Polio, Tetanus 
 HPV - Human papillomavirus 
 Tdap - Tetanus, low dose diphtheria and 
acellular pertussis (whooping cough) 
 Flu  Influenza 
 PPV - pneumococcal polysaccharide vaccine 
Other vaccines that may be provided 
 Hepatitis A and B 
 Rabies 
 Rotavirus 
 Varicella Zoster 
 Cholera 
 Tick-borne encephalitis 
 Typhoid fever 
 Yellow fever 
Vaccination requirements 
Prescription: No 
Certified pharmacist training: Yes 
Vaccination record: Yes 
Specifications on premises, equipment, material and 
waste management: Yes, as specified in PSI  
Guidance on the Provision of Vaccination Services 
by Pharmacists in Retail Pharmacy Businesses. 
Prescription: No 
Vaccination rates 
Seasonal influenza (>18 years old): 53,047 patients 
were vaccinated across 691 community pharmacies 
in Ireland in the 2014/15 season and 62,514 patients 
were vaccinated in the 2015/16 season; this is 
approximately 10% of the total flu vaccinations 
administered in Ireland (estimate). 
Other vaccinations: data not yet available. 
The national flu vaccination rate during the 2013-
2014 campaign reached 59.2% of people aged 65 and 
over (patients holding a medical card or GP visit card 
only). In the two previous seasons this rate was just 
under 57%. 
Source: HSE 
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Administration of vaccines in: 
Registered pharmacies  
Vaccination supply 
the influenza vaccine is provided free of charge by 
the Department of Health for those aged 65 years 
-
staff. The HSE National Cold Chain Service provides 
scheduled deliveries of the vaccine direct to 
registered pharmacies signed up to the service. 
Vaccines for individuals outside of these groups are 
obtained through the private market and paid for by 
the patient. 
The NIO oversees the implementation of the 
national immunisation programme of the HSE and is 
responsible for the procurement and distribution of 
vaccines used in publicly funded programmes. The 
National Cold Chain Service delivers vaccines for 
publicly funded programmes to  surgeries, 
hospitals, Local Health Offices and pharmacies with 
validated temperature records up to the point of 
delivery. Other vaccines can be sourced from the 
vaccine manufacturer or local pharmacy. 
Vaccination payment and reimbursement 
 
(which are schemes for assistance with medical 
receive the vaccine free of charge from pharmacies.  
Pharmacists then claim a fee for providing this 
service from the Primary Care Reimbursement 
Service (which is part of the HSE). Pharmacists are 
permitted to charge a fee to vaccinate patients that 
do not have a medical card or GP visit card as well as 
the cost of the vaccine itself. 
The national immunisation programme of the HSE is 
a publicly funded programme. Travel vaccinations 
have to be paid for by the patient. 
 
 
3.5.3 Training of the pharmacy workforce in immunisation 
Prior to October 2015 pharmacists were only permitted to supply and administer the influenza vaccine. The 
training requirements up until the 2015/2016 influenza season (September 2015-April 2016) were as follows: 
pharmacists administering the seasonal influenza vaccine had to successfully complete training approved by 
the Council of the PSI and accredited by the Irish Institute of Pharmacy (IIOP).  Training requirements were set 
by the PSI and first-  
of online pre-reading to be completed before attending a full day face to face training course.  The face to face 
course included core practical skills for vaccine administration, information on the influenza virus and vaccine, 
and training on anaphylaxis management including CPR.  At the end of this course pharmacists completed an 
assessment to achieve a certificate which enabled them to provide a flu vaccine service in their pharmacy. 
 
Where Ab initio training had been completed, the next year, to build on the acquired knowledge and skills 
pharmacists completed Refresher Level 1 training.  This consisted of a self-study online module, plus a live face 
to face component (half day) on core practical skills of vaccine administration and assessment to build 
confidence and competence in proper vaccine administration and technique. It also highlighted the vaccine 
products specific to the year of administration. At the end of this course pharmacists completed an assessment 
to achieve a certificate of completion.  Refresher Level 1 training also included a live component and 
assessment of CPR and adrenaline administration. Where pharmacists completed both these courses and 
vaccinated for at least 2 consecutive years they completed Refresher Level 2 training,  an online self-study 
module with assessment to achieve a certificate of completion.6 
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Training of the pharmacy workforce 
Contents  Information on the influenza virus and vaccine; Administration of vaccines 
and injectable medicines; Anaphylaxis management with 
cardiopulmonary resuscitation (CPR). 
Certification/accreditation Training accredited through the IIOP and approved and recognised by the 
Council of the Pharmaceutical Society of Ireland. 
Providers Hibernian Healthcare Ltd.; Boots Ireland Ltd. 
Requirement Training is mandatory and depends on previous training and vaccination 
experience level. 
Level Post-registration 
Training duration Ab initio training for new vaccinators is a one-day face to face event, 
Refresher Level 1 is a half day event provided by the training providers 
every July and August. The online reading and Refresher level 2 modules 
also go live at this time of year with up to date information for the 
upcoming influenza season which is roughly from September to April in 
Ireland. 
Cost Ab initio training course and Refresher level 1 training course both include 
a live, face to face component which is paid for by the pharmacist; 
Refresher Level 2 is an online course and is  provided free of charge via the 
IIOP website. 
Refresher requirements Where Ab initio training has been completed, and the pharmacists has 
vaccinated in one previous year, Refresher level 1 must be completed.  
Where Ab initio training has been completed and the pharmacist has 
vaccinated in two of the previous years, Refresher level 2 must be 
completed. 
 
 
This training programme has been superseded due to an amendment in the legislation (SI 449/2015) which came 
into force in October 2015.  This legislation authorises pharmacists to supply and administer two additional 
vaccines: pneumococcal and herpes zoster vaccine.5 From July 2016 a new modular training structure will be in 
ons & Management of 
related to each vaccine.  This new training structure is available through the PSI website. Training courses are 
currently undergoing accreditation by the IIOP, before being approved by the PSI. 
 
Under the new training structure, all online courses will be provided to pharmacists free of charge. CPR training 
 face courses paid for by the pharmacist. 
 
 
3.5.4 Tools and resources available to pharmacy professionals 
The PSI has issued Guidance on the Provision of Vaccination Services by Pharmacists in Retail Pharmacy 
Businesses  which provides support to pharmacists delivering a vaccination service under the legislation.6  In 
addition, the National Immunisation Advisory Committee (NIAC) prepares Immunisation Guidelines for Ireland 
which are regularly updated and published by the NIO on behalf of the Department of Health.  These guidelines 
are intended for doctors, nurses, pharmacists, paramedics, those involved in travel health and in the promotion 
7  The NIO provides up to date information leaflets 
for the public and publications, guidelines and information leaflets for healthcare professionals, including A 
Practical Guide to Immunisation.8  NIO website. 
 
 
An overview of current pharmacy impact on immunisation | p49 
 
 
3.5.5 Vaccination records 
The pharmacist who has administered a vaccine under the legislation must record details (set out in the 
legislation) of each administration in a register kept for that purpose.  This record must be preserved by the 
pharmacy owner for at least eight years; for the first two years this record must be kept at the pharmacy 
premises and available for inspection.  In addition, a copy of the particulars in the vaccine administration record 
GP (where provided by 
the patient) within seven days of the administration.  The details recorded include the name, address, date of 
birth, gender and personal public service number of the person to whom the product was administered; the 
name, dosage, marketing authorisation number, batch number and expiry date of the product; the name and 
and contact particulars of the GP and confirmation that consent was obtained from the patient prior to 
administration of the vaccine. 
 
The HSE has developed an online system which compiles statistics and trend analyses of the vaccinations 
services provided.  Future development of this website will include a live electronic health system where health 
information for all patients, including vaccination data, will be stored and shared enabling pharmacies to 
 
 
Vaccination records 
Details recorded 
address and personal public service number (if provided); name, address 
and contact details of their GP (if provided). 
Vaccine details: name, dosage, expiry date, marketing authorisation and 
batch number. 
number; address of the pharmacy premises where vaccine administered; 
administration date. 
Confirmation that consent was obtained from the patient prior to the 
administration of the product. 
Record format In a register kept for that purpose or if administration details are 
recorded electronically, there must be a daily print-out which is certified 
by the pharmacist(s) that administered the vaccine within 24 hours of 
making the printout. 
Record requirement Mandatory 
Record storage Records relating to the administration of the vaccine, and, if applicable, 
adrenaline following an anaphylactic reaction to a vaccine must be kept 
for two years at the pharmacy premises and available for inspection. 
Records must be stored securely and confidentially for a further 6 years. 
Information is recorded in a register kept for the purpose by the 
pharmacy owner; A national record of vaccinations administered by 
pharmacists is also retained by the HSE. 
Record sharing A copy of the vaccination record must be forwarded to the HSE and to the 
GP (if details provided by patient); records are not usually 
shared between pharmacies but can be shared on request with the 
patient s consent. 
Use of recorded information 
status. 
Minimum record keeping 8 years, 2 of which in the pharmacy premises 
 
 
3.5.6 Outcomes 
To date, each year, the PSI has undertaken an evaluation of the seasonal influenza vaccination service provided 
in pharmacies to analyse trends and to identify any issues needing to be addressed for the following season.  
During the winter of 2014/2015, 53,047 patients were vaccinated against influenza across 691 pharmacies 
providing this service.  The majority of people seeking pharmacy-led vaccination were considered at-risk 
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patients (93%) and a significant percentage (23%) had never had this vaccination before.  Of the 53,047 vaccines, 
46% (24,363 vaccines) were eligible for reimbursement (i.e. at-risk patients with a medical card).  It is estimated 
that in the 2014/2015 flu season, pharmacists administered around 10% of all flu vaccinations in Ireland.  This a 
significant increase compared to the 9,543 patients vaccinated by pharmacists when they were first authorised 
in legislation in 2011.9-11 
 
In November 2015, the PSI commissioned a project to gain comprehensive feedback from patients on their 
experience of receiving the seasonal influenza vaccination service in pharmacies across Ireland. 374 patient 
telephone interviews were conducted with patients who had received the flu vaccine in a pharmacy in the 
previous month and patient feedback was reported anonymously.  99% of respondents rated their overall 
satisfaction with the flu vaccination service as either 8, 9 or 10 out of 10, and 99% of respondents said that they 
would be likely to go to the pharmacist for their flu vaccination again.  The main reasons given for attending a 
pharmacy for a flu vaccination were convenience, efficiency/less waiting time and cost.  The evaluation reports 
can be read in full on PSI website. 
 
Outcomes of Flu Vaccination Campaigns 
Campaign year 9-11 
2011/12 2012/13 2013/14 2014/15 2015/16 
Number of participating pharmacies (% total number of pharmacies) 
484 817 907 691 - 
Number of pharmacies reporting data 
1462 944 936 681 - 
Number of pharmacy vaccinated patients 
9,543 18,954 40,443 53,047 62,514 
Pharmacy vaccinated patients never vaccinated before (% pharmacy vaccinated patients) 
- 27% 24% 23% 13% 
Pharmacy vaccinated at-risk patients (% pharmacy vaccinated patients never vaccinated before) 
- 80% 85% 83% 96% 
 
 
3.5.7 Advocating for immunisation services in community pharmacies, limitations and 
challenges 
Initially some pharmacists were hesitant to participate in the flu vaccination service, mainly with concerns 
about GPs re pharmacists have participated in 
this service, and PSI evaluations have shown that pharmacists are providing a safe and effective service which 
meets the satisfaction of the patients.  This service has also been shown to increase the uptake of the flu 
vaccination in the population. 
 
One of the main challenges associated with vaccination in pharmacies is the cost of service provision; there is 
a mandatory training requirement for pharmacists administering vaccines and, in addition, a stock of 
adrenaline has to be kept in pharmacies at all times to be administered in case of emergency treatment of 
anaphylactic shock following the influenza vaccine.  
 
As previously stated in October 2015 legislation was changed to authorise pharmacists to administer 
pneumococcal and herpes zoster vaccine.5  The pneumococcal (PPV23) vaccine is included in the national 
immunisation programme, however currently pharmacists are not included in the programme for this vaccine.  
The herpes zoster vaccine is not currently included in the routine national immunisation schedule.  Once the 
approved training has been completed, pharmacists will be able to administer both these vaccines to patients 
as a private service, outside of the national immunisation programme. 
 
Pharmacists are now delivering around one in ten flu vaccines and these numbers are predicted to grow as the 
target population widens.  There is scope for pharmacists to also immunise children as part of the childhood 
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vaccination programme however depending on the vaccine, this may require additional training and/or a 
change to legislation. 
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3.6 Philippines 
 
Contributors: 
Yolanda Robles, Chair of the Committee on Education and Advocacy (including Immunizing Pharmacist 
Training) of the Philippines Pharmacists Association (PPhA). Helena Rosado, FIP Collaborating Centre UCL 
School of Pharmacy. 
Disclaimer: the information represents the state in May 2016 and may be subjected to changes 
 
 
Indicators 
Population (millions) 1 98.4 
Population > 65 years (% Total) 1 3.9 
Health expenditure (% GDP) 1 4.4 
Number of community pharmacies 2 32,443 
 
 
3.6.1 Overview 
Details of initiatives and campaigns:  
 
1. -based immunisation services to the Food and Drug 
Administration Director and Department Heads (2014). 
2. -based immunisation services to the Department of 
Health national officers (2014). 
3. Creation of a multisectoral Core Group on Immunisation under PPhA composed of representatives from 
patient groups, medical profession (geriatrics), nursing profession, pharmaceutical industry, community 
and hospital pharmacists, drugstore owners, Food and Drug Administration, and the Department of Health 
immunisation. 
4. Development of training modules for pharmacists which covers all aspects from the epidemiology, 
diseases, vaccine products, patient care and implementation guidelines (December 2015).  
5. Meeting with the Professional Regulation Commission Board of Pharmacy regarding the accreditation of 
the training programme on immunisation (on schedule on 2nd Quarter 2016). 
6. Development of guidelines and protocols on adult immunisation at the level of pharmacies (on schedule 
on 3rd Quarter 2016). 
 
 
3.6.2 Administration of vaccines in pharmacies 
A number of pharmacies in the Philippines currently host immunisation services, including administration of 
vaccines but the latter service is undertaken only by doctors and nurses.  Pharmacists have been tapped as 
potential immunisers in 2014 by the Food and Drug Administration.3  The training for pharmacists to administer 
adult pneumococcal and influenza vaccines will start this year (2016). 
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Administration of vaccines in: 
Community pharmacies 
 rural health units, barangay health 
stations, district hospitals, provincial and regional 
hospitals (public and private). 
Healthcare professional(s) administering vaccinations 
Doctor and nurse 
Pharmacists were given immunisation rights in 2014 
provided that they received adequate training 
(which is currently taking place). 
Doctor and nurse 
Legal accountability 
Doctors and nurses are governed by the Medical Act of 1959 and the Nursing Act of 2010. The proposed 
Pharmacy Law is now at its 3rd reading in the House of Representatives. It defines the legal role of the 
pharmacists to immunise. 
Vaccination provided 
For doctors, it covers the total range of vaccines. 
For pharmacists, it will initially cover influenza and pneumococcal vaccines for adults. 
Vaccination requirements 
Guidelines are being followed for both adult and child vaccination (Annex B). 
Vaccination rates 
For children: 62% of children aged 12-23 months of age for the basic vaccines under EPI. 
For adults: no available data but anecdotal data points to poor vaccination rates. 
Vaccination supply 
From several multinational companies. 
Note: no vaccines are produced locally. 
Vaccination payment and reimbursement 
Immunisation (EPI) provides free immunisation for 
children in all public health facilities for tuberculosis, poliomyelitis, diphtheria, tetanus, pertussis, measles, 
mumps, Rubella, Hepatitis B, and Haemophilus influenzae type B. The Philippine Health Insurance 
Corporation (PHIC) under its Mother and Child Care includes coverage of or reimbursement for BCG and 
Hepatitis B vaccination for its members. Adults, on the other hand, are provided discounted vaccine products 
by PHIC and pharmacies in partnership with the pharmaceutical industry 
 
 
3.6.3 Training of the pharmacy workforce 
Pharmacists have been considered for being granted vaccination rights in 20143 and are currently to be trained 
to administer vaccinations.  The training is to be delivered by an immunizing pharmacist (U.S.  certified), nurses, 
medical doctors and pharmacy educators by the second or third quarter of 2016. 
 
The training will consist of self-study of the six modules, followed by a short face to face review of the course 
(3 days), and one-day training on administration of vaccines.  The final activity is a written exam. The whole 
process is expected to take one month. The costing for all resources needed for the course is currently being 
determined. 
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Training of the pharmacy workforce 
Contents  Public health, immunology and vaccine development, epidemiology of 
vaccine-preventable diseases, patient care, proper handling and storage of 
vaccines, and preparation for operating a pharmacy-based immunisation. 
Certification/accreditation Being worked out with the Professional Regulation Commission. No 
specific accreditation yet. 
Providers Philippine Pharmacists Association 
Requirement Basic Life Support Certificate, Licensed Pharmacist,  Certificate of Current 
employment in an existing Pharmacy 
Level Not yet determined 
Training duration Complete training expected to be undertaken in one month 
 Self-study of six modules + face-to-face review of the course  3 days 
 One-day Training on administration of vaccines  1 day 
Cost Not yet determined  costing of resources currently being undertaken 
Refresher requirements Every two years 
 
 
3.6.4 Tools and resources available to pharmacy professionals 
A training manual has been developed and will be made available to pharmacists who register for the training 
programme.  Standard forms and protocols are to be developed to be used by the pharmacists who will be 
involved in the immunisation programme.  Existing references from the WHO, American Pharmacists 
Association and other relevant reputable organisations and institutions would also be made available to 
pharmacists.  Continuing education modules on vaccination by pharmacists will be made part of the 
Nationwide Continuing Professional Education for pharmacists. 
 
 
3.6.5 Vaccination records 
Vaccination records are not yet finalised in the Philippines. 
 
 
3.6.6 Advocating for immunisation services in community pharmacies, limitations and 
challenges 
Pharmacies in the Philippines traditionally provide dispensing only services.  Therefore, one of the biggest 
challenges in the country is the poor public acceptance and awareness of immunisation services provided in 
community pharmacies.  The PPhA is leading an initiative in collaboration with other health organisations (e.g. 
nurses and medical association, the Institute of Ageing) to raise awareness and to promote pharmacists 
participation in community immunisation campaigns.  There is a great opportunity for pharmacies to provide 
vaccinations, offering adequate and efficient cold chain management and competitive service prices compared 
 
 
challenge that it currently being tackled by offering training opportunities. 
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3.7 Portugal 
 
Contributors: 
Andreia Bruno, Lead for Professional Development; Luis Rhodes Baião, Lead for International Affairs; Ema 
Paulino, President of South and Autonomous Regions Branch, Portuguese Pharmaceutical Society (PPS); Filipa 
Alves da Costa, Invited Assistant Professor at Instituto Superior de Ciências da Saúde Egas Moniz 
(ISCSEM)/Strategic Planning, Portuguese Pharmaceutical Society (PPS); Isabel Jacinto, Pharmacy Services 
Manager of Pharmacy Services Department; Rute Horta, Coordinator of Pharmacy Services Department; Sónia 
Queirós, International Affairs Manager, National Association of Pharmacies (ANF). Helena Rosado, FIP 
Collaborating Centre UCL School of Pharmacy. 
Disclaimer: the information represents the state in July 2016 and may be subjected to changes 
 
 
Indicators 
Population (millions) 1,2 10.4 
Population > 65 years (%Total) 1,2 20.1 
Health expenditure (% GDP) 1,2 8.9 
Pharmaceutical spending (% Health expenditure) 1,2 15.3 
Number of community pharmacies 3 2,885 
 
 
3.7.1 Advocating for immunisation and promoting immunisation services in 
pharmacies 
The reform which allows pharmacies to expand their scope of practice into new areas including immunisation 
was implemented in 2007.  Since then, there has been a strong healthcare promotion of pharmacy 
immunisation activities using posters and leaflets, especially for flu campaigns, as well as presence on the 
media, with TV and radio advertising spots, and social media intervention, creating awareness of the benefits 
of immunisation and advertising the services provided in the pharmacy.  Pharmacists in Portugal are actively 
involved in immunisation advocacy activities, for example, identifying and advising vulnerable individuals 
based on their profile and referring them to their physicians to get the vaccine prescriptions. 
 
with 
prescription. In the first case, pharmacists inform patients about influenza, on some preventive measures and 
the benefits of immunisation.  It is important to advise the patient to have a medical appointment in order to 
get a more thorough evaluation and a prescription for flu vaccination. In the case where the patient has a 
prescription, pharmacists dispense the vaccine, inform that the service of immunisation is available in the 
pharmacy and, if requested by the patient, deliver the service according to procedure and keep a record of the 
service provided. 
 
Currently pharmacies are able to provide more than ten types of vaccines although most campaigns are 
focused on flu immunisation.  The first national flu vaccination campaign was held during the 2008/2009 
autumn/winter season with very encouraging results. Other campaigns were aimed to contribute to the 
prevention of HPV infection and cervical cancer (in 2009) as well as pneumococcal infection (in 2010 and 2011). 
 
 
3.7.2 Administration of vaccines in pharmacies 
In 2007, th
involvement in public health. Several services are currently included, such as information campaigns, health 
education programmes, screening activities, pharmaceutical care programmes, provision of first aid, 
domiciliary/home support, medicines administration and vaccine administration, as set out in the 
Governmental Decree (Portaria) 1429/2007, 2nd November.4  
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To avoid overlapping with the mandatory National Health Service Vaccination Plan, the role of pharmacists is 
considered supplementary since they are only able to administer vaccines outside of the scope of the NHS 
vaccination plan, such as influenza, pneumococcal, human papillomavirus and hepatitis B (the latter depending 
 implement need to be clearly visible in the 
pharmacy, including information about schedules and cost.  Additionally, records of the service provision must 
be noted and kept for traceability purposes. 
 
The Deliberation 139/CD/2010 5 of the National Authority of Medicines and Health Products (INFARMED), as 
amended by Deliberation 145/CD/2010 6, determines that the responsibility of the vaccination process lies on 
the pharmacy manager (pharmacist responsible for all the professional activities within the pharmacy) and 
must be performed either by a trained pharmacist or by a nurse that is exclusively hired for this purpose.  These 
legislations also detail the mandatory requirements for the provision of immunisation services in community 
pharmacies, including specifications on the premises (private room with a minimum of 7m2), equipment, 
material and waste management. 
 
Administration of vaccines in: 
Community pharmacies Healthcare centres 
Healthcare professional(s) administering vaccinations 
Pharmacist or nurse Nurse or physician 
Legal accountability 
Pharmacy manager N/A 
Vaccination provided 
Vaccinations not included in the National Health 
Service Vaccination Plan: 
 Cholera (Dukoral®)  
 Diphtheria, Tetanus and Pertussis 
(Boostrix®)  
 Meningococcal (Menveo®; Bexsero®)  
 Pneumococcal (Pneumo 23®; Prevenar®; 
Prevenar 13®; Synflorix®)  
 Tick-borne Encephalitis (FSME-IMMUN®)  
 Japanese-Encephalitis (Ixiaro®)  
 Yellow Fever (Stamaril®)  
 Typhoid Fever (Typhim Vi®; Typherix®)  
 Influenza (Fluarix®; Influvac®; Istivac®)  
 Hepatitis A (Epaxal®; Havrix® 720 Júnior; 
Havrix® 1440 Adulto; VAQTA®)  
 Hepatitis B (Engerix B®)  
 Hepatitis A and B (Twinrix®)  
 Human Papillomavirus (Cervarix®; 
Gardasil®)  
 Rabies (Rabipur®)  
 Human rotavirus (Rotarix®; RotaTeq®) 
 Varicella (Varivax®; Varilrix®)  
 Herpes Zoster (Zostavax®)  
*Underlined vaccines are included in the NHS 
vaccination plan but may be administered in the 
pharmacy to individuals whose age group falls out of 
the scope of the NHS vaccination plan. 
National Health Service Vaccination Plan: 
 BCG (Tuberculosis)* 
 VHB (Hepatitis B) 
 Hib (Haemophilus Influenzae b) 
 DTPa (Diphtheria, Tetanus, Pertussis / 
Whooping Cough) 
 VIP (Polio) 
 Pn13 (Streptococcus pneumoniae) 
 MenC (Neisseria meningitidis C) 
 VASPR (Measles, Mumps, Rubella) 
 HPV (Human papillomavirus) 
 
healthcare units. 
 
* Since 2016, only for high risk groups  
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Administration of vaccines in: 
Community pharmacies Healthcare centres 
Vaccination requirements 
Prescription: Yes 
Certified/accredited pharmacist training: Yes 
Vaccination record: Yes 
Specifications on premises, equipment, material and 
waste management: Yes 
Prescription: No.  
Flu vaccination is also available for high-risk groups 
for free and not subject to a prescription. 
Vaccination rates 
49% (of all administered flu vaccines) 7 
Source: CEFARa VACCINATION DATA - SEASON 2014/2015  
51% (of all administered flu vaccines) 7 
Source: CEFARa VACCINATION DATA - SEASON 2014/2015  
95% (average population rate of NHS vaccination 
plan coverage) 8 
Source: GENERAL DIRECTORATE FOR HEALTH  HEALTH MINISTRY 
2014 
47.2% (population rate > 65 years old that referred 
taking flu vaccine on the previous year) 9 
Source: NATIONAL HEALTH INQUIRY 2014 
Vaccination supply 
Vaccines are purchased directly from 
pharmaceutical wholesalers or negotiated directly 
with the pharmaceutical industry. 
Vaccines are purchased directly from 
pharmaceutical industry by the state. 
Vaccination payment and reimbursement 
Patients pay for vaccines (reimbursement rates 
apply) and for the pharmacy service of administering 
the vaccine. 
Vaccines from the NHS Vaccination Plan are free of 
charge. 
Flu vaccine and administration are free of charge for 
patients over 65 years old. 
Travel vaccines are not all available in the healthcare 
centres; only few places provide these 
appointments; some pharmacies provide the service 
and dispense these vaccines. 
a CEFAR - Centre for Health Evaluation & Research (ANF Group) 
 
 
3.7.3 Training of the pharmacy workforce 
Certificate Training Program for Pharmacists (Pharmacy-Based Immunization Delivery), in line with the 
qualifications required by the Centres for Disease Control and Prevention (CDC).  Before the definition of the 
Portuguese training model, the ANF Service Manager for this area participated in the American Program and 
became certified in Pharmacy-Based Immunization Delivery by APhA in March 2008. 
 
Following the legislation, the national authority for medicines and health products (INFARMED) has delegated 
on the Portuguese Pharmaceutical Society, through the Deliberations 139/CD/20105 and 145/CD/20106, the 
responsibility to accredit the training of pharmacists for the administration of vaccines and injectable 
medicines. This training is provided at post-registration level.  In 2013, the PPS published guidelines on the 
Recognition of the training for pharmacists in administration of vaccines and injectable medicines in 
community pharmacy.  These guidelines establish the minimum requirements that all training courses 
available should have both for the initial training and the training update, every five years.10  The PPS issues a 
certificate of pharmaceutical competency in administration of vaccines and injectable medicines, valid for five 
years, which must be paired with a certification for Basic Life Support (that falls out of the scope of the PPS). 
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The education and training for the initial certification of the pharmacist in vaccination and administration of 
injectable medicines involves:  
1. Fundamental concepts of immunology;  
2. Knowledge about Vaccines and Injectable Medicines;  
3. Legislation and Good Practices;  
4. Safety procedures (including anaphylaxis counter-measures);  
5. Subject approach;  
6. Injectable Medicines Administration Techniques. 
 
Even though the theoretical component can be provided through distance learning, the practical training must 
take place in a live event; real subjects or test dummies (simulators) can be used for training purposes. This 
practice must never be less than 25% of the whole time of the training. 
 
The ANF training model, for example, fulfils the current requirements by the PPS certification.  Pharmacy 
formal subject of the university curricula in all faculties.  Undergraduate trainees cannot administer vaccines 
or injectable medicines with this training since the PPS Competencies Model, which has been recently 
launched, defines this competency as one that can only be acquired by practicing pharmacists.   
 
Training of the pharmacy workforce 
Contents Administration of vaccines and injectable medicines;  
Basic life support (automated external defibrillation is optional). 
Certification/accreditation Administration of vaccines and injectable medicines training recognised 
and certified by the Portuguese Pharmaceutical Society. 
Basic Life Support by training provider certified by the National Institute 
for Medical Emergency (INEM). 
Providers Portuguese Pharmaceutical Society, National Association of Pharmacies, 
other education and training courses providers. 
Requirement Mandatory 
Level Post-registration 
Training duration Seven hours is the minimum training duration recommended. Although 
duration can vary with the training provider, it must comply with the 
minimum content requisites set by the PPS. 
Cost Paid by employers or individual pharmacists. Costs can vary with the 
training provider. 
Refresher requirements Administration of vaccines and injectable medicines  Every 5 years. Re-
certification can be a theoretical update on the state of the art concerning 
vaccines and injectable medicines. Pharmacists are exempt of further 
practical training if they are able to provide evidence of professional 
practice. 
Basic life support  Every 5 years. 
 
Training covering the administration of vaccines and injectable drugs dates back to 2008. In 2008, the Post-
Graduation School in Health and Management (EPGSG) from ANF developed a training programme for 
pharmacists on immunisation delivery.  The objective was to provide skills on vaccine information and 
administration to support pharmacists in the provision of this service at the pharmacy.  
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Trained pharmacists 
Year of Training 
2008 2009 2010 2011 2012 2013 2014 2015 
Number of pharmacists trained for administration of vaccines/injectable medicines (at EPGSG)a11 
1,914 2,456 3,023 3,289 3,433 3,611 3,725 - 
Number of PPS certified pharmacists for the administration of vaccines and injectable medicines 
- - - - - 1,982 2,848 3,061 
a Cumulative values 
 
 
As stated above, it was only in 2013 that the PPS started to issue the competency certification following the 
2010 regulation of the National Authority for Medicines and Health Products (Deliberation 145/CD/2010). There 
are currently 3061 certified pharmacists for the administration of vaccines and injectable medicines, under the 
scope of the PPS (certified from July 2013 to January 2016). However, an estimation of a few hundred 
pharmacists, who had training between January 2011 and June 2013, still are not certified by the PPS despite 
their training being valid. The PPS will issue these pharmacists a certificate as their initial training expires (5 
year cycle for renewal) and they follow the duty to revalidate this competency. 
 
 
3.7.4 Tools and resources available to pharmacy professionals 
In 2008, with the support and in collaboration with physicians and legal advisers, the ANF developed and 
disseminated a specific intervention model and a set of recommendations for the provision of vaccination 
services in community pharmacies. Currently, the professional associations ANF and PPS provide support to 
their member pharmacies and pharmacists, including recommendations and professional tools that guarantee 
a high quality and safe provision of immunisation. More recently, the PPS launched a book covering the various 
aspects of vaccine administration, which is freely distributed to pharmacists and may be considered a good 
practice guideline.12 In addition, the ANF also developed, in collaboration with physicians, a guideline on 
anaphylactic events which is available to all pharmacies implementing the immunisation service. 
 
 
3.7.5 Vaccination records 
Vaccination records were initially (2008) stored in paper format but since 2012 electronic records were adopted. 
Currently, the pharmacist can register vaccination service provision in the pharmacy software (SIFARMA). The 
vaccination record includes patient name, age and gender, the vaccine name and batch used, route of 
systems; they are neither nationally shared, nor shared between pharmacies, nor between pharmacies and 
other vaccination administration sites, such as healthcare centres. However, pharmacies share anonymous 
data with CEFAR - Centre for Health Evaluation & Research (ANF Group) which are used for research purposes 
and to analyse the trends in service uptake. 
 
 
Vaccination records 
Details recorded Individual details: name, age, gender 
Product details: name, batch, expiry date 
Administration service details: name of the professional administering 
the vaccine, route of administration, administration date, anaphylaxis 
(yes/no).  
Record format Paper or Electronic 
Record requirement Mandatory 
Record storage Pharmacy electronic system 
Record sharing Pharmacies share anonymous data with CEFAR for research purposes  
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Vaccination records 
Use of recorded information Data analysis and evaluation performed by CEFAR - Centre for Health 
Evaluation & Research (ANF Group) 
Minimum record keeping 5 years 
Other information Other information may be recorded in the software, such as the presence 
of chronic diseases or pregnancy, which may be used in the future to 
better understand service uptake by high-risk patients other than the 
elderly. 
 
 
3.7.6 Outcomes 
This next table refers to the values of Flu Vaccination Campaigns. 
 
Outcomes of Flu Vaccination Campaigns 
Campaign year 13 
2008/09 2009/10 2010/11 2011/12 2012/13 2013/14 2014/15 
Number of participating pharmacies (% total number of pharmacies) 
1,588 (57.5%) 1,622 (58.7%) 1,703 (61.7%) 1,785 (64.8%) 1,945 (70.3%) 1,818 (65.7%) 2,125 (76.4%) 
Number of pharmacies reporting data 
775 1,033 1,053 1,227 971 a 2,344 a 2,383 a 
Average number of flu shots administered per pharmacy 
206 284 218 230 117 42 59 
% of flu vaccines administered in pharmacies (max. point estimate) 
36.4% 49.7% 44.2% 49.0% 38.0% b 40.9% b 49.3% b 
% of flu vaccines administered in pharmacies in patients aged 65 years and older 
50.4% 53.7% 45.0% 43.3% 20.5% c 9.8% c 10.0% c 
Vaccinations administered by pharmacists (% total pharmacy administered vaccines) 
91.0% 92.2% 92.0% 93.5% 98.9% 98.5% 98.7% 
13Source: CEFAR - Centre for Health Evaluation & Research (ANF Group) and the Portuguese Pharmaceutical Society. 
a Only considered the data recorded in the software SIFARMA. 
b Changes in the methodology for calculating the influenza immunisation coverage in pharmacies since 2012/13. 
c Healthcare centres provide the immunisation service free of charge to patients older than 65 since 2012/13. 
 
 
The number of participating pharmacies in the flu vaccination campaign increases every year. The first 4 
seasons show evidence of an increase in major indicators. In the 2012/2013 campaign, healthcare centres 
started to provide a public flu immunisation service to citizens older than 65 years old. As a consequence, 
pharmacy vaccination rates decreased by over 20% between the 2011/12 and 2012/13 flu campaigns.  
 
In 2008/2009 a survey of 2,544 patients vaccinated against influenza in pharmacies portrayed a 95% satisfaction 
with the service provided and 99.5% satisfaction with the pharmacists that administered the vaccine. Other 
cited aspects included the convenience of the pharmacy opening times, the privacy and the advice provided 
about flu and vaccinations and the reduced waiting time (an average of 5.1 minutes for the 2008/2009 
campaign). This study also showed that 91.4% of the patients did not have to book a vaccination appointment. 
 
Regarding the reasons for choosing the pharmacy, 75.4% indicated the possibility of purchasing and 
administering the vaccination in the same place, 31.1% because they knew the pharmacist and 21.2% because 
of the proximity to their home or workplace. Finally, 97.9% said they would opt for pharmacy vaccination in the 
future and 98% would recommend the pharmacy vaccination service to family and friends. 
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3.7.7 Advocating for immunisation services in community pharmacies, limitations and 
challenges 
in immunisation were associated to constraints 
in the legislation as well as acceptance, support and recognition by other healthcare professionals, in 
particularly by nurses also performing the vaccine administration role. Throughout the years these issues were 
overcome. In 2007 the government changed the legislation to allow pharmacists to administer vaccinations 
and pharmacy-led immunisation services are now very well recognised and accepted, including by the general 
public. 
One of the main limitations at present is the prescription requirement for vaccine administration in 
pharmacies. This is particularly true for flu vaccinations, for which there is a significant accessibility difference 
between community pharmacies and healthcare centres. In 2012 the government launched a measure allowing 
patients over 65 years old to be vaccinated against influenza in health centres without a prescription and free 
of charge.  This measure was not implemented in community pharmacies and therefore the same service 
required a product prescription. In addition, the limited financial support and lack of remuneration 
programmes provided to pharmacies meant that patients had to continue paying for the vaccines and their 
administration.  As a consequence, there are studies showing that during the autumn/winter season of 
2012/2013, the percentage of pharmacy flu vaccinated patients over 65 dropped almost 30% compared to the 
previous year.14 
 
Nonetheless, the vaccination rate in pharmacies is valuable and a significant number of patients, including the 
elderly, continuously seek the vaccination service from pharmacies due to the reduced waiting time and the 
confidence that patients place on the pharmacist.15  It would be, however, of great benefit if the Health 
Authorities considered allowing qualified community pharmacists to administer flu vaccines to high-risk 
patient groups (for example, patients aged 65 years and older) without prescription and under similar protocols 
and requirements as healthcare centres.  The ANF is leading an initiative to stimulate collaborations and further 
developments for integrating pharmacies in the National Influenza Immunisation Campaign. 
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3.8 South Africa 
 
Contributors: 
Lorraine Osman, Head of Public Affairs, Pharmaceutical Society of South Africa (PSSA). Helena Rosado, FIP 
Collaborating Centre UCL School of Pharmacy. 
Disclaimer: the information represent the state in May 2016 and may be subjected to changes 
 
 
Indicators 
Population (millions) 1 54.0 
Population > 65 years (% Total) 1 5 
Health expenditure (% GDP) 1 8.9 
Number of community pharmacies 2 3,136 
 
 
3.8.1 Advocating for immunisation and promoting immunisation services in 
pharmacies 
access to immunisation services.  Pharm immunisation services varies with each 
practice setting in South Africa and a range of activities can be undertaken including distributing vaccination 
leaflets, educating and advising the public and other health care professionals about immunisation.  
Pharmacists may also participate in multi-disciplinary immunisation campaigns, while some serve on 
immunisation advisory committees.  
 
Many community pharmacies operate a primary healthcare clinic within the pharmacy.  Either the pharmacist 
or a nursing sister performs a number of services, including administration of vaccines. By keeping appropriate 
parents, when the next vaccination is due.  
 
Other activities include advocating paediatric immunisation, alerting travellers about immunisation before 
international travel and identification of high risk patient groups. Individual pharmacists in both community 
pharmacy and the public sector may participate in some or all activities.  Periodically, mass immunisation 
campaigns are implemented to ensure maximum immunisation coverage during sporadic outbreaks of 
communicable diseases. 
 
Example of local activities 
South Africa follows the WHO immunisation as one of 
their indicators for achievement of the child development index.  It is one of the priority interventions that has 
great impact on reducing child mortality. 
 
The South African Expanded Programme on Immunization (EPI-
strategies for polio measles eradication.3,4  While campaigns vary from district to district depending on the 
need, many local authorities have had campaigns focusing on giving measles and polio vaccines to as many 
children as possible in a short period of time. In particular, they make an effort in underserviced areas where 
routine immunisation services may not reach all children.  During May and June 2014, for example, the City of 
Tshwane conducted an immunisation catch-up campaign. 
 
 
The National Department of Health, assisted by implementation by provincial and local authority health 
services, as well as private sector healthcare providers, including community pharmacists, regularly runs 
immunisation campaigns for flu vaccines, targeting people at high risk of serious complications.  
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Since the introduction of the Human Papillomavirus vaccine into the EPI-SA, a number of campaigns have been 
held targeting girls from the age of 9 years. 
 
 
3.8.2 Administration of vaccines in pharmacies 
Trained pharmacists and other healthcare professionals, such as nursing sisters, are legally authorised to 
administer vaccines in South African pharmacies.  Vaccination in pharmacies was never specifically forbidden 
in South Africa - pharmacists were never prevented from administering an injection although they were, and 
still are, not permitted to perform services for which they are not adequately trained or experienced to 
undertake. Initially most vaccines, other than polio and yellow fever, fell into Schedule 2 or below, which meant 
that they could be sold by the pharmacist without a prescription.  The six most commonly used were for polio, 
diphtheria, tuberculosis, pertussis, measles and tetanus.  Since then this list has been considerably extended.  
The Department of Health is committed to achieving the millennium development goal (MDG4) of reducing 
child mortality by implementing a robust National Expanded Programme for Immunization (EPI).  Pharmacists 
must therefore be familiar with the instructions, requirements and guidelines of the EPI.3,4 
 
 
Administration of vaccines in: 
Community pharmacy Public sector healthcare clinics 
Healthcare professional(s) administering vaccinations 
Pharmacist or nurse Doctor or nurse 
Legal accountability 
Responsible pharmacist, who may or may not be the pharmacy owner, and the professional administering 
the vaccine 
Vaccination provided 
EPI vaccines plus MMR (Mumps, Measles, Rubella) 
and the seasonal influenza vaccine 
EPI vaccines3,4 
 Oral Polio Vaccine 
 BCG 
 Rotavirus  
 Diphtheria 
 Tetanus 
 Pertussis 
 Haemophilus influenzae type b 
 Hepatitis B 
 Conjugated Pneumococcal vaccine 
 Measles 
 Human Papillomavirus 
Note: A number of these are contained in 
combination products, e.g. DTaP, DTaP-
IPV/Hib, DTaP-IPV-Hib-HBV 
Additional vaccine: Seasonal influenza vaccine 
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Administration of vaccines in: 
Community pharmacy Public sector healthcare clinics 
Vaccination requirements 
Prescription: No prescription is required for the EPI 
vaccines, the MMR or the seasonal influenza vaccine.  
A prescription is necessary for other vaccines that are 
used by doctors in the private sector, i.e. 
Meningococcal Conjugate Vaccine, Rabies, Varicella 
and Hepatitis A. 
Certified/accredited pharmacist training: Not 
necessarily at this stage 
Vaccination record: Yes 
Specifications on premises, equipment, material and 
waste management: Yes 
Requirements as set out in the Good Pharmacy 
Practice (GPP) Manual.5 
Age groups  EPI is aimed primarily at infants and 
children 
Influenza and pneumococcal vaccines are given to 
people who are at risk. 
Vaccination rates (National data (%); pharmacy only not available) 
Vaccine 
EPI report WHO Country Office3 
2015 2014 
DTaP-IPV/Hib 1 
DTaP-IPV/Hib 3 
DTaP-IPV/Hib 1  3DOR 
Measles (MCV) 1st dose 
DTaP-IPV/Hib 1- MCV 1 DOR(%) 
Measles 2nd dose 
MCV 1  MCV 2 DOR (%) 
Rotavirus 2nd dose 
PCV 3rd dose 
Fully Immunised Child (FIC) 
95.0 
94.0 
1.1 
97 
-2.1 
84 
13.4 
94.0 
94.0 
91.7 
96.0 
95.0 
1.0 
91.0 
5.2 
81.0 
11 
94.0 
90.0 
87.4 
Vaccination supply 
The Department of Health provides some vaccines to 
pharmacies free of charge. This differs according to 
the policies and procedures of the various health 
districts. Other vaccines are purchased through 
pharmaceutical wholesalers and distributors 
In general, all supplies are procured through a tender 
process 
Vaccination payment and reimbursement 
Some vaccines are provided by the Department of 
Health free of charge to the pharmacy. Other 
vaccines sold and/or administered are paid for 
medical scheme rules, are reimbursed by the scheme. 
Immunisation with vaccines listed in the EPI-SA are 
administered free of charge to the patient 
Other information 
Immunisation is seen as a critical healthcare element. Periodic immunisation campaigns for specific vaccines 
are supported by both the public and the private sector. 
 
The Rules relating to Good Pharmacy Practice (GPP), published by the South African Pharmacy Council (SAPC) in 
terms of the Pharmacy Act, set down standards for both facilities and services.  The Minimum Standards for 
Immunization Services deal with the immunisation activities in which pharmacists with training in 
immunisation may participate, the physical facilities and equipment, the procedures to be followed, 
documentation and record keeping, ethical issues and training.  Other standards in the GPP deal with cold chain 
management and waste managemen.5,6 
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Pharmacists are currently not required to submit figures for returns unless the State supplies their stock of 
vaccines. State supply of stock depends on individual local or provincial authorities; although there are some 
areas where it is in practice, in most areas pharmacists obtain their stock from local wholesalers.  For this 
reason it is challenging to retrieve an accurate figure for pharmacy-based vaccination rates. 
 
 
3.8.3 Training of the pharmacy workforce 
Formal theoretical training in immunisation is given during all university undergraduate pharmacy 
programmes; however, in most cases, pharmacists undergo post-registration practical training and exposure 
to the current EPI.  At undergraduate level, the training was theoretical only.  In 1991, with the rising interest in 
primary healthcare, private training institutions started offering training in immunisation, including both 
theory and vaccination technique. 
 
Training is currently mandatory and the SAPC's ethical rules clearly state that pharmacists may not perform 
professional acts for which they are inadequately trained or insufficiently experienced.  As described in the GPP 
manual, pharmacists performing immunisation services must have vaccine administration skills, be familiar 
with the National and Provincial schedules for immunisation of infants, children and travellers as well as the 
WHO guidelines for the prevention of HIV and Hepatitis virus.  Pharmacists must also have knowledge of 
vaccines route of administration, contra-indications and possible adverse reactions, prevention and 
management of anaphylaxis and knowledge of cardio-pulmonary resuscitation.5 
 
Training of the pharmacy workforce 
Contents The contents may significantly vary between training providers and may 
include: 
 Administration of vaccines, contra-indications and adverse 
reactions; 
 Anaphylaxis and cardio-pulmonary resuscitation; 
 Instructions, requirements and guidelines of the National 
Expanded Programme on Immunization (EPI) policy; 
 Guidelines for the prevention of communicable diseases, 
including HIV and Hepatitis virus.   
Certification/accreditation Training is not necessarily accredited/certified, recognised or approved, 
although some providers are accredited by the South African Pharmacy 
Council (SAPC) 
Providers SAPC accredited providers: North-West University, Sefako Makgatho Health 
Sciences University 
There is no official list of non-accredited providers 
Requirement Mandatory 
Level Post-registration 
Training duration Variable depending on each course provided (e.g. 10h, 2 days, etc.) 
Cost Paid either by pharmacists and/or their employers 
Refresher requirements Currently not required 
 
Although some immunisation training providers are accredited by the SAPC, there are currently no published 
or legal training requirements.  For this reason, there are several organisations offering training programmes 
that may not necessarily be accredited/certified, recognised or approved by SAPC and therefore contents may 
significantly vary between training providers. 
 
The initial training courses offered a half-day or evening covering the EPI, travel vaccines, MMR (which was then 
not part of the EPI) and tetanus boosters, injection technique, anaphylaxis prevention and treatment, 
emergency kit required, disposal of biologic waste and the different vaccines and recording on the road to 
health card.  Pharmacists were required to perform one of each type of injection at the course and then were 
required to submit evidence of 20 supervised vaccines before certificates were issued by the provider.  At 
present, there is still a standalone course offered in the same way; however, there is also an extensive Primary 
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Care Drug Therapy course that incorporates immunisation into the knowledge and skills required (e.g. 10h, 2 
days).  The training cost is paid either by pharmacists and/or their employers. 
 
 
3.8.4 Tools and resources available to pharmacy professionals 
Primary Healthcare (PHC) Guidelines, which includes the Standard Treatment Guidelines and Essential 
Medicines List. A new innovation is the PHC Clinical Guide app for iOS and android mobile devices. A full section 
is included on immunisation, including information on immunisation schedules, cold chain management, open 
multi-does vial policy and adverse events following immunisation. A directory of useful contact details is 
provided on the app, including health facilities for referral as well as medicine information centres that can be 
phoned for assistance. 
 
 
3.8.5 Vaccination records 
Immunisation records must be completed using designated immunisation cards as indicated in the GPP 
manual.5   
 
Vaccination records 
Details recorded Patient details:  Patient name, address, ID number, date of birth 
Vaccine details: Name of manufacturer; batch number of vaccine; expiry 
date 
Vaccine administration details: Date of administration of vaccine; route 
of administration; date of next injection; signature of pharmacist/nurse 
who administered vaccine; other important information, e.g. previous 
reactions to vaccines and sensitivity to eggs, antibiotics and 
preservatives which may be contained in vaccines 
Record format Paper and/or electronic; the format varies from pharmacy to pharmacy, 
and also according to local authority requirements 
Record requirement Mandatory 
Record storage Records are stored in the pharmacy 
Record sharing Recorded information can be shared with physicians, other pharmacists 
and local clinics upon request. Immunisation statistics must also be 
provided to the local District Health Co-ordinator for epidemiological 
purposes and for stock control. 
Use of recorded information Information can be used to remind patients when their vaccination is due 
and to generate reminder letter for booster doses. Immunisation 
statistics provided to the local District Health Co-ordinator are used for 
epidemiological purposes and for stock control. 
Minimum record keeping 5 years 
 
Record keeping in pharmacy has always been encouraged, with guidelines following the WHO Expanded 
Programme on Immunization Guidelines.  From 1995, when the South African mandatory record was 
introduced, this became a requirement for everyone providing immunisation services. 
 
For child vaccination, the Department of Health supplies a growth chart ("Road to Health card") which needs to 
be updated accordingly. Recorded information must be kept up-to date for a period of at least five years and 
can be shared with physicians and local clinics upon request.  Pharmacists can use locally stored information 
to remind patients when their vaccination is due and to generate reminder letters for booster doses.  Moreover, 
immunisation statistics must be provided to the local District Health Co-ordinator for epidemiological 
purposes and for stock control, if supplied by the local authority. 
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3.8.6 Outcomes 
neonatal tetanus elimination.  In 2006, SA was pre-certified polio-free by the Africa Regional Certification 
Committee.  
In recent years, local authorities have successfully run outreach programmes during campaigns for the 
eradication of polio and elimination of measles.  The City of Tshwane has an Outbreak Response Team, which 
has been faced with a meningococcal meningitis outbreak in 2011.  Medication was supplied to prevent the 
spread of the disease, and a vaccination campaign ensued in the neighbourhoods in which the outbreaks were 
reported.7 
 
 
3.8.7 Advocating for immunisation services in community pharmacies, limitations and 
challenges 
One of the main challenges for the development of pharmacy-based vaccination services is the limited 
acceptance and support (including financial) by the government and the health system.  With the re-
engineering of the health system to focus on enhanced primary healthcare services, and particularly with the 
preparations for the introduction of universal healthcare coverage, this may well change in future. 
 
One of the biggest challenges is to reach children who do not have access to routine immunisation services. 
Outreach programmes are therefore critical. 
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3.9 Switzerland 
 
Contributors: 
Claudine Leuthold, Project manager, Vaccination expert at pharmaSuisse. Helena Rosado, FIP Collaborating 
Centre UCL School of Pharmacy. 
Disclaimer: the information represents the state in July 2016 and may be subjected to changes 
 
 
Indicators 
Population (millions) 1,2 8.2 
Population > 65 years (% Total) 1,2 18 
Health expenditure (% GDP) 1,2 11.7 
Number of community pharmacies 3  1,774 
 
 
3.9.1 Advocating for immunisation and promoting immunisation services in 
pharmacies 
Pharmacists in Switzerland are very much involved in vaccination activities spanning from vaccine 
administration, currently authorised in 9 Cantons, to a range of vaccination advocacy and promotion activities 
in all 26 Cantons.4  For the first time this year (2016), pharmacists have also been invited to serve on 
immunisation advisory committee with pharmaSuisse invited to join the scientific committee of the biennial 
Swiss congress of vaccination. 
 
In 2015, one Canton (Vaud) initiated a campaign of immunisation record control in pharmacies making use of 
the electronic vaccination record (www.myvaccines.ch)5; the campaign was undertaken during one month 
(October) by the Cantonal Health Department.  In addition, two practical courses were organised (more than 
100 people attended to each) to train pharmacists in the use of the website www.myvaccines.ch.5  This 
Campaign will be repeated in June 2016 (two practical courses already organised) and in 2017 (delivery month 
not yet defined). The report from the first campaign has not been yet published. 
 
 
3.9.2 Administration of vaccines in pharmacies 
The authorisation for pharmacists to vaccinate is under the control of each Canton (there are 26 Cantons in 
Switzerland).  The first two Cantons (Fribourg, Neuchâtel) granted vaccination rights to pharmacists in July 2015.  
Later in the same year, pharmacists from 4 other Cantons were also authorised to administer a number of 
vaccines under specific conditions; these included Basel-Land, Berne, Solothurn and Zurich Basel-Land and 
Berne initiated a pilot test for the influenza season 2015/2016.  Currently, vaccination in pharmacies within 
these 6 Cantons can be undertaken without prescription.  In another Canton, Tessin, vaccination prescription 
is required.4  At present, three other cantons (Grisons, Schwyz, and Thurgau) received authorisation for 
vaccination of cantonal defined vaccines without prescription in 2016. 
 
According to the revised Federal law on medical professionals (LPMéd) article 96 of 1st January 2016 (under 
validation), pharmacists can contribute to the promotion and maintenance of health and prevention of disease 
and obtain the appropriate skills, particularly in the field of vaccinations. Specific legal requirements for 
vaccine administration vary across Cantons; patients must be healthy adults (over 16 years old) and without 
particular vaccination risk. The healthcare professional authorised to administer a vaccine must be a 
pharmacist holding an education certificate provided by pharmaSuisse (or equivalent training provider in 
certain Cantons) and an official authorisation given by the Canton. A summary of the current provision of 
vaccination services is shown in Figure 1. 
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Figure 1. Vaccination services provided in Switzerland across Cantons. 
Source: website www.vaccinationinpharmacies.ch,4 pharmaSuisse (July 2016 - reproduced with permission). 
 
Legend: 
BE/BL/FR/GR/NE/SO/SZ/TG/ZH: Vaccination in pharmacies without prescription 
BE: Influenza (pilot project- 2015/16 and 2016/2017) 
BL: Influenza (pilot project 2015/2016 and regular authorisation planned for 2016/2017  
FR: Influenza 
GR: Influenza, FSME, catch-up vaccination for Hepatitis A, B, A+B  
NE: Influenza, FSME (risk groups), MMR (catch-up vaccination); convention for 2 years, then re-evaluation  
SO: All vaccination according to the Swiss vaccination plan for adults over 16 years old; a validated questionnaire must be available: 
Influenza, FSME, Measles, Hepatitis A, B, A+B  
SZ: Influenza, FSME, catch-up vaccination for Hepatitis A, B, A+B  
TG: All vaccines according to the Swiss vaccination plan for adults over 16 years old (only catch-up vaccination except for Influenza and 
FSME) 
ZH: Influenza, FSME, catch-up vaccination for Hepatitis A, B, A+B 
TI: Vaccination possible in pharmacy only with a prescription from the physician 
 
 
In addition to education and training requirements, there are also room, material including cold chain as well 
as safety specifications. Furthermore, each Canton defines the types and schedule of vaccine(s) that can be 
administered; this usually includes influenza vaccine and in some Cantons also e.g. Tick-borne encephalitis 
(FSME), Measles, Hepatitis A, B and A+B (usually only the second dose). 
  
Vaccination in pharmacies
Vaccination in pharmacies (pilot project)
Vaccination under prescription
Vaccination recommendations only
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Administration of vaccines in: 
Community pharmacies Other primary care providers 
Healthcare professional(s) administering vaccinations 
Pharmacist, nurse or physician  
Legal accountability 
Pharmacy manager  
Vaccination provided 
Vaccinations provided vary across Cantons; 
schedules may include influenza vaccine only or, in 
other Cantons, may include others such as Tick-borne 
encephalitis (FSME), Measles, Hepatitis A, B and A+B 
(usually only the second dose). Patients must be 
healthy adults, i.e. at least 16 years old without 
particular vaccination risk. 
Depends on the type of Healthcare Centre. 
Only authorised Healthcare Centres can administer 
all vaccines including Yellow Fever, usually Travel 
ation Centres. 
Vaccination requirements 
Prescription: Requirements varies across Cantons 
Certified/accredited pharmacist training: Yes, 
depending on Cantonal authorisation 
Vaccination record: yes 
Standardised questionnaires are supplied by 
pharmaSuisse on paper or electronic form and must 
be used for anamnesis and to get the written signed 
informed consent of the patient. 
Specifications on premises, equipment, material 
waste and safety management: Yes 
Prescription: No but anamnesis needed by a certified 
health professional. 
 
 
3.9.3 Training of the pharmacy workforce 
Training in immunisation is available for the pharmacy workforce both during undergraduate and post-
graduate years but it is not yet mandatory. The undergraduate and University training is an optional course 
that can be undertaken during the second year of the Masters of Pharmacy (MPharm). This training will be 
completely integrated into the studies in 2017 (2018 the latest) in the two biggest Universities in Switzerland, 
Basel and Geneva-Lausanne. 
 
Healthcare professionals authorised to administer vaccinations must be pharmacists holding an education 
certificate provided by pharmaSuisse or another comparable education officially accepted by legal authorities 
(so far, the certificate of pharmaSuisse is the only accepted education).  The Certificate is accredited by the 
independent authority FPH Community Pharmacy Society validation committee (FPH = Foederatio 
Pharmaceutica Helvetiae).  The FPH Certificate for Training in Vaccination and Blood Sampling7 is intended for 
pharmacists holding a Federal degree in pharmacy or foreign equivalent according to federal law on medical 
professionals (LPMéd, article 50)6 aiming to expand their knowledge and skills in the field.  The course has 3 
parts: 
1. A practical module including theory on injection techniques and blood sampling.  The duration of this 
training is 2 days of group training composed of 16 periods of 45 minutes and another half-day of an e-
learning module that corresponds to 4 periods of 45 minutes to be completed before the group training.  
An attestation is issued after successfully completing the e-learning module and the practical 
examination. 
2. A theoretical module on vaccinations.  This part is undertaken in a one-day course corresponding to 8 
periods of 45 minutes and another half a day of e-learning of 4 periods of 45 minutes to be completed 
after the group training.  The e-learning part is focused on electronic resources particularly on the use of 
the electronically shared vaccination record, the only existing shared vaccination record.  The pharmacist 
must subscribe to the software viavac® and the website www.InfoVac.ch to be able to follow the e-
learning.  An attestation is issued after successfully completing the final examination and the e-learning 
course. 
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3. Training in Cardio Pulmonary Resuscitation (CPR) or Basic Life Support (BLS) during 1 day in general 
divided in 8 periods of 45 minutes. The CPR/BLS certification is required to obtain the final Certificate. 
A refresher is required every 2 years for CPR/BLS as well as another refresher of one of the other two courses.  
 
Training of the pharmacy workforce 
Contents   
Vaccinations; 
Cardio Pulmonary Resuscitation or Basic Life Support. 
Certification/accreditation Training is certified; the Certificate is accredited by the independent 
authority FPH Community Pharmacy Society validation committee 
Providers pharmaSuisse and training partners 
Requirement Currently optional; it will be mandatory from 2017/2018 
Level Post-graduate (will be integrated in the undergraduate studies in 2017 or 
2018) 
Training duration 5 days in total split into various training periods of 45 minutes 
Cost Depending on the course provider and the membership, from 2400.00 to 
3500.00 Swiss francs. Can be paid by the participant or by the pharmacy 
employer (there is no specification). 
Refresher requirements Every 2 years 
 
In 2015, permission to vaccinate was granted in 6 Cantons in Switzerland and since then the number of 
pharmacists undertaking certified immunisation training significantly increased.  There are currently 
approximately 500 certified pharmacists and 500 others currently in training. 
 
 
3.9.4 Tools and resources available to pharmacy professionals 
A number of leaflets and factsheets are provided by the Federal Office of Public Health8 in electronic format 
and also hardcopy documentation.  Their website also contains a range of information about communicable 
diseases vaccination campaigns including signposting to other online resources and websites.  The InfoVac9 
website and hotline is ran by a network of experts who are available to health professionals practicing in the 
field of vaccinations (doctors, pharmacists and public health professionals) to answer specific questions within 
24 to 48 h (under subscription). 
 
Personalised electronic vaccination records can be created and managed free of charge (and after registration 
on the website) using the Swiss Electronic Vaccination Record www.myvaccines.ch.5  The website is available 
both to healthcare professionals and patients and enables registrants to verify immunisation status and 
receive advice and vaccination recommendations depending on each personal situation.  The record can be 
created either by the health care professional or by the patient, and contents can be shared between these two 
parties.  Each vaccination record entered by a patient must be validated by a physician or a pharmacist to be 
printed and considered as legally valid. 
 
The personalised electronic vaccination record exists also as software available on PC. It enables pharmacists 
to create the vaccination record in the pharmacy and to synchronise it with the website www.myvaccines.ch. 
The principle is that the pharmacist can keep all the records in the pharmacy (local computer) and share it with 
the public wishing to obtain their record. 
 
 
3.9.5 Vaccination records 
Recording of vaccination details in Switzerland is optional and access to information requires double 
authorisation, from the pharmacist and also from the public. Pharmacies can subscribe to the software Viavac10 
which allows the creation and management of electronic vaccination records and the analysis of vaccination 
statuses. These functionalities are available through the use of precise algorithms which enable a real clinical 
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decision system. The Viavac software c
vaccination details. 
 
www.myvaccines.ch5, a free 
national website that enables vaccination record storage. Both systems are interconnected enabling the 
synchronisation of records created in pharmacy or reverse.  Records can be shared between physicians and 
pharmacists that are identified by a global localisation number (GLN), and between the public through the 
website. However, this is not considered as a national electronic system since it is used only on a voluntary 
basis and many healthcare professionals providing vaccination services (especially physicians) still have some 
concerns with the security of the electronic system. Nevertheless, in some Cantons, campaigns for 
management of vaccination records have been organised to encourage the public to get their vaccination plan 
to be registered as electronic vaccination record or checked and printed in the pharmacy. 
 
Vaccination records 
Details recorded Individual details: name, age, gender 
Product details: name or antigen 
Vaccination plan and catch-up plan with suggested vaccination 
schedule 
Administration service details: name and professional registration 
number (Global Localisation Number) of the professional administering 
the vaccine, administration date; Lot number and expiry date of the 
vaccine 
Optional: risk group and pregnancy, to get the vaccination plan or catch-
up (Risk groups and the pregnant women are excluded of the 
vaccination in the pharmacies) , area code (monitoring FSME endemic 
diseases) 
Record format Paper and/or Electronic 
Record requirement Optional 
Record storage Pharmacy software system Viavac linked to the national website 
www.myvaccines.ch run by the Foundation myvaccines.ch and 
supported by the Federal Office of Public Health.5,10  
Record sharing Records can be shared between healthcare professionals and the public 
through the centralised website under authorisation from the 
concerned person 
Use of recorded information Verify vaccination status, list of the patient needing a vaccination 
booster, define catch-up plan, advise and remind patients about 
recommended vaccinations 
Minimum record keeping Records are kept for 10 years (still in evaluation) on the national website 
 
 
3.9.6 Advocating for immunisation services in community pharmacies, limitations and 
challenges 
One of the main challenges for the development of pharmacy-based vaccination services is the limited 
acceptance and support (including financial support) by the government and healthcare system as well as 
other healthcare professionals. Nevertheless, in recent years the evolution of events has been very rapid. This 
year (2016), the changes in the Federal law6 authorised pharmacists to administer vaccines. This law will initiate 
execution phase in 2017 across the country; each Canton will be responsible to abide the law with specific 
decrees or regulations. The vaccination process will require a prescription and the Canton whose pharmacists 
are allowed to administer specific vaccines as decided by each Canton. 
 
The Federal Department of Health developed a National Strategy of vaccination (SNV) in order to define the 
targets and means to guaranty a good protection of the population against vaccine-preventable diseases.  This 
project is under evaluation and the final version will be published at the end of 2016. The strategy identifies 5 
main areas of intervention and 15 domains of action.  Pharmacists can play an active role in 8 of these domains, 
including vaccination promotion activities and advice, improvement of the supply chain, strengthening 
communication among stakeholders and the public, improving accessibility to vaccination (new low-threshold 
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service), encouraging the use of electronic vaccination records, and contribution to the improvement of 
training for healthcare professionals.11, 12 
 
Pharmacists in Switzerland wish to see in the near future an expansion of currently authorised vaccination 
services as well as changes in the law in order to allow pharmacists to be an active part of the vaccination 
strategy in each Canton with a legal and official pricing. Increased collaboration with the other health 
professionals involved in this field is also necessary in order to establish strong partnerships and to officially 
recognise pharmacists as additional vaccination providers. 
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3.10 United Kingdom (Great Britain) 
 
Contributors: 
Ash Soni, President of the Royal Pharmaceutical Society (RPS) until 19 July 2016. Aileen Bryson, Practice and 
Policy Lead RPS Scotland, Christopher John, Workforce Development at RPS, Elen Jones, Practice and Policy Lead 
RPS Wales. Oksana Pyzik, FIP Collaborating Centre UCL School of Pharmacy. 
Disclaimer: the information represent the state in July 2016 and may be subjected to changes 
 
 
Indicators 
Population (millions) 1 64.1 
Population > 65 years (%Total) 1 17.5 
Health expenditure (% GDP) 1 9.1 
Pharmaceutical expenditure (% health expenditure) 2 12.2 
Number of Community Pharmacies 2 14,361 
 
 
3.10.1 Advocating for immunisation and promoting immunisation services in 
pharmacies 
Promotion of pharmacy immunisation services to eligible patients is agreed between the National Health 
Service (NHS) and local government. Pharmacies promote immunisation services mainly through posters 
displayed in pharmacy windows, counter top notices, leaflets and flyers. Pharmacists collaborate with other 
healthcare professionals such as general practitioners (GPs  family doctors) to promote seasonal influenza 
campaigns. For example, in the 2009 seasonal flu campaign, pharmacists worked alongside GPs to raise 
awareness of at-risk groups of patients around the importance of immunisation against influenza. An 
information leaflet was inserted into the prescription bag of at-risk patients, which also advertised GP flu 
clinics and in-pharmacy immunisation services. Uptake of the pharmacy based immunisation service was 
highest amongst the at-risk patients under the age of 65 as it was more convenient for workers to go to a 
pharmacy without an appointment allowing for opportunistic immunisation. GPs were notified within 24-48 
hours of the vaccine being administered. However, since the inclusion of all pharmacies in the national flu 
campaign for the first time in 2015 collaboration with GPs has in some instances declined due to direct 
competition.3 
 
In addition, other outreach methods were used such as website promotion 
(http://www.myhealthlondon.nhs.uk), twitter with @NHSflufighter and #flufighter and photo shoots for 
example with the deputy Mayor of London receiving a flu vaccine. 
 
The promotional material must comply with the NHS brand guideline and cannot offer free gifts or incentives 
to encourage people to get vaccinated. The promotional materials have been translated into the following 
languages to increase access to the service including Gujarati, Hindi, Polish, Portuguese, Punjabi, and Urdu. The 
National Health Service (NHS) runs a seasonal flu vaccination from September through to February, which aims 
to vaccinate all patients who are at risk of developing more serious complications from the influenza virus. The 
target patients include people aged 65 years and over, pregnant women and those with certain health 
conditions. 
 
 
3.10.2 Administration of vaccines in pharmacies 
Until the 2013/2014 flu season, GPs or nurses vaccinated all eligible individuals in England, apart from the few 
small pilot studies in London with pharmacy based delivery.  Previously, most community pharmacies offered 
flu vaccinations as a private service for patients who did not qualify for NHS vaccinations or for those who were 
happy to pay themselves for the service due to its convenience. This is still the case in Scotland where health 
care is devolved to the Scottish Government. 
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In 2013/2014, pharmacies in England were commissioned to provide NHS flu vaccination services alongside the 
national GP vaccination service offering patients alternative choice of venue for their vaccination and helping 
commissioners to meet their local NHS vaccination targets.4 
 
Looking back, a larger role for pharmacists in the arena of public health was first outlined in the 2008 white 
paper Pharmacy in England: Building on Strengths  delivering the future with a focus on pharmacists 
delivering commissioned NHS immunisation services.   The rationale hinged upon using pharmacies to increase 
access for the high risk and hard-to-reach patient population.  In 2009, NHS commissioners started to focus on 
the potential for pharmacists to deliver the H1N1 swine flu vaccine as part of the planning for the swine flu 
pandemic.  As a result of these initial measures, the range of vaccines available has extended beyond seasonal 
flu to human papilloma virus, hepatitis B, and travel vaccines as well as many other. By 2012, over a quarter of a 
vided by community pharmacies in England and 
Wales in one scheme alone.4 
 
Administration of vaccines in primary care: 
Community pharmacy y/Healthcare centre 
Healthcare professional(s) administering vaccinations 
Pharmacist or nurse Nurse 
Legal accountability 
Pharmacy manager and pharmacist N/A 
Vaccination provided 
 Childhood immunisation: Measles, Mumps, 
Rubella (MMR VaxPro®; Priorix®)  
Diptheria, Tetanus, Pertusis,Polio DTaP/IPV 
(Repevax®) 
 Cholera (Dukoral®) 
 Influenza (Fluarix®; Influvac®; Istivac®) 
 Live Attenuated Influenza Vaccine 
(FluenzTetra®) 
 Meningococcal group B (Bexsero®) 
 Meninigococcal group A,C,W and Y 
(Nimenrix®, Menveo®) 
 Pneumococcal polysaccharide vaccine 
 Japanese-Encephalitis and Japanese 
Encephalitis Booster (Ixiaro®) 
 Yellow Fever (Stamaril®) 
 Tick-borne encephalitis (TicoVac®) 
 Typhoid Fever (Typhim Vi®; Typherix®) 
 Hepatitis A and booster (Avaxim®; Epaxal®; 
Havrix Monodose®; VAQTA®paediatric; 
VAQTA® Adult) 
 Hepatitis B and booster (Engerix B®; 
Fendrix®; HBvaxPRO®) 
 Hepatitis A and typhoid vaccine 
(Hepatyrix®; ViaATIM®) 
 Hepatitis A and B (Ambirix®;Twinrix®) 
 Human Papillomavirus (Gardasil®) 
 Rabies and booster (Rabipur®) 
National Health Service Immunisation Plan 20165: 
 Live Attenuated Influenza Vaccine 
(FluenzTetra®) 
 Childhood Immunisations: Measles, Mumps, 
Rubella (MMR VaxPro3®; Priorix®), Diptheria, 
Tetanus, Pertusis,Polio  and Haemophilus 
Influenzae type b DTaP/IPV/Hib (Repevax®) 
 Meningococcal group B (Bexsero®) 
 Meninigococcal group A,C,W and Y 
(Nimenrix®, Menveo®) 
 BCG (Tuberculosis) 
 Pneumococcal (13 stereotypes) 
(Prevenar13®) 
 Pneumococcal (23 stereotypes) 
Pneumococcal polysaccharide vaccine 
 HPV Human papillomavirus (Gardasil ® ) 
 Rotavirus  gastroenteritis (Rotarix® ) 
 Shingles (Zostavax®) 
 
Other vaccines that may be provided: 
 Hepatitis A and B (Ambirix®;Twinrix®) 
 Rabies (Rabipur®) 
 Varicella Zoster 
(Varilrix®;Varivax®;Zostavax®) 
 Cholera (Dukoral®) 
 Tick-borne encephalitis (TicoVac®) 
 Typhoid fever (Typhim Vi®; Typherix®) 
 Yellow fever (Stamaril®) 
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Administration of vaccines in primary care: 
Community pharmacy y/Healthcare centre 
Vaccination requirements 
Prescription:  No 
Certified/accredited pharmacist training: Yes 
Vaccination record: Yes 
Specifications on premises, equipment, material and 
waste management: Yes 
Prescription: No. 
Flu vaccination is also available for high-risk groups 
for free and not subject to a prescription. 
Vaccination rates 
In 2014/2015 season 58.1% of registered patients 
received the flu vaccine in GP/Pharmacy. 
Source: PSNC 2014 
 
In 2014/15 the NHS vaccinated: 
44.1% pregnant women 
54.9% frontline healthcare workers 
50.3% of under-65s in at-risk groups 
Source: PSNC 2014 
Vaccination supply 
Vaccines are purchased directly from 
pharmaceutical wholesalers or negotiated directly 
with the pharmaceutical industry. 
Vaccines are purchased directly from 
pharmaceutical industry by the state. 
Vaccination payment and reimbursement 
Patients pay for vaccines (reimbursement rates 
apply) and for the pharmacy service that includes 
administration of the vaccine. 
given. 
 
In England as of Oct. 2015, both pharmacy 
contractors and GP practices were paid a fee of the 
same value for flu vaccine administration; £7.64 plus 
an additional fee of £1.50 (a total of £9.14 per 
administered vaccine).  The additional fee is in 
recognition of costs incurred relating to the 
provision of the service including training, 
revalidation and disposal of clinical waste as such 
costs are not reimbursed elsewhere in the pharmacy 
contract. 
 
Contractors will also be reimbursed for the vaccine 
costs at the basic price (list price) of the individual 
vaccine administered and an allowance at the 
applicable VAT rate will also be paid. 
 
Funding for the service will be in addition to and 
outside of total agreed community pharmacy 
funding for 2015/16, instead coming from NHS 
vaccination budgets. The total delivered will be 
dependent on uptake of the service, but no cap has 
been set for this.6 
The NHS Vaccination Plan vaccines are free of charge. 
Flu vaccine and administration are free of charge for 
patients over 65 years old. 
 
Travel vaccines are not all available in the healthcare 
centre and some are purchased in the pharmacy. 
 
In September 2015, for the first time community pharmacies in England were commissioned to provide 
seasonal flu vaccinations to patients in at-risk groups as a new advanced service for the 2015/2016 season. In 
England, there are five advanced services within the NHS community pharmacy contractual framework that 
pharmacies may deliver in addition to the core contract. Community pharmacies can choose to provide any of 
these services as long as they meet the requirements set out in the Secretary of State Directions.  NHS England 
has also announced that it will re-commission the Community Pharmacy Vaccination programme in 2016/2017. 
Prior to the implementation of a national flu service, most people would go to their family doctor to get 
immunised because they would get the service for free. Therefore, with this most recent change in 
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commissioning, pharmacists are able to immunise and provide increased scalability of the immunisation 
programme. 
 
Before 2015, Wales was the only part of the UK to have a national pharmacy influenza service. A small pilot study 
was launched in 2011 to increase vaccination rates of hard-to-reach patients in rural areas of Wales and was 
fully implemented by 2012. The contribution of community pharmacies towards vaccination in Wales is 
relatively small. The 7861 individuals vaccinated in pharmacies represent only 1.18% of all those vaccinated.5 
Although some pharmacies did demonstrate that they could provide a relatively high number of vaccinations, 
most provide comparatively few.  
 
In England, out of 25 sub regions 21 (84%) commissioned a flu vaccination service from community pharmacies 
in the 2014/15 flu season. During the 2014/15 season more than 5,000 pharmacy contractors signed up to the 
services, and in some areas 84% of those signed up were active vaccination providers. In England, flu 
vaccination is an Advanced Service and it can be provided by any community pharmacy that has a consultation 
room, can procure the vaccination and meet the data recording requirements, and has appropriately trained 
staff. There is no limit on the number of vaccinations pharmacies can claim for as long as they are given to 
eligible patients.4 
 
 
3.10.3 Training of the pharmacy workforce 
Contractors must demonstrate that all pharmacists have received the appropriate training and are qualified to 
deliver immunisation services.  Public Health England published the National Minimum Standards for 
Immunisation Training which are standards to help provide consistent immunisation training across England 
and Wales and to provide further guidance to those areas where training is not currently established.5  The 
standards should be used in addition to the Core Curriculum which sets out the fundamental knowledge and 
skills required of healthcare professionals.  Pharmacists who will provide the flu vaccination service must have 
completed practical training in vaccination that meets these requirements. Pharmacists that have not 
vaccinated before must be observed and assessed by an experienced vaccinator. 
 
The Core Curriculum covers the following essential core topics which should be included in all immunisation 
training: 
 The aims of immunisation: national policy and schedules 
 The immune system and how vaccines work 
 Vaccine preventable diseases 
 The different types of vaccines used and their composition 
 Current issues and controversies regarding immunisation 
 Communicating with patients and parents 
 Legal aspects of vaccination 
 Storage and handling of vaccines 
 Correct administration of vaccines 
 Anaphylaxis and other adverse events 
 Documentation, record keeping and reporting 
 Strategies for improving immunisation rates 
 
In addition, pharmacists must attend face-to-face practical training course for both injection technique and 
basic life support training every two years. Before delivering the service pharmacists are also required to 
complete a self-assessment as part of the declaration of competence (DoC) system. Pharmacists must complete 
the practical training first before self-declaration of DoC.  
 
There are a number of organisations that provide vaccination training for pharmacists ranging from 
professional associations such as the National Pharmacy Association to private trainers such as ECG Training. 
Currently immunisation training is only available to registered pharmacists. 
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Training of the pharmacy workforce 
Contents  Administration of vaccines and injectable medicines;  
Basic life support (automated external defibrillation is optional). 
Certification/accreditation The Declaration of Competence approach (developed by the Community 
Pharmacy Competence Group) is being used to assure pharmacy 
contractors that pharmacists have the necessary knowledge and skills to 
provide the service. 
Providers Various professional organisations such as the National Pharmacy 
Association, and private companies such as the, Alliance Healthcare, Sonar 
Informatics, Pharmacy PGD, and other education and training courses 
provide training.  
Requirement Mandatory 
Level General Pharmaceutical Council (GPhC) Registered Pharmacists 
Training duration Duration can vary with the training provider but must comply with the 
minimum content requisites set by the National Minimum Standards for 
Immunisation Training.  
Cost Paid by employers or individual pharmacists. Costs can vary with the 
training provider e.g. AAH charges £340.  
Refresher requirements Administration of vaccines and injectable medicines  Every 2 years. Re-
certification can be a theoretical update on the state of the art concerning 
vaccines and injectable medicines.  
All pharmacists must have completed and passed a recognised basic life 
support training course in the past 12 months or an approved alternative 
update training which can be face to face or via e-learning.  
Pharmacists must provide evidence of continuing professional 
development. 
 
 
3.10.4 Tools and resources available to pharmacy professionals 
The following tools and resources are recommended as part of the immunisation training for pharmacists: 
  
 -  
 Centre for Pharmacy Post Graduate Education (CPPE) training package (10 hours does not include 
practical training); 
 CPPE held a number of e-workshops to support community pharmacists in completing the DoC for the 
national flu vaccination service.  A recording of one of the e-workshops (49 minutes) is available to 
listen to on the CPPE website; 
 Health Protection Agency website which provides comprehensive guidance on the most appropriate 
algorithms for assessment of flu sufferers or people exposed to flu sufferers and whether or not they 
require antivirals; 
 Education training resource Immunisation Programme Promoting Effective Immunisation Practice can 
be viewed on the Health Protection Scotland and NHS Education for Scotland website; 
 A Competency & Training Framework for Influenza Vaccination as a National Enhanced Service (NES) 
via a patient group direction (PGD) has been published by the WCPPE and Public Health Wales. The 
framework is based on the national minimum standards for immunisation training.5 
 
 
3.10.5 Vaccination records 
Currently, NHS England has not been able to launch a national IT solution to support provision of immunisation 
services and electronic notification of GP practices of vaccination of their patients. However, in some areas, 
commissioners have been able to arrange IT support for the service. Where IT support is not available, pharmacy 
contractors will instead be able to use a paper-based record keeping system. 
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Contractors must ensure that family doctors are notified of pharmacy based immunisation activity. A 
administered or on the following working day. This can be undertaken by mail, hand delivery, fax, secure email 
or secure electronic data interchange. If IT systems such as PharmOutcomes or Sonar Informatics are available 
family doctors should be notified electronically.6  
 
Vaccination records 
Details recorded Individual details: patient name, age, address; 
Product details: name of vaccine manufacturer, batch number, expiry date; 
Administration service details: name of the professional administering the 
vaccine and signature, GPhC number, route of administration, injection 
 
Record format Paper and electronic 
Record requirement Mandatory 
Record storage Paper and Pharmacy electronic system 
Record sharing GPs, Sonar Informatics  
Use of recorded information Data analysis and evaluation performed by Sonar Informatics, 
PharmOutcomes 
Minimum record keeping Dependent on indemnity insurance provider - further guidance due to be 
released.  NHS Records Management  NHS code of Practice 2009 
the young person was 17 years old at conclusion of treatment. All others 
retain for 10 years after conclusion of treatment. 
Other information Other information may be recorded in the software, such as the presence 
of chronic diseases or pregnancy. 
 
 
3.10.6 Outcomes 
During the 2015/2016 seasonal flu campaign, a total of 10,407,913  flu vaccines were delivered by all 
immunisation providers in the UK.  An additional 240,259 patients chose to receive their vaccination in a 
community pharmacy compared to the previsou year.6  By late October 2015, just one month into the flu season 
8,040 pharmacies were registered to deliver the flu vaccination advanced service.  This represents 68.5% of all 
community pharmacies on the pharmaceutical list. 
 
The total number of flu vaccines recorded in the Sonar and PharmOutcomes system equals 486,897 over a 6 
month period extending from September to February 2015.  However, this data only reflects flu vaccinations 
administered as part of the service which have been entered into the Sonar Informatics or PharmOutcomes 
systems.  As some pharmacy contractors are not able to use or have chosen not to use either of these systems 
to record administrations of vaccine the reported numbers may be lower than in practice.7 
 
The following table shows vaccination rates in pharmacies of specific at-risk patient groups.  This data has been 
extracted from the PharmOutcomes and Sonar Informatics (Sonar updated to 31st January 2016, 
PharmOutcomes updated to 29th February 2016.7 
 
Vaccination eligibility group 7 PharmOutcomes Sonar 
Informatics 
Aged over 65 62.2% 56.6% 
Carer 4.1% 4.1% 
Chronic heart disease 3.0% 3.8% 
Chronic kidney disease 0.4% 0.3% 
Chronic liver disease 0.3% 0.3% 
Chronic neurological disease 1.3% 1.0% 
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Vaccination eligibility group 7 PharmOutcomes Sonar 
Informatics 
Chronic respiratory disease 14.9% 13.5% 
Diabetes 8.4% 14.3% 
Household contact of immunocompromised 
individual 
0.5% 0.7% 
Immunosuppression 2.4% 2.4% 
Person in long-stay residential or home 0.2% 0.5% 
Pregnant woman 2.2% 2.4% 
Splenic dysfunction 0.2% 0.2% 
 
 
3.10.7 Advocating for immunisation services in community pharmacies, limitations 
and challenges 
One of the challenges in delivering immunisation services has been a lack of public awareness that 
immunisation services are available in community pharmacies.    This indicates that pharmacists may need to 
be more active in promoting pharmacy based immunisation services in future.  A poster is not enough to draw 
hard-to-reach patients into the pharmacy for an NHS or private immunisation service. 
 
In addition, a UK survey conducted by the Patients Association in 2003 found that patients had concerns about 
the expertise of pharmacists, confidentiality and privacy in pharmacies.8   Since 2003 and with the re-
commissioning of the national immunisation campaign the public image of pharmacies as immunisation sites 
has improved.  In fact, due to the accessibility and extended opening hours many patients find it more 
convenient to visit a pharmacy rather than their family doctor, as they do not have to make an appointment.9 
 
Furthermore, pharmacy-based immunisation providers have recognised the following issues as barriers to 
successful implementation including training availability, health service disorganization, workload and the 
anding environment with competing priorities, recruitment, and 
vaccine procurement.10 
 
However, the foremost challenge has been the opposition from family doctors (GPs). In particular, where GPs 
received payment for administering flu vaccines, they were least likely to relinquish this income opportunity 
to community pharmacists.11 The  Committee has criticised opening up the national flu campaign to all 
pharmacies in 2015 claiming that it will hinder GPs following up on their at-risk patient groups due to a lack of 
proper protocols between the pharmacist and GP to accurately share records.12  In addition to the issue of 
innacurate shared anaphylaxis training were the most 
cited concerns voiced by GPs.  To improve collobarotive efforts and reduce the administrative burden on GP 
practices it will be important to ensure accurate and timely data transfer is fed back into the GP record. 
 
Another challenge altogether separate from competition is that pharmacists in the community pharmacy 
sector have reported lack of confidence in running the service for the first time and in administering vaccines.  
This signals a need for more support and training opportunities from an early stage for pharmacists.  In the 
future, lack of engagement from pharmacists could lead to a decrease in funding and support from the NHS.  
 
Finally, the UK must do more to recognise the role that support staff have to play in part of the service and 
advocacy, particularly within community as healthy living champions and to dispel myths surrounding 
immunisation schedules and perceived risk of side effects. 
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3.11 United States of America 
 
Contributors: 
Tom Menighan, Executive Vice President/CEO, American Pharmacists Association (APhA). Mitchel C. Rothholz, 
Chief Strategy Officer at the APhA. Oksana Pyzik, FIP Collaborating Centre UCL School of Pharmacy. 
Disclaimer: the information represents information gathered in May 2016 and may be subjected to changes 
 
 
Indicators 
Population (millions) 1 318.9  
Population > 65 years (%Total) 1 14.0 
Health expenditure (% GDP) 1 17.1 
Pharmaceutical expenditure (%health expenditure) 1 11.9 
Number of community pharmacies 32,500 
 
 
3.11.1 Overview 
Pharmacists have made significant strides in the United States over the past 20 years, increasing access to 
immunisations and protecting individuals from vaccine-preventable diseases.  The scope of authority for 
pharmacists has expanded, supported by a public health need and the actions of immunising pharmacists.  
acceptance of pharmacists as immunisers have grown.  Critical 
-Based Immunization Delivery Certificate Training Program (CTP).  The 
CTP began in 1996 and has trained more than 280,000 pharmacists. This has been accomplished through 
partnerships with schools and colleges of pharmacy, state pharmacy associations, pharmacy corporations, and 
a dedicated group of faculty and staff.  The programme prepares pharmacists to assume active roles as 
members of the immunization neighborhood to serve patients across their lifespan.  The Centers for Disease 
the importance of keeping current on CD unization Practice (ACIP) 
recommendations, APhA provides webinars after each ACIP meeting.  The organisation also provides additional 
education and training on contemporary immunisation issues, publications and networking opportunities to 
support pharmacis 2 
 
Snapshot over the past 20 Years: 
 More than 280,000 pharmacists trained to administer vaccines (up from 40,000 in 2007); 
 All 50 states, District of Columbia, and Puerto Rico authorise pharmacists to administer vaccines at 
some level (in 1996, 14 states authorised pharmacists for influenza vaccination); 
 Pharmacists are trained about vaccines across the lifespan and are helping patients complete vaccine 
series; 
 All ACPE-accredited  schools of pharmacy required to include immunisation training in their curricula 
(2016); 
 Number of adults getting influenza vaccinations in community pharmacies increased from 6% of 
adults (2004 2005) to about 25%  (2015 2016); 
 APhA House of Delegates passes policy (2007, 2011) for all pharmacists being up to date on their own 
vaccinations (rates have approached 90%); 
 Pharmacies target immunis
medication use to identify need for specific vaccination; 
  collaborating, coordinating, and 
communicating with other immunisation stakeholders (2013); 
 H1N1 pandemic (2009) highlighted pharmacists as important immunisation provider; 
 Pharmacists implement Travel Health programme. 
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3.11.2 Advocating for immunisation and promoting immunisation services in 
pharmacies 
In 1994, the first organised immunisation training of pharmacists took place in Seattle, Washington.  Followed 
by the nationwide, 20 hours Pharmacy-Based Immunization Delivery Certificate Training programme 
established by the APhA with recognition by the CDC in 1996.  Since the inception of the programme, more than 
280,000 pharmacists have been trained to administer vaccines across the lifespan, and the scope and authority 
of pharmacists has greatly expanded.2 
 
In 1996, the APhA House of Delegates adopted policy that calls on pharmacists to take on at least one of three 
roles: educator, facilitator and/or administer.  The APhA supports pharmacists as key communicators in 
disseminating messages about the importance of immunisations to the general population. In 2010 11, it was 
estimated that the pharmacy community contributed more than $40 million dollars in marketing and 
educating the public at large about the importance of receiving immunisations.  The pharmacist led 
immunisation programmes were promoted using posters, pharmacy signage, and leaflets, as well as presence 
on the media, with TV and radio advertisements, and social media outlets to help increase awareness of the 
benefits of immunisation services provided in the pharmacy. 
 
The Academy of Managed Care Pharmacy reports that the impact of these health promotion campaigns not 
only increased the number of patients seeking immunisation services at pharmacies but also increased the 
number of patients requesting immunisations from their physicians by representatives of the medical 
profession.3 
 
APhA has been awarding pharmacists for their work in vaccination since 2008 and the criteria include an 
evaluation of the impact, collaboration, originality, and ability to overcome challenges and create 
opportunities for pharmacists.3  
Champions Awards recognises pharmacists, support personnel and stakeholder who have made major 
contributions towards improving vaccination rates in their localities and across the nation. 
 
Further health promotion activities offered by pharmacies include incentive programmes that are used to 
motivate people to obtain recommended vaccinations.  The incentive rewards may be monetary or non-
monetary and are given to clients or families in exchange for keeping an appointment, receiving a vaccination, 
returning for a vaccination series, or producing documentation of vaccination status.  The rewards are typically 
food vouchers, gift cards, lottery prizes, and baby products. Incentive reward programmes is separate to 
interventions that enhance access to vaccination services for example arranging transportation, providing 
child-care, home visits and the administration of free vaccinations or at a reduced cost to clients.4 
 
Also, a client reminder and recall systems is another public health intervention used to increase vaccination 
rates by immunisation providers, including community pharmacies.  This form of intervention is used to remind 
members of a target population that vaccinations are due or late.  These reminders and recalls may be delivered 
by various methods such as via the telephone, letter, postcard, text messages, or other and may differ in 
content.  In most cases, reminder and recall notices are individualised for each client, and it often contains 
educational messages about the importance of vaccination.  
 
 coined by the APhA in 2013, is gaining acceptance by immunisation 
stakeholders dedicated to meeting the immunisation needs of the patient and protecting the community from 
vaccine-
community can invest in assessing, administering, and/or referring patients to receive appropriate vaccines, 
including referral between pharmacists and other providers.  Areas that US pharmacists are focusing on include 
supporting the sharing and exchanging of immunisation data among providers and meeting common 
quality/outcome goals. 
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3.11.3 Administration of vaccines in pharmacies 
In 1996, the APhA House of Delegates passed a resolution calling for pharmacists to assume one of the following 
three roles: 
1. Pharmacist as advocate by educating and motivating patients 
2. Pharmacist as facilitator by hosting others who vaccinate 
3. Pharmacist as immuniser by vaccinating patients  
 
Since then, all 50 states, DC and Puerto Rico allow pharmacists to administer influenza vaccinations, with Maine 
as the final state to allow pharmacists to administer influenza immunisations in October of 2009.  The scope of 
pharm
pharmacy practice and therefore is varied across the country.  However, in general the authority to vaccinate 
is centred upon the type of vaccination, the route of administration, and the age of the patient.  Based on these 
criteria many states allow for the use of protocols and standing orders, while some require prescriptions from 
a physician before pharmacists may administer certain vaccines to particular aged patients, and all 
pharmacists must undergo training in order to immunise patients.  Student pharmacists may administer 
vaccines under the supervision of a trained immunising pharmacist in 46 states.  Early on, APhA took the 
position that engaging students pharmacists early in their careers regarding the importance of immunisations 
would carry over into practice.  This is proving true as new graduates seek positions that allow them to 
immunise and employers are requiring new hires to have the skillset. 
 
There are 30 states/territories allowing pharmacists to administer vaccines by a protocol, standing order, or 
prescription.  Each state defines the authorisation and scope for pharmacists to immunise.  The process for 
pharmacists administering vaccines also varies by state and is outlined in the table below.  
 
Administration of vaccines in primary care: 
Community pharmacies Healthcare centres 
Healthcare professional(s) administering vaccinations 
Pharmacist or nurse  Nurse, pharmacists, other healthcare personnel 
Legal accountability  under scope of practice 
Pharmacy manager, pharmacists Pharmacists or other healthcare professionals 
Vaccination provided 
Authority to administer (depends on State): 
 48 states allow pharmacists to administer any 
vaccine through various processes. 
 52 states allow pharmacists to administer 
pneumococcal vaccine. 
 52 states allow pharmacists to administer zoster 
vaccine. 
 52 states allow pharmacists to administer the 
influenza vaccine 
 51 states allow pharmacists to administer 
tetanus diphtheria/tetanus diphtheria
pertussis vaccine. 
 49 states allow pharmacists to administer 
human papillomavirus vaccine 
 49 states allow pharmacists to administer 
measles, mumps, and rubella (MMR) vaccine 
 
isation is 
dependent on the age of the patient as outlined 
within the state statutory regulations. Currently: 
 27 states allow vaccinations for patients of any 
age. 
 34 states allow vaccinations for patients 18 
years or older. 
 Hepatitis B (HepB) vaccine 
 Rotavirus (RV) vaccines; (RV1 [Rotarix] and RV5 
[RotaTeq]) 
 Diphtheria and tetanus toxoids and acellular 
pertussis (DTaP) vaccine. 
 Haemophilus influenzae type b (Hib) conjugate 
vaccine. (PRP-T [ACTHIB, DTaP-IPV/Hib (Pentacel) 
and Hib-MenCY (MenHibrix)], PRP-OMP 
[PedvaxHIB or COMVAX], PRP-T [Hiberix]) 
 Pneumococcal vaccines. (Minimum age: 6 weeks 
for PCV13, 2 years for PPSV23) 
 Pneumococcal vaccines. (PCV13, and PPSV23) 
 Influenza vaccines. (inactivated influenza 
vaccine [IIV],  live attenuated influenza vaccine 
[LAIV]) 
 Measles, mumps, and rubella (MMR) vaccine 
 Varicella (VAR) vaccine 
 Hepatitis A (HepA) vaccine 
 Meningococcal vaccines 
 Tetanus and diphtheria toxoids and acellular 
pertussis (Tdap) vaccine (Boostrix and Adacel) 
 Human papillomavirus (HPV) vaccines 
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Administration of vaccines in primary care: 
Community pharmacies Healthcare centres 
 18 states allow vaccinations at differing age 
levels from age 3 years to 14 years. 
Other vaccines that may be provided 
 Hepatitis A and B 
 Rabies 
 Rotavirus 
 Varicella Zoster 
 Cholera 
 Tick-borne encephalitis 
 Typhoid fever 
 Yellow fever 
Vaccination requirements 
Prescription: Depending on age of patient and type of 
vaccine a prescription is required in some states. 
Certified/accredited pharmacist training: Yes 
Vaccination record: Yes 
Specifications on premises, equipment, material and 
waste management: Yes 
Prescription: depends on antigen and patient age 
Vaccination rates 
 Pharmacists provide vaccinations in 87% of 
community pharmacy settings. 
 25% of flu vaccinations are made in 
community pharmacy setting.  
Source: APhA Annual Pharmacy-Based Influenza and 
Adult Immunization Survey 2014  
First Draft  January 29, 2015 
Flu vaccine- 
40% of other groups, which include children, younger 
individuals with risk factors; 60% for health care 
workers. 
Source: Centre for Disease and Control (CDC)- SEASON 
2014/2015 
Vaccination supply 
Vaccines are purchased directly from pharmaceutical wholesalers or negotiated directly with the 
pharmaceutical industry. 
Vaccination payment and reimbursement 
Payment to pharmacists for vaccinations and 
affiliated services varies from patients paying out of 
pocket to coverage by public and private payers. 
Recognition of pharmacists as in-network providers 
for coverage varies by plan. 
Pharmacists provide travel health services primarily 
covered out of patient pocket. 
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Figure 1: Pharmacist Authority to Adminster HPV Vaccines by State.  
Source: APhA (reproduced with permission). 
 
 
 
 
Figure 2: Pharmacist Authority to Adminster MMR Vaccines by State.  
Source: APhA (reproduced with permission). 
 
 
3.11.4 Training of pharmacy workforce 
The APhA Pharmacy-Based-Immunization Delivery Certificate Training Program provides pharmacists with the 
essential skills to become a primary source for vaccine administration and information in accordance with CDC 
and other professional guidelines, standards and recommendations.  This Accreditation Council for Pharmacy 
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Education (ACPE) activity counts as advanced professional training and a certificate of completion. It is not a 
certification that requires a psychometric approach to the development and measuring of competency. 
 
The education and training for pharmacist vaccination and administration of injectable medicine is divided 
into three components as follows:  
1. 12 hour (1.2 CEU) self-study online modules with case studies and assessment exam  
2. 8.0 hour (0.80 CEU) live seminar with final exam  
3. Hands-on assessment of intramuscular, subcutaneous and other injection techniques  
The first component is centred upon self-study learning activities that are focused upon the role of pharmacists 
as vaccine advocates and administrators and vaccine-preventable diseases.  Within the self-study component 
of the programme there are five learning modules that present in-depth information on immunology, practice 
implementation, and legal and regulatory issues and includes a self-assessment test as well as real-life case 
studies. 
 
Training of the pharmacy workforce 
Contents  Administration of vaccines and injectable medicines;  
Basic life support (automated external defibrillation is optional). 
Certification/accreditation  Administration of vaccines and injectable medicines training delivered by 
the APhA. 
Pharmacy-Based-Immunisation Delivery Certificate Training Program 
developed by the APhA plus Basic Life Support by certified training 
provider. 
Providers American Pharmacists Association, other education and training courses 
providers 
Requirement Mandatory 
Level Pre and post-registration (in some states students may immunise)  
Training duration Will vary by state requirements.  The APhA certificate training programme 
is a 20 hour programme. Duration can vary with the training provider but 
must comply with the minimum content requisites set by the APhA. 
Cost Paid by employers or individual pharmacists. Costs can vary with the 
training provider. 
Refresher requirements Administration of vaccines and injectable medicines  APhA refreshes 
their course yearly, and provides supplemental information after each 
ACIP meeting. APhA Certificates of Achievement do not expire, however it 
is recommended that pharmacists complete an annual immunisation 
update continuing pharmacy education (CPE) activity (1 2 hours). APhA 
provides update after each quarterly CDC Advisory Committee on 
Immunization Practice (ACIP) meeting. 
Basic life support Depends on source (American Heart Association or 
American Red Cross) 
Source: APhA BCACP Recertification Literature Study  
 
 
The second component of the programme includes a live training seminar focusing on pharmacy practice 
implementation.  The live training is based on the experience of practitioners involved in immunisation 
administration as well as advocacy work.  The live training seminar expands on the self-study programme and 
provides injection-technique training for both intramuscular and subcutaneous injections.  A Certificate of 
Achievement is awarded to participants who successfully complete all activity requirements, which include the 
self-study component, live training seminar, and the injection technique assessment.  Successful completion is 
defined as a score of 70% or better on both the self-study and live seminar assessments.  All participants are 
strongly encouraged to obtain Cardiopulmonary Resuscitation (CPR) or Basic Cardiac Life Support (BCLS) 
certification but it is not a prerequisite of the programme.  The Certificate of Achievement is invalid, however, 
without written proof of current CPR or BCLS certification, which can be attained from a variety of providers.  
The stipulations surrounding which type of certification is required, varies according to the employer and state 
requirements.  In some instances, only basic training is required while others require training at the Basic Life 
Support (BLS) for Healthcare Providers level.  Also, when immunising children, there are further requirements 
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such as infant or children CPR classes.  With regards to CPR re-certification some states or employers may 
accept an online training course.  In most states students are able to participate in the APhA training and thus 
are trained to deliver immunisation services as day one pharmacists.4 
 
Number of pharmacists trained for administration of vaccines 
Year of Training 
2008 2009 2010 2011 2012 2013 2014 2015 
Total number of pharmacists trained to date for administration of vaccines and injectable medicines  
60,000 100,000 120,000 150,000 200,000 230,000 250,000 >280,000 
Number of pharmacists trained each year for administration of vaccines and injectable medicines 
YTD 60,000 40,000 20,000 30,000 50,000 30,000 20,000 >30,000 
 
 
 
Figure 3: Number of States authorising pharmacists to administer influenza vaccines and number of trained 
pharmacists to adminster vaccines. Source: APhA (reproduced with permission). 
 
 
3.11.5 Tools and resources available to pharmacy professionals 
The APhA provides support to its members and profession through the provision of resources and guidance.  
Included in this material are CDC recommendations by the ACIP and surveillance guidelines that guarantee a 
high quality and safe provision of immunisation which are available online.  Other resources include the APhA 
immunisation handbook and Epidemiology and Prevention of Vaccine-Preventable Diseases The Pink Book - 
Course Textbook.5 
 
Videos, apps, patient handouts, immunisation schedules and clinical information are also available to 
pharmacists through the Immunization Action Coalition (IAC).  The IAC provides communication resources to 
help pharmacists speak to parents or patients about religious concerns, beliefs in alternative medicine and the 
perceived safety issues around adjuvant ingredients.  Through collaboration with other immunisation 
stakeholders, APhA provides access to useful resources such as those provided by CDC and IAC.  The adoption 
of quality measures that pharmacists can impact related to immunisations continues to be an area under 
discussion within the profession and immunization neighborhood.6 APhA provides an immunisation focused 
electronic newsletter every 2 weeks, a networking e-community, webinars and dedicated column and articles 
related to immunisation issues. 
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3.11.6 Vaccination records 
In the larger healthcare arena, currently there is no coordinated system across the different states, and even 
within some states, to ensure patients are up to date with recommended vaccinations. 
 
The current documentation system is incomplete and fragmented making it difficult for both patients and 
healthcare providers to manage and acquire immunisation records.7  According to the APhA and ACMP, the 
development and implementation of a more sophisticated immunisation information system would improve 
quality and performance measures across a number of different entities from state health departments to 
health systems, payers, and even employers.8 
 
Vaccination records 
Details recorded Individual details: patient name, date of birth; 
Product details: type of vaccine, batch ( lot # ), expiry date; 
Administration service details: name of the professional administering the 
vaccine and signature, route of administration, site of administration, 
administration date, funding source and anaphylaxis. 
Record format Paper and Electronic 
Record requirement Mandatory (depends on state and patient age) 
Record storage Paper and Pharmacy electronic system 
Record sharing Anonymous data is shared with CDC for research purposes  
Use of recorded information Data analysis and evaluation performed by CDC 
Minimum record keeping Varies according to state general minimum 7 years 
Other information Other information may be recorded in the software, such as the presence 
of chronic diseases or pregnancy, which may be used in the future to better 
understand service uptake by high-risk patients other than the elderly. 
 
 
3.11.7 Outcomes 
Pharmacists have demonstrated that through the expansion of pharmacist-provided immunisations, patient 
vaccination rates have improved.  To begin with, pharmacist-provided immunisations focused firstly on 
influenza and pneumococcal vaccines.  However, pharmacists are now increasingly directing their attention on 
improving access to vaccinations across the lifespan and thereby widening the types of vaccines delivered.  
Currently, more than 280,000 pharmacists in the United States have been trained to provide immunisations, 
administer influenza vaccines in all 50 states.  While the data surrounding flu vaccination rates within the 
community pharmacy is not available however, the APhA estimates that over 70% of pharmacies administer the 
flu vaccine.9 
 
 
3.11.8 Advocating for immunisation services in community pharmacies, limitations 
and challenges 
In recent years there has been some increase in the uniformity of legislation around immunisation practice 
across states.  However, this could be further improved as variability in state practice creates a barrier to access 
for certain populations. Variability in mechanisms for documentation of vaccine services also reduces how 
effectively pharmacist-provided immunisations are delivered throughout the United States. 
 
In addition, payment and health insurance benefit design continue to be a major challenge in states where 
pharmacists have not been recognised as healthcare providers under state Medicaid, Medicare, health plans 
and through commercial insurance carriers.  Also, from the patient perspective significant process differences 
in how vaccine services are covered and paid for by commercial and government payers, creates a barrier to 
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access for patients who are eligible to receive the vaccine under their current healthcare insurance benefits 
package.9 
 
Another challenge is the reluctance of pharmacist to immunise or publicise the immunisation service. Focus 
groups have reported that where pharmacists do not engage in the immunisation programme it is often due to 
lack of confidence in providing these services.  The APhA has responded to with regular quarterly updates on 
the website, continuing education programmes, and immunisation special interest groups so pharmacists can 
communicate easily with each other and keep up to date.  It has also been a challenge to provide immunisation 
training to pharmacists in rural areas.10   
 
In some cases, inadequate access to vaccine registries and the lack of real-time transactions for vaccine services 
and to verify eligibility has hindered communication with providers when requesting billing through health 
plans.  A lack of shared patient record systems has also proven to be a technological challenge between the 
patient, pharmacist and primary care physician.  Currently, only 63% of pharmacy immunisation sites send 
an immunisation registry.  Moreover, another 11% of pharmacists are not permitted access to their state or 
local immunisation registries.9 
 
Overall, in the past twenty years the medical community has come to recognise pharmacists as qualified 
providers of immunisations and actively promotes the community pharmacy as an immunisation site to 
patient.  It is important to now focus on documentation to provide robust evidence and expand the value of 
pharmacist provided immunisations and provides more complete vaccination records for practitioners and 
patients.  Also, continued engagement with other immunisation stakeholders is important to enhance 
relationships and improve as well as expand outreach to businesses and commercial carriers.9 
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4 Summary and conclusions 
 
 
This report presents and summarises the current global trends on the role of pharmacists in immunisation and 
vaccination services. 
 
 There is a 
advocacy and communication through to supply chain management and administration. 
 
 Changes of this extended area of pharmacy practice have been gradual across the world, with more 
rapid developments taking place particularly in the last decade. 
 
 Where pharmacists or pharmacies are actively involved with administration of vaccines, there is a 
corresponding greater engagement with public health messaging, multi-disciplinary working and 
immunisation advocacy in general. 
 
 Targeted training for pharmacists, and access to training, is a key ingredient in progressing the 
expansion vaccination services towards routine service delivery through pharmacists and pharmacies. 
 
 There is general agreement that there are challenges and limitations for the further development of 
reimbursement systems would be of benefit in this area. 
 
 The perceived competition threat to other health care professionals providing immunisation services 
is diminishing (especially where pharmacist/pharmacy engagement has been established) but remains 
a challenge in some countries.  Greater advocacy of the known public health gain is recommended and 
leadership bodies should consider targeted campaigns to promote the established societal benefits. 
 
 
vaccination including increased accessibility, increased public vaccination rates and coverage as well 
as public acceptance, trust and support. 
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5 Appendix 
5.1 Questionnaire (English version) 
 
Global survey on the role of pharmacists in immunisation 
Conducted on behalf of FIP 
 
 
FIP has contracted University College of London (UCL) to develop a report on the role of pharmacists in immunisation and 
vaccination as it appears to be very different across the world; in some countries pharmacists are legally allowed to 
administer vaccin organise vaccinations activities and campaigns; in 
other countries, however, pharmacists do not play an active role in immunisation. 
 
We would like to invite you to participate in this global survey. Your input will serve as a foundation for a global 
immunisation study to better understand the role of pharmacists in immunisation across the world and the impact of these 
activities. A subsequent report will be launched at the 2016 FIP Congress in Buenos Aires. 
 
Please state below if you are replying to this questionnaire on behalf of your country or territory. This survey will take you 
approximately 5-20 minutes to complete and the deadline for submission is Friday, 11th March 2016. Completed surveys 
should be submitted by email to h.rosado@ucl.ac.uk. If you feel that you are not able to participate in this study we would 
be really grateful if you could assist us in identifying the relevant contacts. If you have any questions regarding this survey 
or study please contact Dr Helena Rosado at h.rosado@ucl.ac.uk. 
 
Thank you very much for your time and support. 
 
 
Keywords: 
Immunisation: the process by which an individual becomes immune against an infectious disease either by natural contact 
with an infectious agent or by vaccination. 
Vaccination: the administration of a vaccine to stimulate immunisation. 
 
 
Respondent details 
 
Country / Territory Click here to enter text. 
Title Click here to enter text. 
First name Click here to enter text. 
Family name Click here to enter text. 
Job title Click here to enter text. 
Member Organisation Click here to enter text. 
Email Click here to enter text. 
 
 
Q1. Advocating for immunisation 
We would like to gather broad information about the role of pharmacists in advocating for immunisation in your 
country/territory. Feel free to clarify any answers or leave any comments in the box provided at the end of the section. 
 
a) Do pharmacists tend to promote and support vaccination towards patients in your country/territory? 
☐ Yes  ☐ No 
If yes, please answer question b).  If no, please go to Q2. 
 
 
b) In what type of activities do pharmacists participate in? Choose the option or all options that apply. 
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☐ Pharmacists tend to distribute vaccination leaflets 
☐ Pharmacists provide immunisation information and advice to patients (e.g. raising awareness about the benefits of 
vaccination, busting common vaccination myths, etc.) 
☐ Pharmacists organise and/or are actively involved in vaccination campaigns 
☐ Pharmacists participate in multi-disciplinary immunisation campaigns 
☐ immunisation status/schedule and remind them when their next vaccination is due 
☐ Pharmacists identify and advise high risk patient groups about their vaccination (e.g. advising patients aged 65 and over, 
diabetic patients, travel vaccines etc.) 
☐ Pharmacists serve on immunisation advisory committees 
 
Other/Comments 
Click here to enter text. 
 
 
Q2. Administering vaccines 
We would like to gather information about the role of pharmacists as vaccination providers and associated 
legal requirements for administration of vaccines in pharmacies in your country/territory. Feel free to clarify 
any answers or leave any comments in the boxes provided. 
 
a) Can vaccines be legally administered in pharmacies or by pharmacists in your country/territory? 
☐ No, administration of vaccines (or some vaccines) cannot be performed in pharmacies or by pharmacists in my 
country/territory 
☐ Yes, administration of vaccines (or some vaccines) can be performed in pharmacies by trained pharmacists 
☐ Yes, administration of vaccines (or some vaccines) can be performed in pharmacies by other healthcare professionals (e.g. 
nurses or doctors) 
If yes, please answer questions b) to d). If no, please go to Q3. 
 
 
b) Who is legally accountable for the vaccination process? (e.g. the pharmacy owner or manager, the professional 
administering the vaccine, etc.) 
Click here to enter text. 
 
 
c) Are there any specific requirements for administration of vaccines in pharmacies in your country/territory? (e.g. 
specifications on pharmacy premises; adherence/implementation of specific immunisation protocols, standing orders 
and/or guidelines such as waste management, special training of pharmacists, etc.) 
☐ Yes  ☐ No 
Please specify. 
Click here to enter text. 
 
d) Please provide further information including relevant legislations/regulations, types on vaccines administered in 
reimbursement programmes, pharmacy vaccination rates, patient satisfaction or feedback on the pharmacy service. 
Click here to enter text. 
 
 
Q3. Training the pharmacy workforce for immunisation/vaccination services 
We would like to gather information about required and available formal training in immunisation/vaccine administration 
in your country/territory. Feel free to clarify any answers or leave any comments in the box provided at the end of the 
section. 
 
a) Do pharmacists receive any formal or comprehensive immunisation/vaccine administration training in your 
country/territory? 
☐ Yes for all  ☐ Yes for some ☐ No 
If yes, please answer questions b) to f). If no, please go to Q4. 
 
b) At what career stage do pharmacists receive formal or comprehensive immunisation training? 
☐ Undergraduate / university 
☐ Post-registration / Post-graduate/ Continuous professional development 
Comments 
Click here to enter text. 
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c) Is the training mandatory? 
☐ Yes  ☐ No 
Comments 
Click here to enter text. 
 
d) Is there a refresher requirement (the training is only valid for a certain period of time)? 
☐ Yes  ☐ No 
Please specify 
Click here to enter text. 
 
e) Is the training accredited, certified, recognised or approved by a regulator or competent authority? 
☐ Yes  ☐ No 
Please specify 
Click here to enter text. 
 
f) Please provide details of the contents included in the training and the number of training hours? (e.g. general or 
comprehensive training on immunisation, how to advise patients, vaccine administration technique, anaphylaxis, 
cardiopulmonary resuscitation, etc.) 
Click here to enter text. 
 
 
Q4. Vaccination records 
We would like to gather information about vaccination records in your country/territory. Choose the option or all options 
that apply. Feel free to clarify any answers or leave any comments in the boxes provided. 
 
a) Do pharmacies have access to vaccination records or record vaccination details? 
☐ Yes for (almost) all ☐ Yes for some ☐ No 
If yes, please answer questions b) to h). If no, please go to Q5. 
 
b) In what format are vaccination records kept?  
☐ In paper format  ☐ In electronic format 
Comments 
Click here to enter text. 
 
c) Where/How are vaccination records stored? (e.g. In the pharmacy, in local pharmacy electronic systems, in physician-
based electronic systems, in a national electronic system, etc.) 
Click here to enter text. 
 
d) Which vaccination details are recorded?  
☐  
☐ Vaccine details (e.g. name, batch, expiry date, etc.) 
☐ Vaccination administration details (e.g. name of the professional administering the vaccine, route of administration, 
administration date, etc.) 
Please specify 
Click here to enter text. 
 
e) Please indicate if record keeping is optional or mandatory (e.g. patients provide details on a voluntary basis but 
vaccination details have to be recorded) 
Click here to enter text. 
 
f) For how long do vaccination records have to be kept? (e.g. there is no legal requirement, a minimum of 5 years, etc.) 
Click here to enter text. 
 
g) 
nationally shared, etc.) 
☐ Yes  ☐ No 
Please specify 
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Click here to enter text. 
 
h) How is the recorded information used? (e.g. pharmacists are able to retrieve patient vaccination records to help 
immunisation status; records are analysed to determine vaccination rates, etc.) 
Click here to enter text. 
 
 
Q5. Additional services related to vaccinations 
Please describe below any services (outside administering/injecting vaccines) provided by pharmacies to support 
immunisation. 
Click here to enter text. 
 
 
immunisation 
We would like to gather information about the main limitations and or challenges that pharmacists face regarding the 
provision of immunisation services in your country/territory. Choose the option or all options that apply. Feel free to clarify 
any answers or leave any comments in the box provided at the end of the section. 
☐ No significant limitations 
☐ Limited acceptance and/or support by the government / health system 
☐ Limited acceptance and/or support by other healthcare professionals 
☐ Limited financial support from government / health system 
☐ Lack of patient demand / acceptance 
☐ Limited access to training opportunities for pharmacists 
☐ Lack of confidence by pharmacists to perform immunisation services and activities 
 
Other/Comments 
Click here to enter text. 
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5.2 Questionnaire (French version) 
Enquête mondiale sur le rôle des pharmaciens en matière de vaccination 
Menée au nom de la FIP 
 
La FIP a University College of London (UCL) pour développer un rapport sur le rôle des pharmaciens en 
matière de vaccination, car ce rôle varie grandement entre les pays ; dans certains pays, les pharmaciens sont autorisés à 
vacciner, gèrent le calendrier vaccinal des patients ou organizent des campagnes pour soutenir la vaccination ; dans 
 
 
-dessous. Votre réponse permettra une meilleure compréhension du 
immunization 
les conclusions de cette enquête sera dévoilé au congrès 2016 de la FIP à Buenos Aires. 
 
 
-dessous si vous répondez à cette enquête au nom de votre pays. Il vous faudra compter entre 5 et 20 
Vendredi 18 mars 2016 par email à h.rosado@ucl.ac.uk. 
h.rosado@ucl.ac.uk. 
 
Merci par avance pour votre soutien en complétant ce questionnaire. 
 
 
Qui répond à ce questionnaire : 
 
Pays Click here to enter text. 
Civilité Click here to enter text. 
Prénom Click here to enter text. 
Nom de famille Click here to enter text. 
Titre / fonction Click here to enter text. 
Organization Click here to enter text. 
Email Click here to enter text. 
 
 
Q1. Promotion de la vaccination 
Nous souhaitons collecter des informations générales autour du rôle du pharmacien en matière de promotion de la 
attention. 
 
c) Est-ce que les pharmaciens ont tendance à promouvoir et à soutenir la vaccination auprès des patients dans leur 
pays ? 
☐ Oui  ☐ Non 
If vous avez répondu oui, merci de répondre à la question b).  Si vous avez répondu non
question Q2. 
 
d)  ? Merci de sélectionner le (ou les) réponses qui reflètent la 
situation dans votre pays. 
☐ Les pharmaciens distribuent des brochures sur la vaccination 
☐ 
 
☐ Les pharmaciens organize ent dans les campagnes de promotion de la vaccination 
☐ Les pharmaciens participent aux campagnes inter-professionelles de promotion  
☐ Les pharmaciens vérifient le statut vaccinal des patients et leur rappellent quand ils doivent renouveler une vaccination 
☐ Les pharmaciens identifient et conseillent les patients appartenant à des groupes à risque (par exemple, âgés de plus de 
 
☐ Des pharmaciens siègent aux Comités consultatifs officiels sur la Vaccination 
Autres / commentaires 
Click here to enter text. 
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Q2. Administration de vaccins 
que le cadre 
inclure un commentaire) dans les cadres à cette attention. 
 
a) Est-ce que les lois et réglementations autorisent la vaccination dans les pharmacies et/ou par les pharmaciens dans 
votre pays ? 
☐ Non, la vaccination ne peut pas avoir lieu dans les pharmacies ou par les pharmaciens dans mon pays 
☐ Oui, la vaccination peut avoir lieu dans les pharmacies par des pharmaciens autorisés 
☐  
Si vous avez répondu oui, merci de répondre aux questions b à d. Si vous avez répondu non, veuillez aller directement à la 
question Q3. 
 
b) Qui est responsable du processus de vaccination selon la loi / réglementation ? (par exemple, le propriétaire ou 
 
Click here to enter text. 
 
c) Y-a-t-il des exigences particulières pour  ? (par exemple des 
exigences pour les locaux officinaux, suivi de protocoles spécifiques à la vaccination, recommandations quant à la 
 
☐ Oui  ☐ Non 
 : 
Click here to enter text. 
 
d) Merci de fournir toute information complémentaire relative à la législation et réglementation, les types de vaccins 
administrés dans les pharmacies, les populations qui 
 
Click here to enter text. 
 
 
Q3. Formation des personnels pharmaceutiques sur la vaccination et les services associés 
 dans 
 
 
a) Est-
succincte ou poussée) ? 
☐ Oui (pour tous)   ☐ Oui pour certains  ☐ Non 
Si vous avez répondu oui, merci de répondre aux questions b à f. Si vous avez répondu non, veuillez aller directement à la 
question Q4. 
 
b) À quel moment les pharmaciens reçoivent-ils une formation sur la vaccination ? 
☐  
☐  
Commentaires 
Click here to enter text. 
 
c) Cette formation est-elle obligatoire ? 
☐ Oui  ☐ Non 
Commentaires 
Click here to enter text. 
 
d) Est-ce que cette formation doit être actualisée selon un intervalle défini ? 
☐ Oui  ☐ Non 
 : 
Click here to enter text. 
 
e) Cette formation est-
autorités de santé ? 
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☐ Oui  ☐ Non 
 : 
Click here to enter text. 
 
f) Merci de fournir des informations complémentaires sur le contenu de la formation (dont le contenu de la formation 
et la durée en heures) (par exemple : une formation succincte ou poussée sur la vaccination, le conseil au patient, les 
-  
Click here to enter text. 
 
 
Q4. Dossiers / registres vaccinaux 
Nous souhaitons collecter des informations sur les dossiers vaccinaux individuels [ou registres vaccinaux] de votre pays. 
 
réponses (ou inclure un commentaire) dans les cadres à cette attention. 
 
a) Est-ce que les pharmacies ont accès au dossier / registre vaccinal des patients ou enregistrent les données de 
vaccination des patients ? 
☐ Oui, pour (presque) tous  ☐ Oui pour certains  ☐ Non 
Si vous avez répondu oui, merci de répondre aux questions b à h. Si vous avez répondu non, veuillez aller directement à la 
question Q5. 
 
b) Quel est le format de ce dossier / registre vaccinal ? 
☐ Format papier  ☐ Format électronique 
Commentaires 
Click here to enter text. 
 
c) 
 
Click here to enter text. 
 
d) Quelles informations sont enregistrées dans ce dossier / registre ?  
☐  
☐  
☐  
isions au besoin : 
Click here to enter text. 
 
e) (les informations personnelles sont 
 
Click here to enter text. 
 
f) 
 
Click here to enter text. 
 
g) Est-ce que les dossiers / registres vaccinaux sont partagés ? (par exemple, entre les pharmacies, avec les médecins, un 
 
☐ Oui  ☐ Non 
 : 
Click here to enter text. 
 
h)  est-elle utilisée ? (par exemple, les pharmaciens peuvent 
accéder aux données des patients pour évaluer le statut vaccinal des patients, les registres sont utilisés pour évaluer 
 
Click here to enter text. 
 
 
Q5. Autres services associés aux vaccines 
Merci de décrire ci-
de vaccins. 
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Click here to enter text. 
 
 
Q6. Principaux freins au développement du rôle des pharmaciens en matière de vaccination 
Nous souhaitons collecter des informations sur les principaux freins et les défis pour la fourniture de services liés à la 
 de votre pays. 
 
☐ Pas de freins significatifs 
☐ Acceptation ou soutien très limité du gouvernement ou du système de santé 
☐ Acceptation ou soutien très limité des autres professionnels de santé 
☐ Soutien financier limité du gouvernement et/ou des systèmes de santé 
☐ Faible demande et/ou acceptabilité des patients 
☐ Accès limité aux formations destinées aux pharmaciens 
☐ Manque de confiance des pharmaciens pour la fourniture des services et activités 
Autres / commentaires 
Click here to enter text. 
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5.3 Data summary from the global survey 
 
Countries and Territories 
WHO 
region 
OECD 
Members 
Income 
level 
Number of 
Pharmaciesa 
Inhabitants 
per 
pharmacya 
Advocacy for 
vaccination 
Vaccination 
administration 
Training 
required 
Access to 
Records 
Argentina The Americas - Upper middle 20,000 2,149 Y P Y N 
Australia Western Pacific Y High 5,456 4,322 Y PH Y Y 
Belgium Europe Y High 4,950 2,263 Y N N Y 
Bolivia The Americas - Lower middle 4,380 2,289 Y H N N 
Brazil The Americas - Upper middle 77,339 2,644 Y N N Y 
Canada The Americas Y High 9,558 3,740 Y PH Y Y 
China Western Pacific - Upper middle 432,659 3,168 Y N N N 
Congo (Dem. Rep.) Africa - Low - 101,000 Y H Y N 
Costa Rica The Americas - Upper middle 1,019 4,689 Y P Y Y 
Denmark Europe Y High 220 25,786 Y PH Y Y 
Ecuador (Quito) The Americas - Upper middle - - N N N N 
Ethiopia Africa - Low - 142,000 Y N N N 
Finland Europe Y High 814 6,726 Y H N N 
France Europe Y High 22,510 2,954 Y N N Y 
Germany Europe Y High 20,441 3,976 N N N Y 
Hong Kong, China Western Pacific - High 606 12,023 N N N N 
Hungary Europe Y High 2,319 4,241 N N N N 
Iceland Europe Y High 67 4,940 N H N N 
India South East Asia - Lower middle 700,000 1,730 N N N - 
Iraq Eastern Mediterranean - Upper middle 6,586 5,553 Y N N N 
Ireland Europe Y High 1,807 2,526 Y P Y Y 
Israel Europe Y High 498 16,811 N N N - 
Italy Europe Y High 18,201 3,339 Y N N N 
Japan Western Pacific Y High 57,071 2,223 Y N N N 
Jordan Eastern Mediterranean - Upper middle 2,747 2,325 Y - - - 
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Countries and Territories 
WHO 
region 
OECD 
Members 
Income 
level 
Number of 
Pharmaciesa 
Inhabitants 
per 
pharmacya 
Advocacy for 
vaccination 
Vaccination 
administration 
Training 
required 
Access to 
Records 
Lebanon Eastern Mediterranean - Upper middle 2,744 1,563 N H N N 
Netherlands Europe Y High 1,974 8,578 Y H N Y 
New Zealand Western Pacific Y High - - Y P Y N 
Nigeria Africa Y Lower middle 2,800 65,809 Y N Y Y 
Norway Europe - High 778 6,676 N N N N 
Pakistan Eastern Mediterranean - Lower middle 1,200 159,821 Y H N Y 
Paraguay (Asunción) The Americas - Upper middle 2,545 2,752 N N N N 
Philippines Western Pacific - Lower middle 32,443 3,033 Y PH Y N 
Poland Europe Y High 13,144 2,928 Y N N N 
Portugal Europe Y High 2,885 3,604 Y PH Y Y 
Russian Federation Europe - High 50,674 2,842 Y N N N 
Senegal Africa - Lower middle 1,030 13,738 Y N Y N 
South Africa Africa - Upper middle 3,136 17,219 Y PH Y Y 
Spain Europe Y High 21,854 2,120 Y N Y N 
Switzerland Europe Y High 1,774 4,622 Y PH Y Y 
United Arab Emirates Eastern Mediterranean - High 2,500 3,306 N N N N 
Ukraine Europe - Lower middle - - N N N N 
United Kingdom Europe Y High 14,361 4,532 Y PH Y Y 
United States of America The Americas Y High 32,500 9,883 Y PH Y Y 
Uruguay The Americas - High - - N N N N 
aData from this report, FIP Global Trends Shaping Pharmacy: Regulatory Frameworks, Distribution of Medicines and Professional Services and FIP-RPS Global Workforce Observatory (2015) 
 
 
Y Yes N No P Pharmacist H Other healthcare professional PH 
Pharmacist and other 
healthcare professional 
- No data 
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Data summary for the global survey listed according to WHO regions, Income Groups or OECD membership  
 
WHO region 
All WHO 
Member 
States 
In this 
report (n) 
Advocacy for 
vaccination 
Vaccination in 
pharmacies 
Vaccination 
by pharmacists 
Training 
required 
Access to 
records 
Africa 23.7% (46) 11.1% (5) 11.1% (5) 4.4% (2) 2.2% (1) 8.9% (4) 4.4% (2) 
Eastern Mediterranean 11.3% (22) 11.1% (5) 6.7% (3) 4.4% (2) 0% (0) 0% (0) 2.2% (1) 
Europe 27.3% (53) 42.2% (19) 28.9% (13) 17.8% (8) 11.1% (5) 13.3% (6) 20.0% (9) 
South East Asia 18.0% (35) 2.2% (1) 0% (0) 0% (0) 0% (0) 0% (0) 0% (0) 
The Americas 5.7% (11) 20.0% (9) 13.3% (6) 11.1% (5) 8.9% (4) 8.9% (4) 8.9% (4) 
Western Pacific 13.9% (27) 13.3% (6) 11.1% (5) 6.7% (3) 6.7% (3) 6.7% (3) 2.2% (1) 
 
 
Income group  
In this 
report (n) 
Advocacy for 
vaccination 
Vaccination in 
pharmacies 
Vaccination 
by pharmacists 
Training 
Required 
Access to 
records 
High  55.5% (25) 40.0% (18) 26.7% (12) 20.0% (9) 22.2% (10) 26.7% (12) 
Upper middle  22.2% (10) 15.6% (7) 8.9% (4) 6.7% (3) 6.7% (3) 6.7% (3) 
Lower middle  15.6% (7) 11.1% (5) 6.7% (3) 2.2% (1) 6.7% (3) 4.4% (2) 
Low  4.4% (2) 4.4% (2) 2.2% (1) 0% (0) 2.2% (1) 0% (0) 
 
 
OECD  
In this 
report (n) 
Advocacy for 
vaccination 
Vaccination in 
pharmacies 
Vaccination 
by pharmacists 
Training 
required 
Access to 
records 
OECD members  11.3% (22) 40.0% (18) 26.7% (12) 20.0% (9) 24.4% (11) 28.9% (13) 
Non-OECD members  51.1% (23) 31.1% (14) 17.8% (8) 8.9% (4) 13.3% (6) 8.9% (4) 
 
 
Total 100% (194) 100% (45) 71.1% (32) 44.4% (20) 28.9% (13) 37.7% (17) 37.8% (17) 
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5.4 Country and territory specific information (survey) 
Argentina 
See case-study (Part 3) 
Australia 
See case-study (Part 3) 
Belgium 
See case-study (Part 3) 
Bolivia 
Pharmacists are involved in immunisation advocacy such as promoting vaccination and providing patient 
advice. They can also dispense vaccines in community pharmacies. Vaccination cannot be performed by 
pharmacists but can be performed by other healthcare professionals in pharmacies. 
Brazil 
In Brazil, the participation of pharmacists in immunisation activities and vaccine administration is still at 
early development; this area has always been considered an area for nurses, especially in the public service, 
and for doctors, in private practices. Nevertheless, significant developments have taken place in the last few 
years which are reinforcing the integration of pharmacists in immunisation activities. The Brazilian Federal 
Council of Pharmacy (CFF) believes that this will contribute to the increase in access to vaccinations by the 
population and to the redistribution of roles for healthcare professionals, which could lead to an impact in 
the market and vaccines prices. 
One of the most relevant governmental programmes, widely acknowledged, is the National Immunisation 
Programme (PNI), coordinated by the Ministry of Health. All the primary care units in Brazilian cities are 
structured to vaccinate the population and recording of the procedure is mandatory. The vaccination is 
recorded in a paper card which is attributed to all citizens at birth. The process currently has minor 
participation by pharmacists and is almost exclusively voluntary. Pharmacists tend to participate in 
immunisation promotion activities, providing advice to patients and public, participating in multi-
disciplinary campaigns as well as serving on immunisation advisory committees. 
There is great interest in Brazil to expand the role of pharmacists in immunisations. CFF believes that once 
the necessary conditions for the participation of pharmacists in the process of immunisation in Brazil are 
gathered, particularly after the amendment of the sanitary Resolution 44/2009, authorising the vaccination 
in public and private pharmacies and drugstores. 
Canada 
Administration of vaccines is authorised in pharmacies and by pharmacists in most provinces. Specific legal 
authorisation and requirements for pharmacy based vaccination varies across the 10 jurisdictions. In some 
provinces pharmacists can administer a range of vaccines e.g. influenza, hepatitis, HPV, chickenpox and 
rabies post-exposure. In Ontario, only influenza vaccination is authorised. Quebec is the only province that 
only authorises pharmacists to administer vaccines for demonstration/education purposes. 
From a public health perspective, a national immunisation strategy is one of the 3 top advocacy priorities for 
the Canadian Pharmacists Association (CPhA) and pharmacies have a great role to play in public health. 
Moreover, pharmacy-based vaccination is a very cost-effective channel for delivery and a good investment 
in the longer term. 
Regardless of what type of vaccine, pharmacists have to undertake enhanced training and pre-counselling 
with the patient prior to administration. In all 10 provinces across Canada, all pharmacists dispensing 
vaccines, whether they administer vaccinations or not, require electronic record keeping. Vaccination 
records are not nationally shared and they are kept in the community pharmacy. 
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The purchase of vaccines is performed through the Ministry of Health; public remuneration for flu vaccines 
is provided in all provinces. Regarding the vaccine distribution system currently in place, pharmacies are 
looking into cooperating with the government to be the central distribution mechanism to protect the cold 
storage requirements for vaccines. As pharmacies developed their immunisation services, in the early stages 
there were issues of misallocation of supplies e.g. the public health system would have too many vaccines in 
their storage facility but not enough for the pharmacy. Since pharmacies already have a very robust and 
efficient medicines distribution system they could expand their service to include public health distribution 
systems and even distribution for physicians. 
China 
Pharmacists are involved in some immunisation promotion activities such as providing information and 
advice to the public (benefits, adverse reactions, etc.) as well as identify, assess and advise high risk patients 
about their vaccination. There is a perception of limited acceptance and support by the government/health 
system as well as limited training availability to pharmacy professionals. 
Congo (Dem. Rep) 
It is in the public sector that pharmacists in Congo participate more actively in vaccination campaigns, 
storage, logistics and distribution of vaccines or as administration providers of vaccines. Vaccinations can 
be administered in pharmacies, although the process cannot be undertaken by pharmacists but only by 
other competent healthcare professionals. Moreover, pharmacies are not systematically integrated into the 
vaccination process; there are no specific measures for the participation in this activity e.g. no specific 
protocols, management recommendations or even space requirements for pharmacies. 
Nevertheless pharmacists practicing the public sector and who are associated with immunisation activities 
receive ongoing training, in addition to their undergraduate education in pharmacology and public health. 
The current training includes 30 hours on vaccination, patient advice, vaccine administration techniques, 
anaphylaxis and CPR. The Pharmac
vaccination activities and therefore delivery of continuous training is being considered. 
A combination of factors inherent to the pharmacist and to their usual commitment to traditional practices 
does not encourage pharmacy professionals to be more involved in immunisation activities. Furthermore, 
there is a perception that other healthcare professionals are still reluctant to accept and support this 
extended role. Appropriate training, 
acceptance and stimulate participation of these professionals to practice with the required competence. 
Costa Rica 
Pharmacists in Costa Rica are involved in immunisation advocacy and promotion activities and are also 
legally authorised to administer vaccinations. The professional administering the vaccine and the pharmacy 
owner have joint liability during the process and there are also specific requirements e.g. the physical 
environment, storage, the site where vaccines are administered, the cold chain, administration technique of 
injectable medicine, handling anaphylactic shock situations and disposal of infectious and contaminated 
material. 
Training in immunisation in not mandatory for pharmacists although there are both undergraduate and 
post-graduate/CPD opportunities in some circumstances. Certified CPD training is accredited by the College 
of Pharmacists of Costa Rica. 
Pharmacies may have access to vaccination records which can be stored both in paper or electronic format. 
Vaccine records are mandatory (although personal information is not) and have to be legally kept in some 
circumstances for up to ten years. The record system is not shared but this is currently in experimental stage; 
in the future, information will be share between professionals and/or health authorities to enable better 
integration of vaccination services. 
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Denmark 
Pharmacists are actively involved in vaccination promotion and advocacy, providing advice to patients and 
participating in multi-disciplinary campaigns. Vaccinations can be administered in pharmacies both by 
pharmacists or other healthcare professionals. The responsibility lies on the physician, and pharmacists are 
authorised to administer vaccinations un  
Approximately ten pharmacies have specially trained pharmacists and pharmacy technicians who undertake 
seasonal influenza and travel vaccination under a defined protocol. The training is mandatory and there are 
specific requirements from private companies for these professionals to undertake the CPD. Vaccination 
recording is mandatory for the patients receiving vaccination in pharmacies; details (patient and 
vaccine/vaccination) are kept in electronic format and are not shared outside the pharmacy domain. 
Ecuador 
Pharmacists do not tend to be actively involved in immunisation activities. Vaccination programmes are of 
the responsibility of the Epidemiology Service; hospitals and community pharmacists are not involved in 
these activities. 
immunisation including 
limited acceptance and support (including financial) by the government, health system, other healthcare 
professionals and the public. There is also limited training opportunities and consequent lack of confidence 
by pharmacists to undertake immunisation activities. 
Ethiopia 
Pharmacists are involved in vaccine supply, storage and distribution to other healthcare institutions. 
Vaccinations cannot be undertaken in pharmacies and/or by pharmacists although they participate in 
advocacy activities such as providing immunisation information and advice to the public. The main 
perceived limitation for the development of an expanded role is the limited acceptance and support by the 
government /healthcare system. 
Finland 
Pharmacists tend to participate in immunisation promotion activities, distributing leaflets and organising 
vaccination campaigns. They also identify and advise high-risk patient groups about their vaccinations as 
well as provide advice the the general public. Vaccinations can be administered in pharmacies by other 
healthcare professionals (nurses) under a prescription for vaccine requirement. The acting nurse is 
responsible for the vaccination process; a partner physician is legally responsible for the patient safety. There 
are also demanding requirements for the pharmacy premises and the application for authorisation to 
provide the vaccination service in the community pharmacy is complex and expensive. The requirement for 
a prescription and responsible physician, together with the requirement for premises, are two of the main 
perceived challenges for broadening the vaccination service by pharmacies in Finland, where only 1 % of 
pharmacies offer the vaccination service. Vaccines or vaccinations are not reimbursed in Finland and the 
pharmacy vaccination rates tend to be low since the service is not more widely available. The current 
legislation also makes it very difficult for pharmacies to offer the vaccination service. Therefore, the limited 
acceptance and support (including financial support) by the government and the healthcare system are two 
other perceived limitatio immunisation. In 2015, a 
working group was established for the development of pharmacy services; this group includes members 
from the government and has given a recommendation that Finnish pharmacies should be authorised to 
administer influenza vaccinations to patients. According to Association of Finnish Pharmacies, a change in 
the current legislation and the strict vaccination requirements (e.g. prescription requirement) is essential to 
enable pharmacy-based influenza vaccination; this would be considered as an important step towards a 
broader influenza vaccination service provision and consequent higher immunisation rates among Finnish 
people. 
France 
See case-study (Part 3) 
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Germany 
Pharmacists do not tend to be actively involved in immunisation activities. There is no significant 
participation in advocacy and vaccine promotion campaigns, although some pharmacists may have access 
to vaccination records if, for example, the patient needs advice. This does not happen on a regular basis since 
vaccination activities are mostly attributed to physicians. There are several perceived limitations to the 
immunisation including limited acceptance and support (including 
financial) by the government, the health system, other healthcare professionals and the public. 
Hong Kong, China 
Pharmacists do not tend to be actively involved in immunisation activities. There is a great interest to expand 
the role of pharmacists to provide immunisation services to the public. However, the current legislation does 
not define the role and responsibility for pharmacists in this area. Moreover, there is limited acceptance and 
support by other healthcare professionals, including nurses and physicians. 
Hungary 
The present legislation does not authorise pharmacists to undertake any immunisation activities. As all 
vaccines are prescription only medicines, the process is exclusive to physicians and the 
advertisement/promotion of vaccination by pharmacists or in pharmacies is completely prohibited. For this 
reason, pharmacists do not tend to be actively involved in immunisation activities. Training in immunisation 
is also limited and the topic is underrepresented both in the undergraduate and postgraduate curricula, 
during which the students only learn about compulsory vaccines. Nevertheless, more formal immunisation 
training is now starting to be included in further postgraduate education programmes. 
Iceland 
Pharmacists do not tend to advocate for immunisation/vaccination. Administration of influenza vaccine can 
be performed in pharmacies by other healthcare professionals under a prescription and payment 
requirement. It is mandatory for a physician to be responsible for the vaccination service. The main perceived 
immunisation are the limited acceptance and support 
by the government, the health system and other healthcare professionals as well as limited training 
opportunities for pharmacists. 
India 
Pharmacists do not tend to be actively involved in immunisation activities. Only a few participated in the 
Pulse Polio Campaign established by the Government of India to eliminate poliomyelitis by vaccination of 
children under the age of 5. Immunisation (theoretical) is part of the pharmacy curriculum at undergraduate 
level; however, vaccine administration (practical) is not yet included in the training and education. 
Community pharmacists mainly undertake dispensing roles and other patient-centred roles are yet to be 
developed. 
Iraq 
Pharmacists participate in multi-disciplinary immunisation campaigns although it is prohibited to 
administrate vaccinations in pharmacies or by pharmacists. The main perceived limitation to the 
immunisation is the limited acceptance and support by the government, 
the health system and other healthcare professionals. 
Ireland 
See case-study (Part 3) 
Israel 
Pharmacists do not tend to be actively involved in immunisation activities. The main perceived limitation to 
immunisation is the limited acceptance and support by the 
government, the health system and other healthcare professionals; there are current initiatives in the 
attempt to address this issue. 
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Italy 
Pharmacists engage in some immunisation promotion activities such as distributing leaflets and organising 
immunisation campaigns. Vaccinations cannot be administered in pharmacies and/or by pharmacists and 
pharmacists do not have access to vaccination records; however, there are current discussions in this respect 
immunisation is the limited financial support from the 
government/healthcare system. 
Japan 
Pharmacists engage in some immunisation promotion activities such as distributing vaccination leaflets and 
providing information and advice to the public about the importance of vaccination. Administration of 
vaccines cannot be undertaken in pharmacies or by pharmacists. The main perceived limitation for the 
immunisation is the limited acceptance and support by the 
government/healthcare system. 
Jordan 
Pharmacists are involved in immunisation promotion activities such as distributing vaccination leaflets and 
providing information and advice to the public. 
Lebanon 
Pharmacists in Lebanon do not tend to advocate for immunisation/vaccination policies; furthermore, patient 
awareness and promotion campaigns of these activities are very limited. Vaccination initiatives involving 
pharmacists are mainly focused in flu vaccination campaigns. 
Under the Lebanese law, vaccination in pharmacies can only be undertaken by trained healthcare 
professionals (nurses or doctors) and is mainly performed by doctors. There is no legal protection for the 
pharmacist role as immuniser. Moreover, there are several factors affecting and limiting the development of 
immunisation activities in community pharmacies; these include the lack of national pharmacy-
immunisation awareness campaigns, the requirement for a vaccination prescription and also the absence of 
immunisation protocols and guidelines for community pharmacies. 
Regarding the purchasing, storage and supply of vaccines, the Lebanese law states that pharmacists must 
be the responsible healthcare professionals for the purchase from wholesalers, storage and the supply of all 
medications including vaccines. Law-abiding in this respect is pivotal to ensure that high quality cold chain 
practicing of the profession of pharmacy, published in August 1994, community pharmacies must be 
equipped with a well maintained fridge for storage of all medications that specifically require low storage 
temperatures to ensure the quality of product (Article 27). These include vaccines, hormones, serums and all 
other medical ingredients withdrawn from humans and animals (Article 36). 
Pharmaceutical companies and distributors are forbidden to sell or distribute the above medicines to other 
than pharmacies or drugstores (Article 78); the breaching of this law can be punished by prison sentence from 
two to six months and a penalty of 6 to 20 million Lebanese pounds; in the event of repeated infraction, the 
license of pharmaceutical wholesaler can be withdrawn from the owner (Article 87). Moreover, all physicians 
are forbidden to sell or supply any of these medications (Article 35); patients must therefore purchase 
vaccines from community pharmacies and have them administered by an authorised healthcare 
professional. 
Pharmacists in Lebanon do not receive formal immunisation training and they are not authorised by law to 
administer vaccines. There is also very limited information and guidance regarding training and qualification 
opportunities for pharmacists as immunisation providers. Nevertheless, Lebanese pharmacists are very 
eager to receive formal training and to actively participate in the provision of immunisation services and 
other healthcare roles. 
Vaccination records are not currently collected, maintained nor managed in a formal manner by pharmacies 
or other healthcare providers. The Ministry of Health collects records from non-profit organisations offering 
immunisation services; however, the available information does not represent complete national figures. 
Recently, the Ministry of Health introduced a system of unified prescriptions which consist of three copies: 
one is kept by the physician; the patient keeps one copy and delivers the remaining copy to the community 
pharmacy. 
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Unified prescriptions are available in paper format and electronic records have not yet been developed; 
moreover, there is currently very limited understanding on how the information kept and available from 
unified prescript
sometimes undertaken by some community pharmacies; however, there are no specific guidelines, protocols 
or requirements for undertaking this activity. 
Limited advocacy campaigns have taken place to obtain vaccination rights for pharmacists in Lebanon; this 
has been particularly associated with the absence of an association linking and representing all community 
pharmacies and pharmacists. Recently, the Order of Pharmacist in Lebanon (OPL) was granted the approval 
for the initiation of a community pharmacy owners committee; this is a major step in moving advocacy 
activities forward and it will significantly contribute to raising awareness of the great potential of 
pharmacists as essential healthcare providers. 
Inter-professional collaborations to support immunisation in the community are also very unusual in 
Lebanon.  
Pharmacists do not receive any formal immunisation training and have therefore limited understanding of 
the importance of collaborating with other healthcare professionals to contribute to the mutual goal of 
increasing immunisation coverage and rates. Moreover, there is limited acceptance and support by the 
government and other healthcare professionals for the development of pharmacy-based vaccination 
services. The situation is further aggravated by the insufficient financial support and lack of confidence by 
pharmacists to perform immunisation services and activities. It is therefore essential to further develop 
immunisation. 
As described above, there is a great opportunity to further develop the role of pharmacists in immunisation 
in Lebanon. Community pharmacies can strongly contribute to efficient vaccination storage and supply 
systems as well as patient monitoring and advice. Pharmacies are the first and last line of contact with 
patients, the trust and confidence in pharmacists as leading professionals across the healthcare sector is 
very solid suggesting the need for the profession to be more engaged in vaccination activities. 
Nevertheless, the immunisation debate depends on successful promoting of legislatures by national and 
pharmacy associations and is likely to increase the numbers of pharmacists receiving training to administer 
adult vaccinations and therefore making a real contribution on public health. Greater efforts are required to 
develop promotional activities to a more professional and solid level, to increase awareness and to 
 
Netherlands 
Pharmacists tend to participate in immunisation promotion activities, distributing leaflets and providing 
advice to patients and the public. They also identify and advise high-risk patient groups as well as people 
travelling to risk areas requiring immunisation. Vaccinations can be administered in pharmacies by nurses; 
the legal accountability for the vaccination process lies on the professional administering the vaccine and 
the process needs to follow specific guidelines. 
Pharmacists have access to a range of vaccination electronic records; they can verify immunisation statuses 
(optional) as well as information on the vaccine and vaccination administration process (mandatory). 
Records are kept for up to 10 years in electronic format and are shared between all healthcare professionals. 
level. Some perceived limitations to the further development immunisation include 
limited financial support by the government/healthcare system, lack of patient demand/acceptance and lack 
of confidence by pharmacists to perform further immunisation services and activities. 
New Zealand 
Pharmacists are actively engaged in immunisation advocacy activities by distributing vaccination leaflets 
and organising and/or participating in multi-disciplinary vaccination campaigns. They also provide 
immunisation information and advice to patients, identifying high risk patient groups, verifying their 
vaccination status and reminding them when their next vaccination is due. 
Pharmacists take part and support national immunisation activities, providing information to individuals on 
request. The Pharmacy Guild of NZ provides advertising and campaign materials, as organises the national 
Immunisation Advisory Centre (IMAC). 
Administration of vaccines can be undertaken in pharmacies by trained pharmacists. The authorisation of 
vaccinators in New Zealand is in accordance with the Medicines Regulations 1984, clause 44A(2). The Director-
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ise any person to administer a vaccine (which is a 
prescription medicine) for the purposes of an approved immunisation programme. The responsibility for the 
vaccination lies on the pharmacist administering the vaccine and the process follows specific requirements: 
Premises 
 Room layout  privacy space etc. 
 Vaccine storage & stock  cold chain, supplies 
 Emergency equipment  oxygen, resuscitation equipment 
 Appropriate resources are available 
Protocols 
 Consent forms 
 Information 
 pre-vaccination check list 
 Vaccine preparation, site, needle angle and vacinee positioning 
 Safety for vaccinators  waste management  
 Post vaccination advice 
Training 
Becoming a vaccinator is a voluntary professional development since not all pharmacies offer a vaccination 
service.; however it may be required by some employers. 
The vaccine classification requirements for a pharmacist vaccinator require the pharmacist to complete a 
Ministry of Health-approved education update course every two years (refer to Appendix 3: Immunisation 
standards for vaccinators, Standards 1.3 and 1.4). 
Pharmacist vaccinators will be required to: 
1. 
 
2. maintain a summary of their immunisation practice over the past 12 months. 
Prior to the expiry of their previous course, pharmacists will need to complete an approved update course to 
be able to continue vaccinating. Pharmacists who are immunisation providers need to ensure that they are 
using, complying and keeping up-to-date with the current requirements as outlined in the electronic edition 
of the Immunisation Handbook. This information can be found on the Ministry of Health website. 
course and meet the requirements in standards set by the Ministry of Health. Vaccinator training, available 
through the Immunisation Advisory Centre, is comprehensive, and involves a choice of a two-day course or a 
flexible learning course, requiring 12 hours self-guided study followed by a four hour face-to-face clinical 
tutorial. 
To become authorised, the person must complete the training, achieve a pass mark of 80% on an open book 
test, and be clinically assessed on a minimum of two vaccinations relevant to their clinical area. Updates for 
trained vaccinators can be either four hours face-to-face or conducted on-line every two years. Alternatively, 
Pharmacists wishing to administer influenza vaccines only can attend a one-day influenza only course and 
clinical assessment. 
Applicants applying to become an authorised vaccinator must complete the following. 
1. Demonstrate that within the preceding 12 months they have attended, completed and passed a 
vaccinator training course that meets the current Standards for Delivery of Vaccinator Training Courses 
published by the Immunisation  
a. a minimum  
b. a written test (minimum one-hour duration consisting of a combination of multiple choice and short 
 
2. Following successful completion of the course, the applicant will undergo an independent clinical 
assessment by an immunisation coordinator or an approved assessor (as agreed by the medical officer of 
health). Information about the practice environment will be collected at the time of this assessment. 
3. Provide evidence that they hold a current practicing certificate. 
4. Achieve and maintain specified resuscitation requirements for vaccinators, at a standard equivalent to 
that set for NZRC Rescuer Level 4. 
 infant, child and adult Cardiac Pulmonary Resuscitation (CPR) including mouth-to-mouth, mouth-to-
mask and the management of choking 
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 use of airway adjuncts, including the sizing and insertion of oropharyngeal and laryngeal mask 
airways 
 use of an Automated External Defibrillator 
 one- and two-person bag valve mask ventilation and mouth-to-mask technique 
 use of supplemental oxygen. 
Vaccine types available through pharmacy 
 Vibrio cholerae and enterotoxigenic Escherichia coli vaccine (prescription medicine; except in the 
form of an oral liquid containing inactivated Vibrio cholerae and / or its subunits when sold in a 
pharmacy by a registered pharmacist.) 
 Influenza vaccine (prescription medicine; except when administered to a person 13 years of age or 
over by a registered pharmacist who has successfully completed a vaccinator training course 
approved by the Ministry of Health and who is complying with the immunisation standards of the 
Ministry of Health. 
 Diphtheria, tetanus and pertussis (acellular, component) vaccine (Tdap) (a prescription medicine; 
except when administered in a single dose to a person 18 years of age or over by a registered 
pharmacist who has successfully completed a vaccinator training course approved by the Ministry 
of Health and who is complying with the immunisation standards of the Ministry of Health.) 
 Meningococcal vaccine  a prescription medicine; except when administered to a person 16 years of 
age or over by a registered pharmacist who has successfully completed a vaccinator training course 
approved by the Ministry of Health and who is complying with the immunisation standards of the 
Ministry of Health. 
 Varicella (shingles) vaccine (prescription medicine; except when administered for the prevention of 
herpes zoster (shingles) to a person 50 years of age or over by a registered pharmacist who has 
successfully completed a vaccinator training course approved by the Ministry of Health and who is 
complying with the immunisation standards of the Ministry of Health.) 
Vaccination records 
Mandatory vaccination records are kept in paper format, with a local pharmacy site based electronic record 
only. The information recorded includes patient, vaccine and vaccination details as well as pre-vaccination 
check details (e.g. contraindications, cautions, etc.). 
Vaccination records are kept for a minimum of 10 years according to the Health (Retention of Health 
Information) Regulations 1996  
about the vaccination undertaken in their premises and the record may be uploaded into the National 
Register. 
Perceived limitations and challenges 
Currently there is limited financial support by the government and healthcare system. There is no 
government funding for any vaccine administered in pharmacy, although some private medical insurance 
companies may provide some form of reimbursement. Moreover, there is limited acceptance by other 
healthcare professionals. 
The New Zealand Government has set a clear policy direction for delivering health services within a more 
integrated model. New approaches to immunisation encourage clinical integration and collaboration 
between providers to increase the pool of vaccinators, improve access to vaccination and deliver improved 
services. 
Nigeria 
Pharmacists in the private sector tend to advocate for immunisation by distributing vaccination leaflets and 
organising and/or participating in vaccination campaigns. They can also provide immunisation information 
and advice to patients, identifying high risk patient groups, verifying their vaccination status and reminding 
them when their next vaccination is due. Administration of vaccines cannot be undertaken in pharmacies 
and/or by pharmacists; this has been a great limitation to the vaccine uptake in Nigeria since patients often 
change their mind after having been advised by their pharmacists to get their vaccinations and then they 
have to go elsewhere for the vaccine administration. 
Nevertheless pharmacies can store and sell vaccines. Pharmacists also have access to some vaccination 
records through the vaccination cards that are given to all patients. The information is recorded on an 
tion and advice about 
their vaccination status. 
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There are a few training opportunities available for pharmacists although this is not mandatory. General or 
comprehensive training in immunisation is delivered by the LiveWell Initiative in partnership with the 
American Pharmacists Association (APhA) over 2 days (8 hours/day). Contents include patient advice, vaccine 
administration technique, anaphylaxis, etc. 
immunisation include 
limited acceptance and support by the government/healthcare system as well as limited access to training 
opportunities for pharmacists. 
Norway 
Pharmacists do not tend to be actively involved in immunisation activities. There are several perceived 
limita immunisation including limited acceptance and 
support (including financial) by the government, health system and other healthcare professionals. 
Pakistan 
Some pharmacists in Pakistan advocate for immunisation by distributing vaccination leaflets, organising 
and participating in multi-disciplinary vaccination campaigns and serving on immunisation advisory 
committees. They also provide immunisation information and advice to patients, identifying high risk 
patient groups, verifying their vaccination status and reminding them when their next vaccination is due. 
Nevertheless, the level of engagement in immunisation advocacy activities can vary across the country and 
across pharmacies. On a national level, only a few pharmacies participate in activities to promote and 
support vaccination. 
Pharmacies in Pakistan are legally authorised to provide immunisation services although in 90% of the cases, 
vaccination tend to be undertaken by nurses and doctors in clinics and hospitals. The administration of 
vaccines in pharmacies is undertaken by nurses and doctors and the legal accountability for this process lies 
on the pharmacy manager or owner. Most of the vaccines from the Childhood Immunisation Schedule are 
funded through WHO, including Polio, BCG, Measles, Pneumococcal and (DPT+HIB+ Hep B). Vaccines for other 
communicable diseases (such as pneumonia, flu, meningitis, chickenpox, rubella, hepatitis A and B, typhoid 
and rabies) are also available but they are not covered by any funding schemes. According to WHO, Pakistan 
does not meet the optimal requirement of 80% or higher immunisation rate and this is perceived to be due 
to high poverty and low literacy rate throughout country. 
Pharmacies can have access to some vaccination records although is the majority of settings they are not 
shared with the pharmacist. Records can be kept in paper and/or electronic format in an immunisation 
record system/computerised physician order system. In some centres, vaccination record keeping is 
details as well as information about the vaccination administration procedure. Currently there is no 
specification on how long these records must be kept for. 
Pharmacists in Pakistan are not directly involved in the administration of vaccines and they do not currently 
receive any form of comprehensive or structured training. Nevertheless, immunisation is a subject included 
in the undergraduate pharmacy curriculum. There are also online training opportunities for pharmacy 
professionals wishing to advance the knowledge in this area of practice. For example, the Aga Khan 
University Hospital provides online immunisation training delivered by the Collaborative Education Institute 
(CEI); in addition, pharmacists can also undertake the Basic Life Support training through the American Heart 
Association (AHA). The available online training is not mandatory and there is no specific recognition, 
accreditation or credentialing by a recognised regulatory authority. 
immunisation are the limited 
acceptance and support (including financial) by the government and the health system as well as limited 
access to training opportunities for pharmacists. Recently, global health leaders called for increased political 
support for immunisation in Pakistan in the attempt to ensure that children do not die from a vaccine-
preventable disease. The lives of millions of children across Pakistan are at risk because of limited access to 
vaccines. Advocacy initiatives for the development of immunisation services in community pharmacies 
continue. 
Paraguay 
Pharmacists do not tend to be actively involved in immunisation activities. The main perceived limitation to 
ss to training opportunities. 
The Association of Pharmaceutical Chemists of Paraguay has attempted several times to advocate for 
administration of vaccines in community pharmacies; this would be of extreme advantage since, to date, 
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vaccination campaigns (especially seasonal influenza) usually see an excess of vaccines that are not 
administered  pharmacists could have an essential role to increase vaccination promotion, accessibility and 
uptake. 
Philippines 
See case-study (Part 3) 
Poland 
Pharmacists tend to participate in immunisation promotion activities, distributing leaflets and providing 
advice to patients and the public taking into consideration their age and health status. They also take part in 
several multi-disciplinary campaigns as well as serving on immunisation advisory committees. The main 
immunisation is the limited 
acceptance and support from the government/healthcare system. 
Portugal 
See case-study (Part 3) 
Russia 
Pharmacies can provide information about immunisation through posters, special booklets, general 
consultations etc. The information usually includes the basic principles, benefits and risks of the 
immunisation process as well as details on how, when and where the immunisation service is undertaken. 
immunisation including 
limited acceptance and support (including financial) by the government, the health system and other 
healthcare professionals. There is also limited access to training opportunities for pharmacists. 
Senegal 
Pharmacists tend to advocate for immunisation by providing information and advice to patients and to the 
general public; they can also verify their vaccination status and remind them when their next vaccination is 
due. Vaccinations cannot be undertaken in pharmacies and/or by pharmacists. 
All pharmacy undergraduate students receive training in immunisation/vaccination during their Pharmacy 
degree; there are also post-graduate training opportunities although these are not mandatory. Training 
courses are provided under the auspices of the College of Pharmacists. Training contents focus mainly on 
the vaccination policy and vaccination schedules. 
Children (from the first prenatal visit from their mothers and until their teens) receive a health card which is 
kept by their parents. The booklet enables health monitoring during pregnancy, at birth and childhood (e.g. 
growth monitoring, vaccinations, etc.). Although pharmacists have no direct access to these individual heath 
record booklets parents can use the information to request vaccination advice. 
support (including financial support) by the government and the healthcare system. Moreover, pharmacists 
training opportunities in this area are also very limited. 
South Africa 
See case-study (Part 3) 
Spain 
Pharmacists tend to advocate for immunisation in Spain by distributing vaccination leaflets and organising 
and/or participating in multi-disciplinary vaccination campaigns. They also provide immunisation 
information and advice to patients, identifying high risk patient groups, verifying their vaccination status 
and reminding them when their next vaccination is due. Vaccinations cannot be undertaken in pharmacies 
and/or by pharmacists and there is also no access to vaccination records. Nevertheless, all pharmacy 
undergraduates receive training in immunology/vaccination during their Pharmacy degree. 
Moreover, there are several continuous professional development activities, aimed at updating the 
knowledge of immunisation/vaccines, available for all the pharmacists interested. These CPD activities are 
not mandatory; however, pharmacists must ensure that they are up-to-date in this area in order to be able to 
provide accurate information on medicines to the population they serve. 
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CPD activities tend to be accredited and recognised when the activity has been successfully completed. A 
variety of courses is available in this subject and so there is not a specific official training currently offered. 
immunisation is the current 
legislation since it does not recognise the administration of vaccines by pharmacists. 
Switzerland 
See case-study (Part 3) 
United Arab Emirates 
Pharmacists cannot administer vaccinations; however, they can be involved in controlling the inventory, 
ordering, purchasing and the distribution of vaccines as part of the service provided by the Ministry of Health 
(MoH). Pharmacist working in the MoH-preventative department support the national immunisation 
programme supply chain and related campaign at national level. 
immunisation including 
limited acceptance and support (including financial) by the government, the health system, other healthcare 
professionals and the public. There is also limited access to training opportunities for pharmacists. 
Ukraine 
Pharmacists do not tend to be actively involved in immunisation activities. According to the Ukrainian 
legislation, the activities related to immunisation can only be undertaken in hospitals, following the national 
immunisation schedule approved by the Ministry of Health. 
United Kingdom 
See case-study (Part 3) 
United States of America 
See case-study (Part 3) 
Uruguay 
Pharmacists do not tend to be actively involved in immunisation activities; the governmental vaccination 
scheme is very good and easily accessible. The main perceived limitation for the further development of 
immunisation is the lack of patient demand/acceptance. 
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